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ABSTRACT 
 
Factors Regulating 
Arteriolar Tone during Microvascular Growth 
 
Julie Balch Samora 
Growth of the arteriolar network is accompanied by progressive changes in 
pressure and flow, and in the metabolic environment to which the arterioles are exposed.  
This dissertation was carried out to investigate the extent to which mechanisms involved 
in local blood flow regulation may also change during this growth.  We isolated gracilis 
muscle arterioles from weanling (age 25-26 days) and juvenile (44-66 days) rats, and 
studied the responsiveness of these vessels to both myogenic and endothelium-dependent 
stimuli.  Overall arteriolar responses to the endothelium-dependent agonists acetylcholine 
(ACh), A23187, VEGF and simvastatin were not different between age groups.  
Responses of juvenile arterioles to ACh and simvastatin were significantly reduced by 
inhibition of nitric oxide synthase or cyclooxygenase, by the hydrogen peroxide 
scavenger catalase, and by potassium channel inhibition.  Responses of weanling 
arterioles to ACh and simvastatin were unaffected by these treatments, but significantly 
reduced by heme oxygenase inhibition.  Arteriolar growth during juvenile maturation is 
accompanied by an increase in myogenic responsiveness, possibly because endothelium-
derived PGH2 or TXA2 assumes a role in reinforcing myogenic activity over this period.  
In conclusion, mediators of endothelium-dependent dilation change during growth, with 
carbon monoxide contributing largely to these responses in young animals, and a 
combination of nitric oxide, prostanoids and hydrogen peroxide contributing to these 
responses in older animals.  These data suggest that age-dependent differences in the 
control of vascular tone exist and may have significant implications for the regulation of 
tissue perfusion.  
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 I. LITERATURE REVIEW 
 
1.  Introduction 
 
 
The cardiovascular system is comprised of the heart, blood vessels, and blood.  As 
early as the 2nd Century AD, Greek physician Galen of Pergamum studied this complex 
circulatory system and proposed that blood was made in the liver, pumped by arterial 
pulsations, passed from one side of the heart to the other via invisible pores in the 
dividing membrane, and was delivered to the organs of the body where it was consumed, 
rather than recycled to the heart.  He also strongly argued that the venous and arterial 
systems were separate.  Galen’s teachings remained relatively unchallenged for centuries.  
It was not until 1628 that English physician William Harvey correctly described how 
blood was pumped around the body by the heart before returning to be re-circulated in a 
closed system (Harvey, 1628).   
The cardiovascular system is responsible for transporting nutrients, water, 
electrolytes, hormones and oxygen (O2) to organs and cells within the body, and 
eliminating products of metabolism, such as carbon dioxide (CO2) and ammonia (NH3).  
It not only functions as a transport system, but also contributes to homeostasis by 
maintaining body temperature, regulating body pH, increasing blood flow to meet energy 
demands, transmitting antibodies and white blood cells to sites of infection, and 
mediating hemostasis (Sherwood, 2007). 
The large elastic and muscular arteries transport blood from the heart to the 
organs and serve as a pressure reservoir.  The muscular arterioles are the major resistance 
vessels in the vascular tree and determine, by changes in vessel caliber, the amount of 
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 blood that flows to a given tissue (Bevan, 1987; Segal, 2000; Hester & Hammer, 2002).  
Although multiple factors influence microvascular tone, such as circulating hormones, 
physical forces, sympathetic input, and local chemical changes, this dissertation will 
focus on vascular smooth muscle (VSM) and endothelial cell function in skeletal muscle 
arterioles.  The following literature review will highlight the fundamental importance of 
endothelium-derived autacoids, myogenic activity, reactive oxygen species (ROS), and 
carbon monoxide (CO) to vascular function.  The experimental approaches taken to study 
each of these areas will also be explored.  It will conclude with a discussion on how 
vascular function changes with postnatal growth and maturation.   
 
2.  Mechanisms of Vascular Control 
 
A. Endothelium-Dependent Control of Vascular Tone 
1. General Aspects   
The vascular endothelium, which lines the lumenal surface of all vessels, lies 
between the circulating blood and the VSM.  Only a few decades ago, the endothelium 
was considered to have few functional properties.  It is now well documented that the 
endothelium is a regionally specific, multifunctional organ that plays a pivotal role in 
maintaining cardiovascular homeostasis, and that can also contribute to the pathological 
mechanisms of numerous cardiovascular diseases (Rubanyi, 1993).  The multiple duties 
performed by the endothelium include endocrine, exocrine, cell adhesion, clotting, 
growth, remodeling, and transport functions, provision of a physical permeability barrier, 
mediation of inflammatory responses, modulation of VSM tone, and adaptation to 
intermittent hypoxia (Lew et al., 1989; Pohl & Busse, 1990; Manukhina et al., 2006; 
 2
 Pries & Kuebler, 2006; Sherwood, 2007).  In 1980, Furchgott and Zawadzki were the 
first to report their in vitro observations that vasodilation to some agonists is dependent 
on an intact and healthy endothelium (Furchgott & Zawadzki, 1980).  Consequently, 
endothelial dysfunction can lead to vasospasm, thrombosis, atherosclerosis, restenosis, 
and an impaired ability to reduce vascular resistance (Rubanyi, 1993; Rongen et al., 
1994). 
The vascular tree consists of arteries, arterioles, capillaries, venules and veins, all 
of which are lined with a thin layer of smooth, flat endothelial cells.  Conduit arteries 
differ from resistance arteries in size and function, as well as local environment (Agewall 
et al., 2006).  Whereas arteries are thick, highly elastic and have large radii, arterioles are 
highly muscular, and have well-innervated walls and small radii (Sherwood, 2007).  
Furthermore, Joannides and colleagues (2006) demonstrated a great heterogeneity of 
mechanisms and alterations in vasomotor responses between conduit and resistance 
arteries in various disease states suggesting the presence of different pathophysiological 
processes and degrees of alteration in endothelial function.  Others have established that 
even though endothelial dysfunction occurs at the level of both conduit and resistance 
arteries in hypertension and coronary artery disease, the kinetics of these alterations 
differs (Anderson et al., 1995; Neunteufl et al., 2000; Park et al., 2001).  For example, 
alteration in endothelial function occurs earlier in resistance arteries than in conduit 
arteries in atherosclerosis (Joannides et al., 2006), and acetylcholine induces less 
vasodilation in resistance arteries and constriction in conduit arteries in hypertension 
(Zeiher et al., 1991; Houghton et al., 1998; Belhassen et al., 2001). 
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 One of the ways in which the endothelium regulates cardiovascular homeostasis is 
through the release of multiple factors that influence permeability and vascular tone 
(Kubes, 1995).  The three main vasodilators which are released by the endothelium are 
endothelium-derived relaxing factor (EDRF, also known as nitric oxide (NO)) (Furchgott 
& Vanhoutte, 1989), prostacyclin (PGI2) (Moncada et al., 1976), and endothelium-
derived hyperpolarizing factor (EDHF) (Chen et al., 1988; Feletou & Vanhoutte, 1988).  
These mediators can function independently or can operate together in a complex, but 
integrated manner to regulate vascular tone (Villar et al., 2006).  For example, PGI2 can 
facilitate NO release from endothelial cells (ECs) and NO can activate PGI2 synthesis 
(Davidge et al., 1995).  However, there is no uniform contribution of these dilators 
between vascular beds or species.  Sometimes the contribution of PGI2 and EDHF to 
endothelium-dependent relaxation is only evident after NOS inhibition or in the absence 
of NO (Feletou & Vanhoutte, 1996; Beverelli et al., 1997; Wu et al., 2001).    Although 
NO appears to be the predominant vasodilator in some conduit vessels (Villar et al., 
2006), investigators have demonstrated that as the size of the vessel diminishes, the 
contribution that EDHF makes to endothelium-dependent dilation increases (Shimokawa 
et al, 1996).   
Several other endothelium-derived vasoactive factors can be released, including 
adenosine triphosphate (ATP), adenosine diphosphate (ADP), serotonin, substance P, 
various cytochrome P450 (CYP) metabolites, adenosine, and a host of endothelium-
derived contracting factors (EDCFs) that include endothelin (ET) and various arachidonic 
acid (AA) metabolites such as Prostaglandin H2 (PGH2) and thromboxane A2 (TxA2) 
(Furchgott & Zawadzki, 1980; Furchgott & Vanhoutte, 1989; Marshall & Kontos, 1990; 
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 Dai et al., 1992; Huang & Koller, 1997).  These multiple endothelium-derived vasoactive 
factors can be released in response to numerous stimuli, including hemodynamic shear 
stress, decreases in perivascular PO2, angiotensin II (Ang II), vasopressin, thrombin, 
cytokines, autonomic and sensory stimulation, hormones, thrombin, temperature changes, 
vascular endothelial growth factor (VEGF), and increases in metabolic demand (Rubanyi 
et al., 1986; Pohl & Busse, 1989; Vanhoutte, 1989; La & Reid, 1995). 
  
2. Nitric Oxide 
 
Nitric Oxide (NO), originally named Endothelium-Derived Relaxing Factor 
(EDRF) before its chemical nature was determined (Furchgott & Zawadzki, 1980), was 
the first gas to be identified as an endogenously generated cell signaling and effector 
molecule (Ignarro et al., 1987).  NO regulates blood flow, affects glucose uptake into 
muscle fibers, and inhibits glycolysis, mitochondrial respiration, creatine kinase and 
muscle contraction (Reid, 1998).   
NO is produced by conversion of L-Arginine to L-Citrulline via a five-electron 
oxidation by the enzyme nitric oxide synthase (NOS) (Palmer et al., 1988).  This reaction 
requires three substrates: L-arginine, O2, and nicotinamide adenine dinucleotide 
phosphate (NADPH), and four cofactors: tetrahydrobiopterin (H4B), calmodulin (CaM), 
flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) (Sessa et al., 1992; 
Griffith & Stuehr, 1995). 
NO initiates relaxation of the VSM by activating soluble guanylyl cyclase (sGC) 
(Hobbs, 1997), which causes a rise in cyclic guanosine 3’, 5’-monophosphate (cGMP) 
(Furchgott et al., 1984).  cGMP acts as a second messenger in a variety of physiological 
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 processes, including vasodilation and neuronal signal transduction (Collier & Vallance, 
1989).  cGMP can activate cGMP-dependent protein kinase G (PKG), phosphorylate heat 
shock protein (Hsp) 20 (Brophy et al., 2002), and can hyperpolarize the smooth muscle 
by opening calcium-activated potassium (KCa) channels (Carrier et al., 1997).  This in 
turn leads to inhibition of voltage-gated Ca2+ (VGC) channels and decreased entry of 
Ca2+ into cells.  In smooth muscle, the drop in intracellular calcium [Ca2+]i leads to 
relaxation (Carvajal et al., 2000).   
There are three major isoforms of nitric oxide synthase: NOS1 (neuronal, nNOS), 
NOS2 (inducible, iNOS), and NOS3 (endothelial, eNOS) (Forstermann et al., 1998).  
eNOS and nNOS are considered constitutive, meaning they are present and active under 
normal, steady-state conditions.  The NOS enzymes are dimers consisting of two 
identical myristoylated and palmitoylated subunits; only the dimer is able to bind 
substrate and cofactor (Fleming & Busse, 1999).  The eNOS enzyme is controlled both 
via transcriptional and post-translational regulation.  Post-translational regulation 
includes Ca2+/CaM binding, fatty acid modification (myristoylation/palmitoylation), 
alterations in intracellular translocation, substrate and cofactor bioavailability, 
dimerization, binding to cofactors, and phosphorylation (Musicki & Burnett, 2006). 
There are at least two distinct signaling pathways for eNOS activation in the 
endothelium: Ca2+-dependent and Ca2+-independent activation (Fleming & Busse, 1999; 
Ungvari et al., 2001; Wyatt et al., 2004).  Receptor-dependent agonists such as ACh, 
adenosine, ATP, and bradykinin (BK) (Busse & Mulsch, 1990; Korenaga et al., 1993; 
Muller et al., 1999) and receptor-independent agonists such as calcium ionophores 
(Busse et al., 1993; Huang & Koller, 1996) stimulate eNOS in a Ca2+-dependent fashion.  
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 Activation of NOS coupled with Ca2+ release is transient and produces NO rapidly (Bredt 
& Snyder, 1990).  Although eNOS is the most sensitive NOS isoform to changes in 
intracellular Ca2+ levels (Luckhoff et al., 1988), it can also be activated by fluid shear 
stress without a sustained increase in [Ca2+]i (Ayajiki et al., 1996; Fisslthaler et al., 
2000).  This Ca2+-independent pathway involves activation of phosphatidylinositol 3-
kinase (PI3K) and serine (Ser) kinases Akt and protein kinase A (PKA), which cause 
phosphorylation of Ser1177 on eNOS, thereby increasing eNOS activity (Dimmeler et al., 
1999).   
 
3. Endothelium-Derived Arachidonic Acid Products 
 
Arachidonic acid, a polyunsaturated essential fatty acid that is cleaved from 
membrane phospholipids by phospholipases, is metabolized to eicosanoids by the 
cyclooxygenase (COX), lipoxygenase (LOX), or CYP monooxygenase pathways (Imig, 
1999).  The COX enzyme catalyzes the rate-limiting step in prostaglandin synthesis by 
converting AA to into prostaglandin H2, which can then be further metabolized to PGI2 or 
dinoprostone (PGE2) (Funk, 2001), both of which can relax VSM by stimulating either 
guanylyl cyclase (GC) or adenylyl cyclase (AC) (Gryglewski et al., 1988; Waldman & 
Murad, 1988).  PGI2 elicits its powerful vasodilation by stimulating a cell-surface 
receptor (IPR) which leads to increasing levels of cyclic adenosine 3’,5’-monophosphate 
(cAMP) and sequestration of Ca2+ (Vanhoutte & Scott-Burden, 1994; Tanaka et al., 
2004).  Whereas the primary products of LOX are multiple forms of leukotrienes (LTs) 
(Funk, 2001), the CYP enzymes form epoxyeicosatrienoic acids (EETs), 
dihydroxyeicosatrienoic acids (DiHETEs), and 19- and 20-hydroxyeicosatetraenoic acids 
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 (19- and 20-HETE, respectively) from AA (Roman et al., 2000).  These metabolites have 
been shown to play an essential role in regulating vascular function (Campbell & Harder, 
1999; Roman et al., 2000).  For example, EETs can modulate intracellular Ca2+ levels in 
endothelial cells resulting in hyperpolarization (Rueben et al, 2004), and 11,12-EET 
activates protein kinase A (PKA) leading to afferent arteriolar vasodilatation (Imig et al., 
1999).  Furthermore, whereas EETs dilate vessels by hyperpolarizing VSM cells through 
the activation of KCa channels (Roman et al., 2000), 20-HETE exerts its constrictor 
effects via KCa channel inhibition and subsequent depolarization of the VSM (Zou et al., 
1996; Harder et al., 1997).  Inhibition of endogenous 20-HETE production prevents the 
vasoconstrictor response to elevations in local PO2, suggesting that 20-HETE may serve 
as a vascular O2 sensor (Harder et al, 1996; Lombard et al, 1999a).  20-HETE can also 
mediate myogenic responses, as inhibition of its production in renal and cerebral 
arterioles reduces pressure-dependent myogenic tone (Harder et al., 1997; Roman et al., 
2000). 
 
4. Endothelium-Derived Hyperpolarizing Factors 
 
Not all endothelium-dependent relaxations can be fully explained by the release 
of either NO or vasodilator prostanoids (Feletou & Vanhoutte, 1996).  There are various 
relaxing factors which are named EDHF because of their role in hyperpolarizing VSM 
(Bolz, de Wit & Pohl, 1999; Ungvari & Koller, 2001).  Although several substances have 
been proposed, including cyclic AMP, c-type natriuretic peptide (CNP), metabolites of 
AA by CYP epoxygenase (such as EETs), hydrogen peroxide (H2O2), and potassium ion 
(K+) (Feletou & Vanhoutte, 1996; Edwards et al., 2000; Matoba et al., 2000; Campbell & 
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 Gauthier, 2002), only a few of these chemical factors have been conclusively determined 
to be EDHFs.  Of the identified EDHFs, the particular molecule(s) that contribute to the 
regulation of vascular tone can differ depending on vascular bed and species (Feletou & 
Vanhoutte, 1996). 
VSM hyperpolarization can also occur through the electrotonic spread of 
hyperpolarization from ECs to SMCs (Yamamoto et al., 1998; Emerson & Segal, 2000; 
Coleman et al., 2001; Sandow et al., 2002), perhaps via myoendothelial gap junctions 
(Edwards et al., 2000).  Electrical coupling between SMCs and ECs was demonstrated in 
isolated vessels by simultaneously impaling one EC and one SMC with microelectrodes.  
At rest and after challenge with ACh, membrane potentials were identical, suggesting that 
electrical signals conducted along the endothelium can be directly communicated to the 
SMCs (Emerson & Segal, 2000).  Still others have proposed that the rise in SMC Ca2+ 
generates a diffusion gradient that drives Ca2+ through myoendothelial cell junctions and 
into the endothelial cells, thereby initiating the synthesis of NO (Dora et al., 1997). 
 
5. Experimental Approaches for Studying Endothelium-Dependent 
Responses  
 
There are numerous experimental means that have been developed to study 
endothelium-derived responses.  Only those approaches relevant to this dissertation 
project are highlighted in this section.  As mentioned earlier, the release of endothelium-
derived vasoactive factors can be induced by numerous exogenously applied substances, 
including ACh, the calcium ionophore A23187, NE, ET, VEGF, simvastatin, as well as 
by physical forces, such as shear stress (Vanhoutte, 1989; La & Reid, 1995).  ACh 
 9
 activates eNOS by stimulating endothelial muscarinic receptors coupled to G-proteins, 
which then form inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), leading to 
an increase in [Ca2+]i.  Ca2+ then binds with CaM, promoting NADPH-dependent electron 
flux (Busse & Mulsch, 1990).  The calcium ionophore A-23187 promotes receptor-
independent entry of Ca2+ into ECs, which activates eNOS, thereby releasing NO to 
dilate vessels (Huang & Koller, 1996).   
Simvastatin and VEGF stimulate NO production independent of Ca2+, via 
activation of the PI3K/Akt pathway, leading to direct phosphorylation and increased 
activity of eNOS (Dimmeler et al., 1999; Kureishi et al., 2000; Shiojima & Walsh, 2002).  
This Ca2+-independent signaling pathway for eNOS activation can be inhibited by 
tyrosine kinase inhibitors such as erbstatin A (Ayajiki et al., 1996), and the Hsp90-
binding protein, geldanamycin (Fleming et al., 1997; Ungvari et al., 2001). 
NO production from all NOS isoforms can be inhibited in a concentration-
dependent manner by substituted L-Arginine analogs, such as NG- monomethyl-L-
arginine (L-NMMA), N-iminoethyl-L-ornithine (L-NIO), and Nω-Nitro-L-arginine 
methyl ester hydrochloride (L-NAME) (Rees et al., 1990).  As described above, NO is 
produced by conversion of the required substrate L-Arginine to L-Citrulline via a five-
electron oxidation by eNOS (Palmer et al., 1988; Sessa et al., 1992; Griffith & Stuehr, 
1995).  L-arginine, a positively charged guanidino group-containing basic amino acid at 
neutral pH which is involved in many physiological processes (Masic, 2006), must 
compete with the L-Arginine analogs for substrate binding (Moncada et al., 1991).  These 
analogs are reversible, as the inhibition can be overcome by exogenous addition of L-
Arginine (Rees et al., 1990).  AA epoxygenation reactions can be selectively inhibited by 
 10
 6-(2 proparglyoxylphenyl) hexanoic acid (PPOH), a synthetic acetylenic fatty acid (Wang 
et al., 1998; Imig, 1999).  PPOH inhibits the reaction of epoxide formation at 
arachidonate positions 11 and 12 by CYP4A2 and CYP4A3 isozymes, but does not 
inhibit the omega-hydroxylation reaction of CYP4A1 leading to 20-HETE formation 
(Wang et al., 1998).  To inhibit constrictor prostanoids, the prostaglandin 
H2/thromboxane A2 (PGH2/TxA2) receptor antagonist SQ-29548 can be utilized (Cseko, 
et al., 2004). 
The endothelium can also be removed to determine its role in mediating various 
vascular responses.  There are generally four different means of de-endothelialization: 
mechanical (inserting a wire, hair, or pipette tip into the vascular lumen to abrade the 
endothelium), physical (infusing distilled water through a vessel), chemical (investigators 
can use either Triton X-100 or saponin to eliminate endothelial responses) and enzymatic 
(via trypsin) (Uluoglu & Zengil, 2003).  With all of these methods, verification of 
endothelial elimination, either by functional or histologic assessment, must be performed. 
 
B.  Myogenic Control of Vascular Tone 
 
 
Local regulation of blood flow, as demonstrated by phenomena such as active 
hyperemia and reactive hyperemia, can occur largely through adjustments in arteriolar 
tone that do not rely on a functioning endothelium.  The myogenic response is an 
important example of such endothelium-independent behavior. 
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 1. Historical Background and Definition 
 
The myogenic “mechanism” or “response” was first described by Sir William 
Bayliss in 1902, when he noted that as pressure was raised inside the isolated dog carotid 
artery, “a powerful contraction took place in which the artery appeared to writhe like a 
worm…The reaction is…myogenic in nature” (Bayliss, 1902).  Other investigators, at the 
time unable to replicate his findings, shunned his hypothesis, and developed their own 
explanations for this phenomenon (Hooker, 1911; Anrep, 1912).  It was not until 1949 
that the myogenic mechanism was accepted when Folkow demonstrated in several 
vascular beds a sustained vascular tone in the absence of neural input (Folkow, 1949). 
The term myogenic response has traditionally referred to an alteration of vascular 
diameter in response to changes in intralumenal or transmural pressure (Johnson, 1964; 
D'Angelo & Meininger, 1994).  Contraction by VSM occurs when stretch is applied to 
the muscle, and conversely, relaxation occurs following a reduction in stretch (Johnson, 
1980; Su et al., 2003).  Myogenic activity contributes to vascular resistance and assists in 
the maintenance of a relatively constant blood flow and capillary hydrostatic pressure 
(Davis & Hill, 1999).  However, myogenic activity is only operational over a specific 
pressure range (Johnson, 1980; Falcone et al., 1993), and the magnitude of this activity 
varies depending on the vascular bed and branch-order of the vessel (Bouskela & 
Wiederhielm, 1979; Meininger et al., 1987).   
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2. Mechanisms 
 
The mechanisms by which VSM cells transduce a mechanical change (wall 
deformation or stretch) into first an electrical signal, then a chemical response, and finally 
a mechanical outcome (diameter change) are not completely elucidated.  However, most 
investigations converge on similar signaling pathways (See Figure 1 below).  An increase 
in transmural pressure (i.e. a rise in the pressure gradient across the vascular wall) causes 
the vessel wall to stretch, increasing the activity of stretch-activated ion channels (SAC), 
also referred to as mechanosensitive (MS) channels, in the VSM membrane (Sachs & 
Morris, 1998).  This increase in MS channel activity leads to a graded membrane 
depolarization, due to increased movement of sodium (Na+) and/or Ca2+ into the cell, and 
a secondary influx of Ca2+ through VGC channels (Davis et al., 1992).   
The myogenic mechanism is dependent in large part on the presence of 
extracellular Ca2+ ([Ca2+]o).  For example, stretch-induced tone can be eliminated in 
resistance arteries in the presence of Ca2+ chelators (Hwa & Bevan, 1986a), or by 
incubating resistance arteries in a Ca2+-free solution (Hwa & Bevan, 1986b).  
Furthermore, myogenic activation of VSM contraction and spontaneous action potentials 
of small renal arteries at higher transmural pressures can be blocked by Ca2+ channel 
inhibition with verapamil (Harder et al., 1987).  More recently, investigators have 
demonstrated a significant role for Ca2+ released from intracellular stores in modulating 
myogenic activity in the microvasculature (Zou et al., 2000; Hill et al., 2001). 
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 The stretch-induced increase in [Ca2+]i activates Ca2+/CaM myosin light chain 
kinase (MLCK), which phosphorylates myosin ATPase, thereby increasing contractile 
activity (Horowitz et al., 1996).  Increases in intralumenal pressure also stimulate 
membrane bound G proteins leading to the activation of phospholipase C (PLC), and 
subsequent formation of IP3 and DAG (Narayanan et al., 1994; Inscho et al., 1998; see 
Figure 1).  Whereas IP3 leads to release of Ca2+ from the sarcoplasmic reticulum (SR), 
DAG activates the serine/threonine protein kinase C (PKC) (Osol et al., 1991; Narayanan 
et al., 1994).  PKC activity is essential for myogenic Ca2+-contraction coupling, as PKC 
inhibition completely abolishes myogenic activity (Wesselman et al., 2001). 
Several ancillary mechanisms have been proposed to mediate or sustain myogenic 
responses.  Although K+ channels do not initiate myogenic activity per se, Ca2+-sensitive 
K+ currents can modulate the intensity of myogenic responses (Brayden & Nelson, 1992; 
Nelson et al., 1995).  Voltage-dependent K+ (KV) and Ca2+-activated K+ (KCa) channels 
can both repolarize membranes after VSM stretch (Davis & Hill, 1999).  For example, 
inhibition of KCa channels augments myogenic tone in mesenteric arteries (Wesselman et 
al., 1997).  20-HETE, a metabolite of AA, can sustain or initiate myogenic responses 
by inhibiting large-conductance KCa channels (Zou et al., 1996; Harder et al., 1997).  
Some investigators maintain that activation of smooth muscle-derived chloride channels 
(Yamazaki et al., 1998) may also affect myogenic activity (Nelson et al., 1997). 
It appears as though initiation of the myogenic response may occur without 
endothelial input, as evidenced by maintenance of myogenic responsiveness after 
removal of the endothelium in many vessel types (McCarron et al., 1989; Falcone et al., 
1991; Sun et al., 1994; Wallis et al., 1996).  However, some studies have demonstrated  
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 Figure 1: Smooth Muscle Pathways for Myogenic Activation 
 
 
DAG: Diacylglycerol. PKC: Protein Kinase C. PLC: Phospholipase C. Vm: Membrane 
potential. VDCC: Voltage-dependent Ca2+ Channels. MLCK: myosin light chain kinase. 
IP3: Inositol 1,4,5-trisphosphate. PT: Transmural pressure. SAC: Stretch-activated 
channels. 
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 increased myogenic responses with endothelial dysfunction (Huang et al., 1993).  
Therefore, the endothelium clearly has the potential to influence the response due to 
release of one or more vasoactive factors (see Section 2A above).  In fact, endothelium- 
derived NO has been shown to antagonize myogenic tone (Kuo et al., 1991; van Breemen 
et al., 1997; Nguyen et al., 1999).  \ 
Although controversial due to the method of endothelial removal, myogenic 
constriction in cat cerebral arteries was found to be completely dependent on the 
endothelium, as removal eliminated their ability to respond to changes in transmural 
pressure (Harder, 1987).  Furthermore, other studies in either carotid (Rubanyi, 1988) or 
basilar (Katusic et al., 1987) arteries have also found a role for the endothelium in 
pressure-dependent constriction, which may be a characteristic unique to the cerebral 
vasculature. 
 
3. Experimental Approaches for Studying Myogenic Activity 
 
Most of the earliest work investigating myogenic reactivity was obtained from in 
vivo experiments on whole organs (Bayliss, 1902; Folkow, 1949; Haddy et al., 1957).  
However, in such complex integrative settings, flow-dependent mechanisms (Kuo et al., 
1990; Koller & Kaley, 1991) and metabolic responses (Hudlicka & el Khelly, 1985; 
Meininger et al., 1987; Segal, 2005) may either enhance or minimize myogenic activity, 
thereby complicating interpretation of the results.  Another in vivo technique, developed 
in the late 1970s, encloses the animal in a pressurized box with the vascular bed to be 
studied outside of the box (Bouskela & Wiederhielm, 1979).  Pressure within the box is 
then either increased or decreased, and these pressure changes are transmitted equally to 
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 both arterial and venous systems, thereby changing intravascular pressure without 
altering the pressure gradient for flow across the vascular bed of interest.  A similar 
approach places only the tissue to be studied in a pressurized box.  These pressurized box 
techniques are considered to be the best methods in which to study myogenic 
mechanisms in an in vivo setting.   
More recently, in vitro approaches, such as wire-mounted rings/strips and isolated 
pressurized vessels, have become the principal approaches to study myogenic reactivity.  
Duling and colleagues (Duling et al., 1981) refined the isolated microvessel technique in 
the early 1980s, which allowed the myogenic response and its underlying mechanisms to 
be studied in more detail by eliminating potential metabolic, neural, humoral and 
endothelial influences.  Experiments were first performed in small arteries (Osol & 
Halpern, 1985), and then in arterioles (Kuo et al., 1988; Jackson & Duling, 1989), where 
the myogenic response is the most pronounced (Davis, 1993). 
In isolated pressurized vessel protocols, segments of the vessel are cannulated 
(Laher & Bevan, 1993) and outflow occluded, such that changes in intralumenal pressure 
can be made without changes in flow (Halpern et al., 1984).  Alternatively, by connecting 
pressure and flow servo-control systems into the cannulation system, investigators can 
independently control both transmural pressure and intralumenal flow, such that constant 
flow can occur at preset pressure gradients (Laher & Bevan, 1993).  These isolated 
vessels are subjected to a transmural pressure gradient similar to that experienced in the 
in vivo environment.  Wire-mounted vascular strips are placed between two fine wires, 
one of which is attached to a fixed holder connected to a transducer, with the other 
attached to a micrometer (Mulvany & Halpern, 1976).  The vessel is initially mounted 
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 unstretched, allowed to equilibrate, and then stretched in an isometric fashion (Osol, 
1991).  Because the vessels are stretched circumferentially, they do not experience 
changes in transmural pressure (Osol, 1991).  Some investigators (Johnson, 1980; Laher 
& Bevan, 1993) argue that isolated vessel strips or segments, which are isobaric 
preparations and are subjected to wall stretch in a similar fashion as experienced in vivo, 
may be the ideal preparations to study myogenic mechanisms. 
 
C. Potassium Channels and Vascular Tone 
1. General Aspects 
 
Microvascular SMCs and ECs express several different types of ion channels 
which can determine and modulate membrane potential (Jackson, 2000, 2005), but for the 
purposes of this dissertation, the focus will be on K+ channels.  There are over 150 K+ 
channel types, which can respond uniquely to various stimuli (Korn & Trapani, 2005).  
Whereas microvascular SMCs express inward-rectifier (KIR), ATP-sensitive (KATP), 
voltage-gated (KV) and large conductance Ca2+-activated (BKCa) K+ channels, 
microvascular ECs express KIR, KATP, KV, and small (SKCa) and intermediate (IKCa) 
conductance Ca2+-activated K+ channels (Jackson, 2005).  However, it has been found 
that KCa channels are one of the major ion channels in VSM (Nelson & Quayle, 1995), 
and that BKCa channels are present in great quantities in arteriolar endothelial cells 
(Ungvari et al., 2002). 
K+ channels play a pivotal role in controlling smooth muscle electrical and 
mechanical activities (Tanaka et al., 2004) and are largely responsible for setting the 
vascular membrane potential (Fallet et al., 2001; Korn & Trapani, 2005).  Even a slight 
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 change in the activity of K+ channels is sufficient to alter membrane potential and tone 
(Quayle et al., 1993; Nelson & Quayle, 1995).  Currents through K+ channels are always 
hyperpolarizing (Korn & Trapani, 2005), such that activation of K+ channels leads to 
membrane hyperpolarization and relaxation, whereas inhibition leads to depolarization 
and contraction (Tanaka et al., 2004; Ledoux et al., 2006).  As mentioned earlier, K+ 
channels are generally thought to serve a negative feedback role in regulating myogenic 
constrictions (Nelson et al., 1995; Knot & Nelson, 1998), whereas membrane 
depolarization plays a major role in the response of smooth muscle to stretch (Harder et 
al., 1987; Knot & Nelson, 1995).   
K+ channels also play an instrumental role in communicating chemical signals 
generated in the endothelium to the VSM.  For example, K+ channels have been shown to 
play a role in the mechanisms by which NO, PGI2, and EDHF exert their effects 
(Brayden, 2002; Tanaka et al., 2004; Krummen et al., 2005).  BKCa channels in the VSM 
can be activated by EETs (Zhang et al., 2001b).  Endothelium-derived vasoconstrictors 
can close smooth muscle KATP, KV, and BKCa channels through PKC, Rho kinase, or c-
Src pathways, thereby leading to depolarization and the vasoconstrictor response 
(Jackson, 2005). 
 
2. Pharmacological Approaches for Evaluation of Potassium Channel 
Activity 
 
 
Because K+ channels play such an important physiological role in regulating 
vascular membrane potential, investigators have used various tools to more fully 
understand K+ channel pharmacology, structure, function, and mechanisms of activation.  
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 Patch-clamp techniques are utilized to directly study K+ channel activity and its influence 
on membrane potential in isolated cell membrane patches or single cells in vitro 
(Gebremedhin et al., 1996; Prior et al., 1998), whereas the development and discovery of 
pharmacological inhibitors and activators of K+ channel activity have made it possible to 
test various hypotheses related to K+ channel activity in vivo, albeit in a less direct 
fashion.  Tetraethylammonium (TEA) can inhibit most K+ channels (Korn & Trapani, 
2005), but at relatively small concentrations it has been used to specifically block KCa 
channels (Nelson & Quayle, 1995).  Iberiotoxin (Ibtx) and charybdotoxin (two scorpion 
venom peptides) are used for more specific inhibition of these channels (Galvez et al., 
1990; Gribkoff et al., 1997).  Scyllatoxin, biccuculline, dequalinium, clotrimazole, and 
UCL 1685 are inhibitors of various types of SKCa channels (Dunn, 1999; Strobaek et al., 
2000; Syme et al., 2000), whereas the antidiabetic sulphonylureas glibenclamide and 
tolbutamide selectively block KATP channels (Standen et al., 1989; Lombard et al., 
1999b; Brayden, 2002).  Activators or openers of K+ channels include the synthetic BKCa 
channel opener NS 1619 (1-(2’-hydroxy-5’-trifluoromethylphenyl)-5-trifluoromethyl-
2(3H)benzimidazolone) (Olesen et al., 1994; Fallet et al., 2001).  Chlorzoxazone, 
zoxazolamine, and riluzole have been used as SKCa channel stimulators (Syme et al., 
2000), whereas pinacidil, cromakalim, and diazoxide are KATP channel openers (Quayle 
et al., 1997; Brayden, 2002; Mabanta et al., 2006). 
 
3.  Reactive Oxygen Species and Vascular Tone 
 
A. Background 
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 ROS are formed via reduction of molecular O2 during normal metabolic 
processes.  With the generation of superoxide anion (O2·-), other reactive intermediates 
can also be produced either spontaneously or enzymatically.  The complete reduction of 
O2 to H2O requires several steps, and in the process can generate numerous byproducts 
(see Table 1 below).  Some of these O2-derived intermediates are chemically reactive due 
to unstable electron configurations, and can lead to the formation of other free radicals.  
These reactive molecules can cause lipid peroxidation, DNA damage and protein 
degradation, and are commonly implicated in the progression of Alzheimer’s disease, 
cancer, atherosclerosis, hypertension, and diabetes (Cadenas, 1989; Mullarkey et al., 
1990; Nakazono et al., 1991; Munzel et al., 1995; Rajagopalan et al., 1996; Oskarsson & 
Hofmeyer, 1997).   
The protonation of O2·- results in the formation of perhydroxyl radical, which is 
highly reactive.  O2·- can also act as a Bronsted base in aqueous solutions to form a 
hydroperoxyl radical, thereby forming H2O2 in acidic environments.  H2O2 is also formed 
when O2·- is dismutated by superoxide dismutase (SOD) at a neutral or acidic pH.  
Hydroxyl radical (OH·), one of the most potent reactive oxidants, can be formed 
spontaneously by the reduction of H2O2, through the interaction of O2·- with H2O2, or 
through the interaction between H2O2 and reduced metal ions (e.g. copper, iron).  This 
latter means of OH· production occurs via the Fenton reaction (Aruoma & Halliwell, 
1987; Aruoma et al., 1991).  O2·- can also react with NO to generate peroxynitrite 
(ONOO·-), which can lead to severe tissue injury (Li & Shah, 2004).   
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 B. Sources of ROS in the Vasculature 
 
Endothelial and VSM cells can generate O2·-, H2O2, NO, ONOO·-, as well as other 
radicals (Droge, 2001; Cai et al., 2003; Wassman et al., 2004) via the NOS, COX, LOX, 
NADPH oxidase, or CYP monooxygenase enzymes (Katusic, 1996; Lassegue & 
Clempus, 2003; Ardanaz & Pagano, 2006).  NADPH oxidases, which are arguably the 
best studied enzymes of ROS production in the vasculature (Lassegue & Clempus, 2003), 
serve as a principal source of O2·- (Rajagopalan et al., 1996; Babior, 1999; Gorlach et al., 
2000; Griendling et al., 2000b; Smith et al., 2001).  NADPH oxidase is a respiratory 
burst, multicomponent enzyme that is important in host defense.  Most of the components 
of this enzyme are distributed in VSMCs, ECs, and adventitial fibroblasts (Pagano et al., 
1997; Griendling et al., 2000b; Ardanaz & Pagano, 2006).  The NADPH oxidase enzyme 
can be activated by hypoxia-reoxygenation, flow cessation, membrane depolarization, 
hormones and growth factors (Al-Mehdi et al., 1998; Griendling & Harrison, 1999; 
Griendling et al., 2000a; Sohn et al., 2003).  Endothelial NADPH oxidases continuously 
generate low levels of O2·-, most of which is produced intracellularly (Li & Shah, 2004).  
CYP enzymes responsible for metabolizing AA (specifically CYP2 and CYP4A) are also 
implicated in ROS production (Fleming, 2001).  In the absence of cofactors or substrate, 
eNOS may become uncoupled and reduce molecular O2 rather than transfer electrons to 
L-arginine (Vasquez-Vivar et al., 1998), thereby generating O2·-.  Cardiovascular diseases 
including hypercholesterolemia, atherosclerosis, hypertension and ischemia/reperfusion 
injury all demonstrate impaired endothelial function and increased ROS, as eNOS  
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 Table 1: Various steps and by-products in the reduction of molecular oxygen. 
Bracketed items highlight potential mechanisms of reactions 
 
 
O2 + e- → O2·- + e- (superoxide radical) 
 
            [lipoxygenase, COX, CP450, XO, NADPH oxidase, uncoupled eNOS, 
  mitochondrial electron transport chain complexes I and III] 
 
O2 + 2e- → H2O2 (hydrogen peroxide) 
 [xanthine oxidase or glucose oxidase] 
 
O2·- + e- →  H2O2 + e- (hydrogen peroxide) 
 [spontaneous or via superoxide dismutase] 
 
O2·- + H2O → HO2· + OH (hydroperoxyl radical) in acidic environments 
 
HO2· + e- + H → H2O2 (hydrogen peroxide) in acidic environments 
 
O2·- + Fe3+ → Fe2+ + O2 
 [via Haber-Weiss reaction] 
 
H2O2 + Fe2+ → Fe3+ + -OH + OH· (hydroxyl radical) 
 [via Fenton reaction] 
 
H2O2 + e- → -OH + OH· (hydroxyl radical) 
 [spontaneous] 
 
H2O2  → H2O + O2 
 [spontaneous or via catalase or glutathione peroxidase] 
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  uncoupling occurs during such pathologic conditions (Cosentino et al., 1998; Xia et al., 
1998).   
Xanthine oxidoreductase (XOR), highly expressed on the lumenal surface of the 
endothelium, is a metalloflavoprotein found as one of two functionally distinct forms: the 
constitutively expressed xanthine dehydrogenase (XD), and xanthine oxidase (XO), 
which is generated by posttranslational modification of XD (Li & Shah, 2004).  Both XD 
and XO catalyze the oxidation of hypoxanthine and xanthine to urate, but because XO 
requires the reduction of O2, it is the enzyme responsible for generating O2·- and H2O2 as 
byproducts (Houston et al., 1999; Harrison, 2002).  However, in certain situations, such 
as ischemia, XD can be converted to XO, thereby generating ROS (Harrison, 2004). 
The electron transport chain reactions of the inner mitochondrial membrane 
generate ROS due to the constant production and escape of electrons (Cadenas & Davies, 
2000).  ROS production occurs principally at complex I (NADH dehydrogenase) and 
complex III (ubiquinone-cytochrome bc1).  Monoamine oxidase in the outer 
mitochondrial membrane has been proposed as an additional source of ROS (Chen et al., 
2003).  Although mitochondria do not normally contribute significantly to total vascular 
ROS production (Pagano et al., 1995; Pagano et al., 1997), this contribution may be 
enhanced during pathological conditions, such as hypoxia (Chandel et al., 2000) and 
diabetes (Nishikawa et al., 2000). 
 
C. Endogenous Scavenger Systems that Regulate ROS Levels 
 
“Aerobic organisms have evolved a multitude of  
ways to protect themselves from the deleterious  
aspects of an aerobic existence”   
                                                      (Pryor et al., 2006) 
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The effects of ROS are highly dependent on their local concentrations, which in 
turn are a function of not only the rate of their production, but also their rate of 
degradation or inactivation.  In order to minimize the deleterious effects of ROS, the 
human body manufactures antioxidant enzymes, proteins, and low molecular weight 
scavengers (Gutteridge & Halliwell, 1999).  Dietarily obtained antioxidants may also 
reduce oxidative stress, and have been promoted under the assertion that they may reduce 
rates and/or severity of coronary artery disease, stroke, dementias, and various cancers 
(Ames et al., 1993), all of which have increased levels of oxidant damage (Finkel & 
Holbrook, 2000).   
Nonenzymatic antioxidant molecules include uric acid, ubiquinone, ascorbic acid 
(vitamin C), α-tocopherol (vitamin E), and glutathione (GSH) (Suttorp et al., 1986; 
Harris et al., 1992; Droge, 2001; Dickinson & Forman, 2002).  Whereas vitamins C and 
E are only obtained through the diet, the body can synthesize GSH and ubiquinone de 
novo (Andree et al., 1999).  GSH is the major cellular thiol antioxidant buffer, which 
serves as a substrate for glutathione peroxidase (gpx1) thereby eliminating lipid 
hydroperoxides and H2O2 (Dickinson & Forman, 2002).  Ubiquinone and vitamin E, both 
lipid soluble antioxidants found in mitochondrial and other cellular membranes (Andree 
et al., 1999), aid in the removal of lipophilic radicals (Gutteridge & Halliwell, 1999).  
Ceruloplasmin, a copper-containing protein, protects the body from extracellular oxidant 
stress (Gutteridge & Stocks, 1981).   
Antioxidant enzymes include the family of SODs, catalase, the thioredoxin 
system, gpx1, and heme oxygenases (Suttorp et al., 1986; Yamawaki et al., 2003; 
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 Wassman et al., 2004; Szasz et al., 2007).  The SODs convert to O2·- to H2O2, which is 
then degraded to water by either catalase or gpx1.  There are three main SODs, which are 
expressed throughout all of the vascular layers (Faraci & Didion, 2004; Szasz et al., 
2007).  Nonetheless, each SOD has a primary area of localization and distinctive means 
of regulation.  Cytosolic CuZnSOD, a homodimer with similar amino acid sequence 
homology with extracellular SOD (ecSOD), is the predominant SOD isoform in the 
endothelium (Cai & Harrison, 2000).  Its activity and mRNA expression can be increased 
by shear stress (Tao et al., 2007).  Manganese superoxide dismutase (MnSOD) is a 
nucleus-encoded mitochondrial matrix protein (Bannister et al., 1987) whose expression 
is induced by VEGF (Abid et al., 2001) and thioredoxin (Wassman et al., 2004).  Ang II 
can increase vascular ecSOD expression, which involves both an increase in ecSOD 
transcription and stabilization of ecSOD mRNA (Fukai et al., 1999).  Although the 
glycosylated, tetrameric CuZnSOD (ecSOD) protects against extracelluar O2·- (Fridovich, 
1995), generally very low levels of SODs or catalase enzymes exist in human 
extracellular fluid (Gutteridge & Halliwell, 1999).   
 Gpx1 is found in the plasma, cellular cytosol, and in mitochondria, and uses 
glutathione to reduce H2O2 and lipid peroxides to their respective alcohols (Ursini et al., 
1995).  Catalase, a homotetrameric heme-containing enzyme, is found primarily in 
peroxisomes and catalyzes the conversion of H2O2 to water and O2 (Gutteridge & 
Halliwell, 1999; Szasz et al., 2007).  Whereas gpx1 is thought to be more important as a 
scavenger of endogenous basal levels of H2O2 (Harlan et al., 1984; Suttorp et al., 1986), 
catalase is thought to be more important under conditions in which there are large 
quantities of H2O2 (Suttorp et al., 1986).  Thioredoxin reductase with thioredoxin and 
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 NADPH, all of which are expressed in EC and VSM cells (Yamawaki et al., 2003), 
function together to lower ROS levels.  Heme oxygenase, found in endothelial and VSM 
cells (Christodoulides et al., 1995; Marks et al., 1997; Yet et al., 1997; Motterlini et al., 
1998; Sammut et al., 1998; Parfenova et al., 2001), degrades free heme, which can be 
pro-oxigenic, and generates biliverdin and bilirubin, both of which have antioxidase 
properties (Perrella & Yet, 2003).   
 
D. H2O2 as a Second Messenger and Regulator of Vascular Tone 
 
 
Although researchers traditionally believed that ROS were simply by-products of 
normal oxidative metabolism or functioned solely in an antimicrobial capacity, we now 
know that some ROS can also serve as signaling molecules for a variety of functions, 
including the regulation of vascular tone.  O2·- is a relatively membrane impermeable and 
unstable radical that is rapidly dismutated to H2O2, a more stable and membrane-
permeable molecule.  Therefore, many biological effects that have been attributed to O2·- 
may actually be mediated by H2O2.  Similar to NO, H2O2 can freely diffuse between 
cells, and is capable of traversing a distance equal to several cell diameters before 
reacting with another molecule or being catabolized (Griendling & Harrison, 1999; Chen 
et al., 2003).   
Several studies support the role of H2O2 as a signaling molecule for changes in 
VSM tone (Burke-Wolin et al., 1991; Yang et al., 1998a; Fujimoto et al., 2001; Yada et 
al., 2003).  Depending on the vascular bed, species, or local concentration, H2O2 can 
elicit either contractile or relaxant responses.  H2O2 was first proposed as an EDHF by 
Matoba and colleagues (Matoba et al., 2000), after they found that catalase inhibited 
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 ACh-induced dilation and VSM hyperpolarization in mouse mesenteric arteries.  There is 
also evidence to suggest that H2O2 plays an important role in the autoregulation of 
coronary blood flow (Yada et al., 2003), and in flow-induced dilation of both human 
coronary arterioles and human mesenteric arteries (Miura et al., 2003; Mabanta et al., 
2006).  Others have demonstrated that H2O2 is an EDHF in the BK-induced dilation of 
pig pial arterioles (Lacza et al., 2002).  It appears as though there is a role for H2O2-
induced dilation in pathologic states as well.  For example, in spontaneously hypertensive 
rats (SHR), relaxation of aortas to the calcium ionophore A23187 relies on the presence 
of H2O2 (Cosentino et al., 1998).  In coronary arterioles from patients with coronary 
artery disease, H2O2 can also contribute to flow-induced dilation (Miura et al., 2003). 
H2O2 can elicit vasodilation through both endothelium-dependent and 
endothelium-independent mechanisms (Zembowicz et al., 1993; Barlow & White, 1998; 
Yang et al., 1998a; Thengchaisri & Kuo, 2003).  H2O2 has also been shown to increase 
endothelial NOS expression and activity (Cai et al., 2003), and there is extensive 
evidence from other studies to indicate that NO release is in fact the predominant 
endothelium-dependent mechanism through which H2O2 induces dilation (Zembowicz et 
al., 1993; Yang et al., 1998a; Cai et al., 2002; Shimizu et al., 2003; Cseko et al., 2004; 
Gil-Longo & Gonzalez-Vazquez, 2005).  H2O2-induced dilation in the coronary 
microcirculation is also mediated, in part, by the release of endothelial PGE2 and 
subsequent activation of smooth muscle prostaglandin receptors (Thengchaisri & Kuo, 
2003).  However, H2O2 can also induce VSM hyperpolarization and relaxation in an 
endothelium-independent manner via activation of K+ channels (Campbell et al., 1996; 
Sobey et al., 1997; Miura et al., 1999; Matoba et al., 2000; Thengchaisri & Kuo, 2003).  
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 The main contributing type of K+ channel appears to depend on the species and/or 
vascular bed; in some cases the mediators are KCa channels (Campbell et al., 1996; Miura 
et al., 1999; Iida & Katusic, 2000; Miura et al., 2003; Thengchaisri & Kuo, 2003), and in 
other cases KATP channels (Wei et al., 1996; Filipovic & Reeves, 1997; Lacza et al., 
2002). 
H2O2 has also been found to induce contractile responses.  For example, H2O2 
causes constriction of the aorta, pulmonary artery and superior mesenteric artery of the 
rat (Jin & Rhoades, 1997; Rodriguez-Martinez et al., 1998; Sotnikova, 1998; Yang et al., 
1998b; Pelaez et al., 2000a; Gao & Lee, 2001), pig pulmonary arteries (Pelaez et al., 
2000b), and canine basilar arteries (Yang et al., 1999).  H2O2 can also increase the tone of 
KCl-preconstricted mouse mesenteric arteries (Lucchesi et al., 2005).   
There have been multiple proposed mechanisms of H2O2-induced 
vasoconstriction.  For example, in rat gracilis muscle arterioles, removal of the 
endothelium partly reduces constrictions to lower concentrations of H2O2, but these 
constrictions are completely abolished either by inhibition of prostaglandin synthesis or 
antagonism of PGH2/TxA2 receptors, suggesting that H2O2 must elicit its constrictor 
effect via endothelial and smooth muscle PGH2/TxA2 release (Cseko et al., 2004).  
Consistent with this finding is the observation that H2O2 activates cyclooxygenase to 
produce PGH2, among other prostaglandins (Hemler et al., 1979).  Others have 
demonstrated that H2O2 triggers increases in VSM [Ca2+]i by direct stimulation of VGC 
channels, mobilization of intracellular Ca2+ from the sarcoplasmic reticulum via 
ryanodine receptors, inhibition of Ca2+ ATPase, or stimulation of IP3-induced Ca2+ 
release (Grover & Samson, 1988; Grover et al., 1992; Horowitz et al., 1996; Favero et 
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 al., 1995; Tabet et al., 2004).  Increased intracellular Ca2+ allows for activation of myosin 
light chain kinase (MLCK), and subsequent phosphorylation of 20-kDa myosin light 
chains (MLC20), thereby leading to constriction (Ardanaz & Pagano, 2006).   
 
E. Experimental Approaches for Detecting H2O2 In Vivo 
 
 
Although many approaches have been developed to detect and quantify H2O2 
concentrations, none are ideal.  Fluorescent probes are usually linked to horse radish 
peroxidase (HRP), such that in the presence of H2O2, hydrogen donors can be oxidized by 
HRP, causing a change in fluorescence intensity (Boveris, 1984; Tarpey & Fridovich, 
2001).  Although some probes, such as scopoletin (7-hydroxy-6-methoxy-coumarin, 
Boveris et al., 1977), result in decreased intensity in the presence of H2O2, other 
previously non-fluorescent probes increase in fluorescence intensity with H2O2 contact; 
these types of probes include 2′,7′ dichlorodihydrofluorescein diacetate (DCFH-DA, 
Miura et al., 2003; Silveira et al., 2003), p-hydroxyphenylacetate (Hyslop & Sklar, 
1984), homovanillic acid (3-methoxy-4-hydroxyphenylacetic acid, Ruch et al., 1983), 
and N-acetyl-3,7-dihydroxyphenoxazine (Cohen et al., 1996).  Spectrophotometric assays 
including tetramethylbenzidine (Staniek & Nohl, 1999) and phenol red (Pick & Keisari, 
1980) are other options which also work via H2O2-induced oxidation.  There are many 
drawbacks to using assays which depend on oxidation reactions, as cellular peroxidases, 
peroxynitrite, hypochlorous acid, and even NO can also oxidize the target compound, 
leading to inaccurate estimations of H2O2 concentration (Tarpey & Fridovich, 2001; 
Silveira et al., 2003).  Nanoelectrodes, which allow for amperometric detection of H2O2 
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 at concentrations as low as 10-7 M, function via Prussian Blue (PB), which is the most 
effective electrocatalyst for H2O2 reduction (Vreeke et al., 1994; Karyakin et al., 2004; 
Ricci & Palleschi, 2005).  Although nanoelectrodes allow for more quantitative and 
sensitive measurements of H2O2 concentrations, their in vivo use is limited by sensor 
selectivity (ascorbate can also react with PB) and instability (Karyakin et al., 2004). 
In addition to the methodological limitations, in vivo concentrations of H2O2 have 
been difficult to measure due to the complex H2O2 catalytic and degradation processes 
that occur and because of the contribution from intricate scavenger systems.  H2O2 can 
readily react with heme proteins and protein sulfhydryl groups (van der Vliet et al., 1994; 
Halliwell et al., 2000).  Both nonenzymatic antioxidant molecules, including uric acid, 
Vitamin C, Vitamin A, and glutathione (Droge, 2001; Dickinson & Forman, 2002), and 
enzymatic systems, including SODs, catalase, the thioredoxin system, glutathione 
peroxidases, and heme oxygenases (Cai & Harrison, 2000; Faraci & Didion, 2004; Szasz 
et al., 2007) also affect relative H2O2 concentrations. 
Nonetheless, various investigators have attempted to quantify H2O2 production in 
the vasculature.  Cosentino and colleagues (1998) used electrochemical sensors to detect 
H2O2 concentrations in aortas from Wistar Kyoto (WKY) rats and SHRs.  When 
pretreated with SOD and stimulated with the calcium ionophore A23187, these 
concentrations reached ~10 nmol/L in WKYs and ~60 nmol/L in SHRs.  Others have 
measured the extracellular H2O2 concentration surrounding stimulated human neutrophils 
(Test & Weiss, 1984).  When neutrophils were stimulated with the croton oil derivative 
PMA, H2O2 levels reached ~60 μM.  H2O2 levels as high as ~9 μM/L were detected in 
blood from patients with a history of myocardial infarction drawn after exercise (Deskur 
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 et al., 1998).  In genetic hypertensive patients, plasma H2O2 levels were measured via 
electrode and found to be ~3 μM/L (Lacy et al., 1998).  
 
4.  Carbon Monoxide and Vascular Tone 
 
A. Background 
 
 
Since the 19th century, it has been known that the blood contains CO (Grehant, 
1894; Coburn et al., 1963).  In 1949, Torgny Sjöstrand demonstrated that CO is produced 
in man, finding higher CO concentrations in expired air than in inspired air (Sjostrand, 
1949).  CO, a simple diatomic, colorless gas at room temperature and pressure (Pryor et 
al., 2006), has primarily been considered a toxic molecule, capable of displacing O2 from 
hemoglobin and causing tissue hypoxia (Weaver, 1999) as well as cardiovascular and 
neurological damage (Penney, 1990).  In fact, as little as 0.4% of CO in the air can cause 
death in less than one hour (Otterbein & Choi, 2000). 
CO is generated mainly through the catabolism of the ubiquitous 
metalloporphyrin ferric heme (FeIII) by heme oxygenase (HO) enzymes.  However, 
minor sources of CO production include auto-oxidation of phenols, flavenoids, and 
halomethanes, photo-oxidation of organic compounds, and lipid peroxidation of 
membrane lipids (Rodgers et al., 1994; Archakov et al., 2002). 
HO is the only known enzyme that generates three reaction products (Ryter & 
Otterbein, 2004): heme is oxidatively cleaved to produce CO, biliverdin-IXα, and ferrous 
iron (FeII) in equimolar quantities (Yoshida & Kikuchi, 1978).  The HO system was 
originally thought to only regulate cellular heme homeostasis, with its products 
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 considered waste materials (Maines, 1997).  However, biliverdin has been demonstrated 
to have antioxidant activities and iron prooxidant capabilities (Ryter & Tyrrell, 2000), 
and CO has been found to play a role as a second messenger in various biological 
systems (Marks et al., 1991).   
Three HO isoforms have been characterized: HO-1 (also referred to as heat shock 
protein 32), HO-2, and HO-3 (McCoubrey et al., 1997; Naik et al., 2003).  Whereas HO-
1 was identified in the early 1970s (Maines & Kappas, 1974; Yoshida et al., 1974), HO-2 
was not identified until the mid-1980s (Maines et al., 1986; Trakshel et al., 1986), and 
HO-3, still not fully characterized, was first identified in the late 1990’s (McCoubrey et 
al., 1997).  HO-1, the inducible form of heme oxygenase, can be stimulated by many 
different factors and conditions, including hypoxia, hypertension, endotoxic shock, and 
shear stress (Johnson et al., 1996; Wagner et al., 1997; Yet et al., 1997; Jernigan et al., 
2001).  HO-2 is constitutively expressed in most tissues and is generally not inducible 
(Maines, 1997).  HO-3 is also expressed constitutively, but its heme degrading activity is 
low (McCoubrey et al., 1997). 
Both HO-1 and HO-2 have been demonstrated in endothelial cells (Marks et al., 
1997; Yet et al., 1997; Sammut et al., 1998; Parfenova et al., 2001) and VSM cells 
(Christodoulides et al., 1995; Yet et al., 1997; Motterlini et al., 1998).  HO-1 can be 
readily induced in the heart and blood vessels, but HO-2 is the predominant enzyme 
expressed under normal conditions in the cardiovascular system (Ewing et al., 1994).   
HO-1 and HO-2 are very different enzymes, coming from different gene products 
and sharing little similarity in amino acid composition, structure, or gene organization 
(Muller et al., 1987; Cruse & Maines, 1988; Keyse & Tyrrell, 1989).  They also differ 
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 with regard to cell type, tissue distribution, and regulation.  However, they are similar in 
their mechanism of heme catalysis, substrate specificity, and cofactor requirements 
(Maines et al., 1986; Trakshel et al., 1986).   
 
B. Mechanisms by which CO Can Influence Biological Processes 
 
 
Because CO can bind to heme moieties, it can either increase or decrease the 
activity of many enzymes that contain a heme group (Roberts et al., 2004).  For example, 
CO has been shown to interact with hemoglobin, myoglobin, catalase, cytochrome c 
oxidase, NADPH oxidase, soluble guanylyl cyclase, NOS, and CYP enzymes (Stone & 
Marletta, 1994; Maines, 1997; Ryter et al., 2002; Ryter & Otterbein, 2004; Ishikawa et 
al., 2005; Kim et al., 2006; Pryor et al., 2006).  However, outcomes differ depending on 
the specific interaction. 
Although CO has both vasodilatory and vasoconstrictor properties, it is generally 
considered to be a vasodilator molecule (Johnson et al., 1999).  CO relaxes rabbit 
(Furchgott & Jothianandan, 1991) and rat (Lin & McGrath, 1988) aorta, dog coronary 
arteries (Furchgott & Jothianandan, 1991), rabbit pulmonary arteries (Steinhorn et al., 
1994), rat tail arteries (Wang et al., 1997a), rat afferent arterioles (Thorup et al., 1999) 
and pial arterioles of newborn pigs (Leffler et al., 1999).   
Low levels of CO can induce release of NO from a large intracellular pool 
(Thorup et al., 1999) and can directly activate sGC (Furchgott & Jothianandan, 1991; 
Schmidt, 1992), thereby causing vasorelaxation.  CO generated by HO activity in the 
cardiovascular system appears to increase tissue cGMP levels (Ewing et al., 1994).  
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 Although sGC is involved in CO vasodilation in rabbit aorta, as seen by increases in 
tissue cGMP levels (Furchgott & Jothianandan, 1991; Hussain et al., 1997), inhibitors of 
sGC only partially reduce the relaxant effects of CO in either rat tail artery (Wang et al., 
1997a) or lamb ductus arteriosus (Coceani et al., 1996).   
Others have demonstrated that CO plays no role in activating GC in rat aortic and 
pulmonary artery SMCs (Morita et al., 1995).  Some of the cGMP-independent dilations 
are attributed to mechanisms involving CYP enzymes (Coceani et al., 1994) and KCa 
channels (Wang et al., 1997b; Leffler et al., 1999; Zhang et al., 2001a; Jaggar et al., 
2002).  Coceani and colleagues (1994) found that CO relaxes lamb ductus arteriosus via 
inhibition of a cytochrome P450-based mono-oxygenase reaction controlling the 
formation of ET (Coceani et al., 1994).  CO elicits smooth muscle hyperpolarization by 
activating large-conductance KCa channels (Xi et al., 2004), or increasing the Ca2+ 
sensitivity of these channels (Jaggar et al., 2002; Xi et al., 2004).  More specifically, CO 
increases the open state probability of KCa channels via modification of a histidine 
residue on the external membrane side of these channels (Wang & Wu, 1997).  
Furthermore, CO-induced dilation of newborn porcine pial arterioles is blocked by COX 
and NOS (Leffler et al., 2001), suggesting that perhaps COX-derived prostaglandins and 
NO play a role in CO-mediated dilation of these vessels. 
The relaxing action of CO in some arteries has been found to be endothelium 
independent (Lin & McGrath, 1988; Furchgott & Jothianandan, 1991; Hussain et al., 
1997).  In small rat mesenteric arteries, whereas exogenously applied CO resulted in 
dilation in the absence of an intact endothelium, endothelial removal eliminated the 
vasodilator response to endogenously produced CO (Naik et al., 2003).  These results 
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 suggest that although the endothelium may be responsible for CO production, CO-
mediated vasodilation occurs via actions on the VSM in a similar fashion to NO.   
Although several studies have documented the ability of CO to inhibit NO 
synthesis by blocking NOS (White & Marletta, 1992; Pufahl & Marletta, 1993; Matsuoka 
et al., 1994), fewer studies have demonstrated a constrictor role for CO.  However, CO 
was shown to induce concentration-dependent vasoconstriction in the intact vascular bed 
of the rat hindlimb (Marks et al., 2003).  Induction of HO-1 has been shown to attenuate 
muscarinic agonist-induced NO release (Thorup et al., 1999) and vasorelaxation (Kaide 
et al., 2002) in isolated renal arteries.  Both exogenously applied and endogenously 
formed CO induce constriction of rat gracilis muscle arterioles pretreated with 
phenylephrine (Johnson & Johnson, 2003).  This latter study suggests that CO might 
exert its vasoconstrictor properties by inhibiting NOS, because L-arginine treatment 
abolished CO-induced vasoconstriction (Johnson & Johnson, 2003).   
In some pathological states, HO expression and CO formation are increased, 
possibly leading to increased inhibition of NOS (see Section 4E below).  Salt-induced 
hypertension in Dahl salt-sensitive rats (DS) is accompanied by increased production of 
endogenous CO, and aortic and arteriolar HO-1 protein levels (Johnson et al., 2003).  As 
early as 1984, investigators found that CO enhances the development of salt-induced 
hypertension in DS rats, although they were unable at that time to elucidate the 
underlying mechanism (Shiotsuka et al., 1984).  In support of an inhibition of NOS by 
CO during salt-induced hypertension is the observation that NOS inhibition with L-
NAME has no effect on arteriolar tone in hypertensive DS rats, even though it causes 
arteriolar constriction in normotensive DS rats (Boegehold, 1992).  This is consistent 
 36
 with the possibility that increased CO production in these pathologic conditions may be 
responsible for NOS inhibition.  Further supporting this theory is the finding that skeletal 
muscle arterioles from Dahl-Rapp salt-sensitive hypertensive rats do not demonstrate 
endothelium-dependent dilation, but these responses can be completely restored by in 
vitro treatment with a HO inhibitor (Johnson et al., 2003).  Finally, in transgenic mice 
that overexpress VSM HO-1, vasodilatory responses to NO are suppressed, primarily by 
impairing activation of sGC, leading to elevation of arterial pressure (Imai et al., 2001).   
 Still others have found no role for CO-mediated vascular responses.  CO at 
concentrations ranging from 10-6 to 3 x 10-4 mol/L does not appear to have a significant 
effect on tone in rabbit or dog cerebral arteries (Brian et al., 1994).  Other investigators 
found that the diameters of isolated, pressurized and perfused rat middle cerebral arteries 
were not altered by 10-6 to 10-4 M CO (Andresen et al., 2006).  Although CO regulates 
vascular tone in many tissues, perhaps it is not an important mediator of vascular function 
in the adult cerebral circulation, even though it may influence vascular responses in 
cerebral vessels from young animals (Leffler et al., 1999). 
 
C. Regulation of CO Production 
 
 
As the information in Section 4A clearly indicates, there is not a sole regulator of 
HO activity and subsequent CO production in vivo (Cary & Marletta, 2001).  However, 
HO levels are developmentally regulated, at least in the central nervous system.  Whereas 
the Purkinje neurons of the cerebellum demonstrate intense HO-2 immunoreactivity in 
adult rats, this is not seen in two-week-old rats (Maines et al., 1996).  Steroids appear to 
play a major role in regulating HO-2, as corticosterone treatment in postnatal rats results 
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 in enhanced gene transcription in the promoter region of HO-2, in increased HO-2 
transcription, and in elevated levels of HO activity and protein (Maines et al., 1996; 
Maines, 1997).   
Regulation of CO production by cerebral microvessels can include stimulation of 
HO-2 catalytic activity by tyrosine phosphorylation (Leffler et al., 2003).  In neurons, 
HO-2 activity is stimulated by casein kinase 2 (CK2)-catalyzed phosphorylation of 
serine-79 (Boehning et al., 2003).  Nonetheless, one definite prerequisite for HO activity 
is the presence of sufficient substrate, in the form of heme or the heme precursor 
aminolevulinate (Leffler et al., 2003).   
 
D. Experimental Approaches for Studying CO and Determining its In 
Vivo Concentrations  
 
 
Although there are multiple ways to detect CO, including infrared absorption, 
calorimetry, electrochemical methods based on selective membranes, gas 
chromatography, and radioisotope counting (Morimoto et al., 2001), in vivo 
measurements are difficult.  Nonetheless, tissue contents of CO are reported to be 1-50 
pmol/mg fresh weight (Vreman et al., 2000), which others have calculated to be 
approximately 1-50 μmol/l (10-6 – 5x10-5 M) (Johnson & Johnson, 2003). 
Different experimental methods have been used to stimulate endogenous 
production of CO.  The rate-limiting step in heme synthesis is the production in 
mitochondria of δ-aminolevulinic acid (δ-ALA) from succinyl coA and glycine, a 
reaction that is catalyzed by the tightly regulated enzyme δ-ALA synthase (Kikuchi & 
Hayashi, 1981; May et al., 1990).  Whereas heme-L-lysinate (HLL), another HO 
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 substrate, is utilized in some experiments, δ-ALA is the preferred choice in others 
because HLL contains iron and may lead to iron loading and detrimental effects on 
tissues (Johnson & Johnson, 2003).  However, the dose-dependent vasodilator response 
of HLL is mediated by a product of the HO reaction (Naik et al., 2003). 
Different metalloporphyrins are used to inhibit HO activity, including zinc 
protoporphyrin IX (ZnPPIX), tin protoporphyrin IX, chromium mesoporphyrin IX 
(CrMP) (Vreman et al., 1993), zinc deuteroporphyrin IX 2,4-bis-ethylene glycol (ZnBG) 
(Chernick et al., 1989), and zinc N-methylprotoporphyrin IX (ZnPP) (De Matteis et al., 
1985).  The potency of metalloporphyrins in inhibiting HO is affected by the metal cation 
associated with the porphyrin ring and by different ring substituents (Vreman et al., 
1993), and therefore some chemicals appear to be better suited for experimentation 
purposes than others.  Investigators have demonstrated some nonspecific effects of the 
metalloporphyrin HO inhibitors (Luo & Vincent, 1994; Appleton et al., 1999).  For 
example, metalloporphyrins have been suggested to either inhibit (Luo & Vincent, 1994) 
or activate (Chakder et al., 1996) NOS, or to inhibit sGC (Grundemar & Ny, 1997).  All 
of these reasons may help to explain the variability of vascular responses observed after 
HO inhibition (see below). 
Some have found no effect of HO inhibition on rat tail artery (Wang et al., 
1997a), aorta (Kozma et al., 1999) or femoral artery (Kozma et al., 1999) diameters.  
Others have found that HO inhibition increases hindlimb resistance in animals pretreated 
with L-NAME, but not in those unexposed to L-NAME (Johnson et al., 2002).  Others 
have demonstrated that CrMP promotes constriction of gracilis muscle arterioles in the 
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 presence of L-NAME (Kozma et al., 1997; Kozma et al., 1999), whereas CrMP has been 
found to dilate newborn pig pial arterioles (Leffler et al., 1999).  
Systemic administration of ZnPPIX increases renal vascular resistance, but does 
not change mean arterial pressure in Sprague-Dawley rats subjected to chronic hypoxia 
(Jernigan et al., 2001).  ZnPPIX does not affect either renal vascular resistance or mean 
arterial pressure in control rats (Jernigan et al., 2001).  In contrast, ZnPPIX 
administration leads to sustained increases in arterial pressure, vasoconstriction and 
elevated total peripheral resistance in Sprague-Dawley rats (Johnson et al., 1995).  These 
inconsistent findings may be due to the relative concentrations of ZnPPIX, as Johnson’s 
group utilized 45 μmol/kg, whereas Jernigan’s group utilized 11 μmol/kg.  At higher 
concentrations, ZnPPIX can inhibit sGC and NOS (in addition to HO), which may 
account for the observed increases in mean arterial pressure and total peripheral 
resistance (Appleton et al., 1999).  Others have found that increased HO activity induced 
by tin chloride treatment is associated with a lowering of blood pressures of 
spontaneously hypertensive rats (Sacerdoti et al., 1989).   
 
E. CO vs. NO: Comparisons and Interactions 
 
 
 NO and CO are both simple gases with similar water solubilities that are produced 
endogenously by enzymatic means (Pryor et al., 2006).  They are equally capable of 
forming complexes with most hemoproteins at the heme iron center, and they can act as 
heme ligands (Maines, 1997).  Both can activate sGC, induce vasorelaxation, and 
stimulate K+ channel activity (Rees et al., 1989; Furchgott & Jothianandan, 1991; 
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 Bolotina et al., 1994; Wang et al., 1997a; Wang, 1998).  NO and CO can also inhibit 
platelet aggregation (Brune & Ullrich, 1987; Hobbs & Moncada, 2003). 
The enzymatic regulators of these gaseous products, HO and NOS, can be either 
constitutively expressed or induced.  The inducible forms of the enzymes (HO-1 and 
NOS2/iNOS) both involve gene activation and de novo enzyme protein synthesis 
(Maines, 1997).  Furthermore, NOS2 can be induced by many of the same stimuli that 
induce HO-1, including cytokines, ROS, and endotoxins (Nathan, 1992; North et al., 
1996).  Both inducible enzymes are stimulated in highly inflammatory processes 
(Ignarro, 1993; Willis et al., 1996). 
NO, a free radical having a half-life on the order of seconds, is much more labile 
and unstable than the nonradical CO (Moncada & Higgs, 1995; Cary & Marletta, 2001).  
Although NO can bind both ferric and ferrous heme, CO can only bind ferrous heme 
(Pryor et al., 2006).  Whereas both NO and CO activate sGC, NO is five times more 
capable of activating sGC (Stone & Marletta, 1994; Kharitonov et al., 1995).  However, 
some investigators have observed relative relaxation potencies of CO to NO to vary from 
1:1000 for rabbit aorta to 1:1 in canine circumflex coronary arteries (Furchgott & 
Jothianandan, 1991).  Whereas constitutive NOS is relatively absent from VSM, 
constitutive HO is abundant in these cells (Johnson et al., 1999).   
Interestingly, the NO and CO pathways exhibit complex patterns of interaction.  
For example, NO has been found to either inhibit HO activity (Willis et al., 1995; Ding et 
al., 1999) or enhance it (Motterlini et al., 1996; Leffler et al., 2005).  Exogenously 
administered or endogenously produced NO can selectively induce HO-1 gene expression 
and CO release in VSM cells (Durante et al., 1997).  NO can also cause the release of 
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 free heme from heme proteins (Lipton et al., 1993), which may well lead to increased CO 
production through increased substrate availability.  Maines (Maines, 1997) proposes that 
the ability of NO to affect HO activity may be accounted for by the free radical nature of 
NO, such that it may bind to heme, thereby inhibiting or inducing HO activity. 
CO can hamper nitric oxide synthesis via eNOS, nNOS and iNOS inhibition 
(McMillan et al., 1992; White & Marletta, 1992; Matsuoka et al., 1994; Fan et al., 1997; 
Thorup et al., 1999; Ishikawa et al., 2005) as well as increase NO production via NOS 
activation (Lim et al., 2005).  This duality is also evident in the observation that CO can 
influence NO release in a biphasic manner; at high CO levels (10μm), NO release from 
isolated perfused rat afferent arterioles is suppressed, whereas with lower levels (0.01-0.1 
μm), NO release is maximal (Thorup et al., 1999).  At concentrations of 1-10μm, CO can 
induce oxidative stress, resulting in the production of peroxynitrite, which further limits 
the availability of NO (Thom et al., 1997).  Furthermore, repeated exposure to brief 
pulses of CO results in a decreased NO release (Thorup et al., 1999), which may occur by 
depletion of intracellular pools of heme-bound NO. 
 
5.  Postnatal Growth and Maturation: Effects on the Vasculature 
 
A. Introduction 
 
The vascular dysfunction associated with some cardiovascular diseases can begin 
to develop well before adulthood (Bohlen & Lobach, 1978; Zweifach et al., 1981; Prewitt 
et al., 1982; Bohlen, 1987; Kunert et al., 2001), so that changes linked to the pathological 
process become superimposed on the changes in vascular function that normally occur 
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 with juvenile growth.  Therefore, to more clearly elucidate the mechanisms of 
progressive vascular dysfunction under such circumstances, it is necessary to gain a 
deeper understanding of those changes in vascular function that accompany normal 
growth.   
Early studies in this area were focused almost exclusively on conduit arteries, 
which differ from resistance vessels in size, function, and local environment.  Although 
these earlier studies have provided valuable information with regards to the elastic 
muscular transport arteries which serve as a pressure reservoir, these data cannot be 
generalized to the microcirculation.  More information is gradually becoming available 
on such growth-related changes at the microvascular level. 
The rapid postnatal enlargement of organs is accompanied by extensive growth of 
their arteriolar, capillary and venular networks (Sarelius et al., 1981; Unthank & Bohlen, 
1988; Wang & Prewitt, 1991; Linderman & Boegehold, 1996) and increases in 
microvascular wall mass (Bohlen & Lobach, 1978; Wang & Prewitt, 1991).  These 
structural changes are accompanied by a progressive increase in microvascular pressure 
and volume flow (Zweifach et al., 1981; Wang & Prewitt, 1991; Linderman & 
Boegehold, 1998, 1999).  Not surprisingly, studies across different species also suggest 
that the mechanisms responsible for controlling arteriolar resistance and blood flow are 
not fixed at birth, but instead undergo marked changes during subsequent microvascular 
growth.  The intent of this section is to summarize the current state of knowledge on 
growth-related changes in the function of both conduit arteries and resistance vessels, and 
the impact of these latter changes on the regulation of blood flow. 
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 B. Conduit Arteries 
i. Endothelium-Dependent Control 
 
Studies on conduit arteries have demonstrated changes in endothelium-dependent 
control with postnatal growth, although there are inconsistent findings.  For example, 
endothelium-dependent dilator responses to histamine are similar in large mesenteric 
arteries from 2- and 8-week-old rats, but then decline to smaller responses in arteries 
from 13-week-old rats (Moritoki et al., 1986).  In contrast, the endothelium-dependent 
relaxation of porcine pulmonary arteries to ACh, BK and the calcium ionophore A23187 
progressively increases from 3 to 30 days of age (Zellers & Vanhoutte, 1991).   
Activation of endothelial alpha-2 (α2) receptors does not produce NO in porcine 
pulmonary arteries at birth or 3 days of age, but does at 10 days of age, and α2-stimulated 
NO release is fully developed by 10 weeks (Wilson et al., 1993).  ACh elicits larger 
increases in cGMP formation and greater endothelium-dependent relaxations in 
pulmonary artery rings from adult sheep than in those from newborn sheep (Kolber et al., 
2000), and at least part of this difference may be due to increased expression of sGC in 
these vessels in the first 2 weeks after birth  (Moreno et al, 2005).  In contrast, pulmonary 
artery rings from 2-day-old sheep are more responsive to ACh and BK than those from 1-
month old sheep, and an L-arginine analog can reduce these relaxations in 2-day-old 
vessels but not in 1-month-old vessels, suggesting that these agonists stimulate greater 
NO release in the younger vessels (O'Donnell et al., 1996).   
In the rat, endothelial P2-purinergic receptors coupled to the L-arginine/NO 
pathway are nonfunctional in the aorta at 4-6 weeks of age, but become fully functional 
by 13 weeks of age (Koga et al., 1992).  Over this same time period, there is also a 
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 progressive decrease in aortic relaxation to ACh due to the offsetting actions of an 
endothelium-derived vasoconstrictor prostanoid (Koga et al., 1989).   L-NMMA has no 
effect on the dilation of porcine femoral arteries to ACh at birth, but it significantly 
reduces these responses at 7-10 days of age (Stoen et al., 1997).  Although LNA reduces 
ACh-induced relaxation of renal arteries in both newborn and adult guinea pigs, this 
effect is greater in adults (Thompson & Weiner, 1996).  
Fluid shear stress induces a graded release of NO that is significantly greater in 
carotid arteries from adult sheep than those from term fetal lambs, due to the significantly 
greater ability of fluid shear stress to activate eNOS in adult than in fetal arteries (White 
et al., 2005).  This group also reported that stimulation of NO release by the receptor-
independent endothelial activator A23187 was significantly greater in adult than in fetal 
arteries.  When NO release (induced from either fluid shear stress or A23187) was 
normalized to eNOS abundance between groups, eNOS-specific activity was also 
significantly greater in adult than in fetal arteries.  In contrast, however, stimulation with 
the receptor-dependent endothelial activator ADP resulted in no difference between fetal 
and adult arteries in both overall NO release and eNOS-specific activity (White et al., 
2005).  The authors propose that “fractional” activation of eNOS in response to ADP may 
be upregulated in fetal compared with adult arteries, which could compensate for the 
attenuated eNOS activity, thereby maintaining endothelium-dependent responses in 
arteries from fetal lambs. 
Some investigators have looked at NOS protein and expression in various beds 
with growth.  Although age-related differences in NO release in lamb/sheep carotid 
arteries have been found, no age-related differences in eNOS protein or mRNA levels 
 45
 were observed (White et al., 2005).  However, other investigators have detected a greater 
nNOS mRNA in immature compared with mature kidneys in pigs (Solhaug et al., 2000).   
ii. Smooth Muscle Responsiveness to NO 
Smooth muscle responsiveness to NO can also change with postnatal growth.  
Although femoral arterial rings from newborn and 7-10 day old piglets can relax 
completely to the NO donor sodium nitroprusside (SNP), the 7-day-old group is more 
sensitive to SNP than the newborn (Stoen et al., 1997).  Similarly, pulmonary artery rings 
from 10 day old piglets are significantly more responsive to exogenous NO than those 
from newborn or 3-day-old animals (Wilson et al., 1993).  Sensitivity to SNP also 
increases with age in guinea pig renal arteries (Thompson & Weiner, 1996).  In contrast, 
relaxation to SNP is significantly less in pulmonary artery rings from 1 month old lambs 
than those from 2 day old lambs (O'Donnell et al., 1996).  Similarly, maximum efficacy 
for relaxation to other NO donors (S-nitroso-N-acetyl-penicillamine and nitroglycerin) 
decreases with maturation (from 3-7 day old to adult) in sheep basilar and carotid arteries 
(Pearce et al., 1994).  Still others have found no change with growth, as demonstrated by 
no difference in sensitivity to SNP among porcine pulmonary artery rings from 3-, 10-, 
and 30-day-old animals (Zellers & Vanhoutte, 1991). 
 
iii. Ion Channel Activity 
 
The activity of various types of plasma membrane K+ channels, and the effect of 
this activity on membrane potential and vascular tone, may also change during juvenile 
growth.  Many studies have found that K+ channel density, mRNA expression, and 
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 sensitivity increase with age.  Whole-cell patch-clamp recordings in type I carotid body 
cells indicate that K+ current density increases with postnatal age in the rat, such that 
between 4 and 10 days, there is an enhanced activation of KCa channels and an increased 
hypoxic sensitivity to K+ currents (Hatton et al., 1997).  In ovine middle cerebral arteries, 
dilator responses to the KATP channel agonist lemakalim are enhanced by maturation, 
with the -log ED50 values for dilation 29 to 43 times greater in adult than in newborn 
arteries (Pearce & Elliott, 1994).  Voltage-gated K+ channel protein and mRNA 
expression in ovine pulmonary arteries also increases with age (Cornfield et al., 2000), as 
does KATP channel density in rat neuronal tissue (Miller et al., 1991). 
 Some investigators have found a change in the relative importance of different K+ 
channels with maturation.  The predominant K+ channel that regulates resting membrane 
potential in the ovine pulmonary circulation changes after birth from a KCa to a KV 
channel (Reeve et al., 1998).  Maturation also modulates the contribution of KV, KCa, and 
KATP channels to basal and/ or serotonin (5HT)-induced cerebrovascular tone in ovine 
middle cerebral arteries, with KV and KCa channel currents also more responsive to 
stretch in adult than in fetal arteries (Teng et al., 2002). 
  
C. Structural Changes during Microvascular Growth 
 
 
An understanding of microvascular network structure is important for assessing 
the ultimate functional impact of any growth-related changes in microvascular tone or its 
regulation.  Anatomical modifications of the vasculature can be dramatic during postnatal 
growth.  For example, the hypertrophic growth of skeletal muscle fibers during juvenile 
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 maturation is accompanied by growth of the vasculature (Enesco & Puddy, 1964; Sillau 
& Banchero, 1977; Ripoll et al., 1979; Aquin et al., 1980).  However, Wang and Prewitt 
(1991) reported that large and small arteriolar density actually decreases from 35 days of 
age to 132 days of age in the cremaster muscle of Wistar rats, suggesting that the rate of 
tissue growth is greater than the rate of network growth.  These investigators determined 
that this arteriolar development primarily consists of increases in length, diameter and 
wall mass of pre-existing vessels, rather than new vessel growth.  Similar findings were 
observed in the rat spinotrapezius muscle, where network growth during maturation 
(from 3-4 weeks, to 7-8 weeks, to 11-12 weeks) occurs by elongation of pre-existing 
vessels with angiogenesis only occurring in the distal segments of transverse arteriolar 
trees (Linderman & Boegehold, 1996).  In this latter study, morphometric analysis 
revealed that there was no significant change in the total number of arcade arteriole 
segments per network even though the muscle dramatically grew during this time. 
Not only are there pronounced reductions in arteriolar density during maturation, 
but capillary density has also been found to progressively decline.  This has been 
observed in hamster cremaster muscle (Sarelius et al., 1981), and rat soleus (Sillau & 
Banchero, 1977), tibialis anterior, and gastrocnemius muscles (Sillau & Banchero, 1977; 
Ripoll et al., 1979).  In growing guinea pig soleus and gastrocnemius muscles, capillary 
density decreases with increased fiber cross-sectional area, but the absolute number of 
capillaries around the fiber increases, as does myoglobin concentration (Aquin et al., 
1980).  These increases may at least partially compensate for the lower capillary density 
to assure adequate O2 delivery in tissue beds of older animals (Aquin et al., 1980). 
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 Muscle fiber type may affect capillary density, and therefore alterations in fiber 
type might be an important influence to consider when analyzing the vascular changes 
that occur during postnatal growth.  Changes in fiber type have, in fact, been 
demonstrated with maturation; in rat tibialis anterior muscle, red fibers increase, but in rat 
soleus muscle, the percentage of red fibers decreases.  These increases or decreases in red 
fibers affects the capillary to fiber (C: F) ratio, with more red fibers leading to higher C: F 
ratio and fewer red fibers leading to decreased C: F ratios (Sillau & Banchero, 1977). 
 
D. Hemodynamic Changes during Microvascular Growth 
 
 
During arteriolar network growth in skeletal muscle, there is a progressive 
increase in microvascular pressure (Zweifach et al., 1981; Wang & Prewitt, 1991; 
Linderman & Boegehold, 1998, 1999).  In our laboratory, we utilized in vivo microscopy 
to study proximal arterioles in the spinotrapezius muscle of rats 4-5 wks, 7-8 wks, and 
11-12 wks of age.  As animals matured, resting diameter and volume flows increased, but 
resting wall shear rate decreased due to a proportionately greater increase in arteriolar 
diameters than in blood flow velocity (Linderman & Boegehold, 1998, 1999).   
 
 
E. Regulation of Microvascular Tone and Tissue Blood Flow during 
Growth 
 
i. Influences on Arteriolar Tone 
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 In growing skeletal muscle, resting arteriolar tone has been found to either 
progressively increase (Proctor et al., 1981; Linderman & Boegehold, 1998), or remain 
relatively constant (Wang & Prewitt, 1991; Linderman & Boegehold, 1999).  Even in 
cases where there is no change in overall resting tone with growth, there is some evidence 
to indicate that the relative importance of the different mechanisms contributing to that 
tone (e.g., influences from endothelium-derived vasoactive factors and smooth muscle 
myogenic activity) may vary greatly over this period.  Our laboratory previously found 
that L-NMMA treatment reduces arteriolar diameters in the spinotrapezius muscle of 
more juvenile rats, but not younger rats (Linderman & Boegehold, 1998; Linderman & 
Boegehold, 1999; Nurkiewicz & Boegehold, 2004), whereas meclofenamate reduces 
resting arteriolar diameters in rats of all ages (Linderman & Boegehold, 1998).  These 
findings suggest that continuously-released NO and vasodilator prostanoids exert a 
moderating influence on arteriolar tone in the juvenile spinotrapezius muscle, whereas 
prostanoids, but not NO, exert such an influence in the younger animals.  Similarly, NOS 
inhibition with L-NAME has no effect on the diameter of pial arterioles in newborn pigs 
(Zuckerman et al., 1996; Willis & Leffler, 2001), but it reduces the diameter of these 
arterioles in juvenile pigs (Willis & Leffler, 2001).  L-NAME significantly constricts 
cerebral resistance arteries from adult mice, but not those from neonatal mice (Geary et 
al., 2003).  In contrast, inhibition of NOS increases renal vascular resistance in conscious 
lambs, but this effect is greatest at 1 week of age and then progressively declines at 3 and 
6 weeks of age (Sener & Smith, 2001).  These heterogeneous observations suggest that 
synthesis of and responses to various endothelium-derived mediators can change with 
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 age, and that these changes in vascular tone regulation may not be consistent among 
different vascular beds or species. 
As in larger vessels, postnatal growth of the microvasculature can be 
accompanied by significant changes in the endothelium-dependent mechanisms that 
mediate acute changes in vascular tone.  For example, the effectiveness of the 
endothelium-dependent dilators ACh or histamine in reducing mesenteric vascular 
resistance in the rat increases from ages 3 weeks to 3 months (Fleisch & Spaethe, 1981).  
Similarly, DeMey and Gray reported a progressive increase in the responsiveness of 
isolated rat mesenteric resistance arteries to ACh or histamine during the first two weeks 
of life.  Furthermore, these investigators found that BK constricted resistance arteries 
from rats less than 4 weeks of age, but elicited an endothelium-dependent dilation of 
those from older rats.  In the microcirculation of the rat sciatic nerve, ACh induces a non-
NO, non-prostanoid-dependent vasodilatation which is larger in 1-2 week old rats than in 
18-20 week old rats (Thomsen et al., 2002). 
In pial arterioles of juvenile pigs, ACh induces an early prostanoid-associated 
constriction followed by a NO-associated dilation, whereas in pial arterioles of newborn 
pigs, ACh induces only a brief prostanoid-associated vasoconstriction (Zuckerman et al., 
1996).  Although the dilation of these vessels to BK relies on the COX and NOS systems 
in both juvenile and newborn pigs, the juvenile vessels are more dependent on NO, 
whereas the newborn vessels are more dependent on prostanoids (Willis & Leffler, 2001).  
Such a finding could reflect age-related differences in COX or NOS expression, or in the 
activity of these enzymes.  Using cultured microvascular ECs from newborn and adult 
pig cortex, Parfenova et al. (2000) found no differences in COX expression or activity 
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 between these groups, but did find higher NOS expression and activity in adult cells than 
in newborn cells.  Cerebrovascular dilations to hypercapnia and histamine are also 
prostanoid dependent in the newborn pig, with NO assuming an increasing role in these 
responses during subsequent growth (Willis & Leffler, 1999).   
Linderman and Boegehold (1999) found no age-related differences in overall 
arteriolar responsiveness to locally applied ACh in the spinotrapezius muscle of rats 4-5 
wks, 7-8 wks, and 11-12 wks of age.  However, they did report that the L-NMMA-
sensitive portion of the ACh response was smaller in mature rats than in weanling rats.  
Although elevation of flow-related shear stress resulted in arteriolar dilation in juvenile 
rats, it had no effect in the weanling rats.  In a subsequent study (Nurkiewicz & 
Boegehold, 2004), arterioles from weanling and juvenile rats exhibited identical dilator 
responses to the Ca2+ ionophore A23187, and these responses were equally sensitive to L-
NMMA in both age groups.  However, the Ca2+-independent agonists VEGF and 
simvastatin elicited dose-dependent, L-NMMA sensitive, arteriolar dilations in juveniles, 
but no or only minimal responses in the weanling group.  These findings suggest that 
Ca2+-dependent signaling pathways for NO release do not change with rapid arteriolar 
network growth during juvenile maturation, whereas Ca2+-independent NO release is 
absent in the weanling endothelium but these pathways become functional during 
maturation.   
Numerous studies indicate that the intrinsic responsiveness of arteriolar smooth 
muscle to NO does not change during microvascular growth, either in skeletal muscle (Li 
& Joshua, 1993; Linderman & Boegehold, 1999) or other vascular beds (Fleisch & 
Spaethe, 1981; Willis & Leffler, 1999).  This suggests that age-related changes in the 
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 contribution of NO to the regulation of arteriolar diameter are primarily attributable to 
functional changes in endothelial cells rather than VSM cells. 
The myogenic response contributes largely to the establishment of basal vascular 
tone, and to autoregulation of blood flow and capillary hydrostatic pressure (Davis & 
Hill, 1999; see Section 2B above).  Although resting tone is due in part to myogenic 
activity, diameter changes in response to an abrupt increase or decrease in transmural 
pressure more clearly define myogenic responsiveness (Su et al., 2003).  As some studies 
suggest that endothelium-dependent control may not be fully developed in early stages of 
postnatal growth, perhaps myogenic activity might be enhanced during this time period.  
Some authors have found that there is an increased intensity of the myogenic response in 
1-day old piglet mesenteric resistance arteries when compared to 10-day old vessels (Su 
et al., 2003).  Pressure-induced myogenic tone is regulated similarly in neonatal and adult 
mouse cerebral arteries, but recent work by Geary and colleagues (2003) indicates that 
the modulation of this activity by endothelial vasoactive factors is age dependent.  In that 
study, whereas L-NAME treatment significantly reduced arterial diameters at all 
pressures (ranging from 20 to 80 mmHg) in adults, it had no effect on neonatal arteries at 
any pressure.  Furthermore, although indomethacin treatment had no effect on either adult 
or neonatal arteries alone, subsequent addition of L-NAME significantly enhanced 
arterial tone over the entire pressure range in both groups.  In arteries pre-treated with L-
NAME, subsequent addition of indomethacin enhanced tone to an even greater extent at 
all pressures in adult arteries, but had no further effect in the neonatal arteries.  Finally, 
during combined NOS/COX inhibition, intrinsic tone was significantly greater in 
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 neonatal than adult arteries, but when the endothelium was removed, tone was similar in 
neonatal and adult arteries at all pressures (Geary et al., 2003). 
 
ii. Tissue Blood Flow and Oxygen Delivery 
 
Various factors that influence tissue O2 delivery and consumption have been 
found to change with growth and development.  For example, capillary hematocrit 
(Sarelius et al., 1981) and skeletal muscle oxidative metabolism (Hudlicka, 1985) 
decrease with maturation.  Capillary red cell content (number per unit length) and 
maximal red cell flux also decrease with age (Berg & Sarelius, 1996).  It appears that 
young animals have superior arteriolar sensitivity to O2 and are able to maintain tissue 
PO2 during muscle contraction more precisely than older animals (Proctor et al., 1981).  
Whereas resting tissue PO2 over a wide range of superfusate PO2 levels is not different in 
the cremaster muscle from hamsters aged 32, 60 and 80 days, increased metabolic 
demand, via muscle stimulation, causes tissue PO2 to decrease significantly in adult 
animals, but not in the immature or intermediate groups.  For any given increase in tissue 
PO2, the arteriolar constriction is also age dependent, with the oldest animals 
demonstrating the smallest response (Proctor et al., 1981). 
Metabolic requirements are constantly changing throughout postnatal growth, and 
skeletal muscle blood flow is distributed according to metabolic demand (Hudlicka, 
1969).  We and others have found an increase in total network blood flow in rat 
spinotrapezius muscle (Linderman & Boegehold, 1999) and rat cremaster muscle (Wang 
& Prewitt, 1991).  However, as the muscle mass increases dramatically during this period 
of growth, blood flow per gram of tissue actually decreases, which is consistent with 
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 numerous studies documenting a progressive decrease in total skeletal muscle blood flow 
during maturation (Hudlicka, 1985).  With postnatal growth, animals also experience 
increases in cardiac output (Teitel & Rudolph, 1985), myoglobin content (Aquin et al., 
1980), and body temperature (Mueggler et al., 1979), and overall decreases in arteriolar 
wall shear stress (Linderman & Boegehold, 1999).  Furtherore, fetal hemoglobin is 
gradually replaced by adult hemoglobin (Teitel & Rudolph, 1985), such that decreases in 
total hemoglobin O2 affinity also occur (Lister et al., 1979). 
Whereas some suggest that younger animals may have a superior blood flow 
regulatory capability (Proctor et al., 1981), Berg and Sarelius (1996) have argued that 
despite all of the changes in RBC flow variables which occur with maturation, the 
capacity for networks to deliver O2 remains constant; even with variability in network 
flow parameters during maturation, mean capillary wall PO2 remains within a narrow 
range both at rest and with maximal dilation.  These investigators attribute this to the 
more extensive recruitment of capillary networks (Berg & Sarelius, 1995), and the higher 
capacity of recruited networks to deliver O2 in adults compared to younger animals.   
It is important to keep in mind that the vascular network is not static.  During 
development the vasculature can accommodate increased metabolic demands or 
decreased O2 supply via a number of methods.  For example, changes in the activity of 
oxidative enzymes, or volume density of mitochondria may allow the network to adapt 
(Hoppeler et al., 1981; Hudlicka, 1985).  Perhaps local hypoxia might trigger an 
induction of capillary growth (Adair et al., 1990), thereby allowing adaptation to 
metabolic needs.  Others have suggested flow-induced shear stress or local changes in 
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growth factors as being possible stimuli for network development (Wang & Prewitt, 
1991; Dawson & Hudlicka, 1993). 
 
6. Conclusion 
 
 
 This literature review highlights the challenges associated with interpreting 
findings from different vascular beds and species, and synthesizing such heterogeneous 
findings into a cogent understanding of how vascular function may change with postnatal 
growth.  Much of the literature is focused on the pulmonary vasculature, which is 
substantially different from that of other vascular beds.  The fetal pulmonary vasculature 
is a high-tone, low flow system, which changes quickly at birth to accommodate an 8-10-
fold increase in blood flow and an increase in intravascular pressure (Dawes et al., 1953; 
Cassin et al., 1964).  Given all these differences among species, vessel sizes, and 
preparations, caution must be taken when synthesizing a coherent analysis of postnatal 
vascular changes.  However, Table 2 summarizes some of the general trends that have 
been observed with growth and development in the larger and smaller vessels.   
Investigators have studied mechanisms regulating arteriolar tone across a wide 
variety of tissues and organs, and much has been learned about these complex 
mechanisms.  However, there is much less known about how these mechanisms may 
change during postnatal growth and maturation.  A thorough understanding of the normal 
changes in endothelial/ smooth muscle signaling pathways and vascular mechanics 
during postnatal growth may lead to a better understanding of the pathophysiological 
changes that can also occur over this time in some disease states.  
       Table 2: Changes in endothelium-dependent vascular control during postnatal growth: A summary of findings from the literature 
 
Animal Tissue Stimulus Change in Vascular 
Response 
(↑, ↓, ↔) 
Ages Studied  Investigators 
Rat  
(Sprague- 
Dawley)  
Mesenteric artery ACh, histamine ↑ with age 3 wks, 3 mo, 6 mo Fleisch & Spaethe, 
1981 
Rat 
(Wistar-
Kyoto) 
Mesenteric artery ACh, histamine ↑ during 1st 2 wks, but are 
then maintained throughout 
adult life 
4, 7, 14, 28, 80, 280 
days 
DeMey & Gray, 1985 
Rat 
(Wistar-
Kyoto) 
Mesenteric artery BK Constriction until 4 wks, then 
relaxation 
4, 7, 14, 28, 80, 280 
days 
DeMey & Gray, 1985 
Rat 
(Wistar) 
Mesenteric artery histamine ↓ with age 2-8 weeks, 13 wks, 
56 wks 
Moritoki et al., 1986 
Pig Pulmonary artery ACh, BK, A23187 ↑ with age 3, 10, 30 days Zellers & Vanhoutte, 
1991 
Sheep Pulmonary artery ACh ↑ with age fetal, newborn, adult Kolber et al., 2000 
Sheep Pulmonary artery A23187 ↑ with age Fetal, 4 wks Mata-Greenwood et 
al., 2006 
Sheep Pulmonary artery ACh, BK ↓ with age 2 d, 1 mo O'Donnell et al., 1996 
Rat 
(Wistar-
Kyoto) 
Aorta ACh ↓ with age 4-6 wks, 3-6 mo, 
12-25 mo 
Koga et al., 1989 
(continued on next page)  
 57 
  58 
Animal Tissue Stimulus Change in Vascular 
Response 
(↑, ↓, ↔) 
Ages Studied  Investigators 
Rat 
(Wistar-
Kyoto) 
Aorta ATP Endothelium-independent 
relaxation (4-6 wks) to 
endothelium-dependent 
relaxation (13-14 wks) 
4-6, 9-10, 13-14 
wks 
Koga et al., 1992 
Dog Aorta ACh ↓ with age fetal, newborn, adult Torok & Gerova, 
1996 
Pig Pial arteriole ACh, BK Newborn relies on 
prostaglandins, juvenile relies 
more on NO 
Newborn, 3-4 mo Zuckerman et al., 
1996; Willis & 
Leffler, 2001 
Rat  
(Sprague- 
Dawley) 
Spinotrapezius 
muscle 
ACh: 
 
 
 
 
 
 
Increased shear 
stress: 
No difference in response, 
although L-NMMA-sensitive 
part of this response was 
smaller in mature rats 
 
 
 
No response in weanlings, but 
dilation in juveniles 
4-5, 7-8, 11-12 wks Linderman & 
Boegehold, 1999 
Rat  
(Sprague-
Dawley) 
Spinotrapezius 
muscle 
A23187: 
 
 
VEGF/Simvastatin: 
No difference in responses 
 
 
No response in weanlings, but 
dose-dependent responses in 
juveniles  
4-5 wks, 7-8 wks Nurkiewicz & 
Boegehold, 2004 
 7. Dissertation Objectives 
 
Because there are few studies that have investigated how postnatal growth affects 
microvascular function, we undertook these experiments, in part, to help fill a critical gap 
in the literature.  Specifically, we wanted to gain further insight into growth-related 
changes in the control of skeletal muscle arterioles.   
A clearer understanding of how the endothelium and smooth muscle work 
together to translate biochemical signals into vascular responses during blood vessel 
growth may ultimately lead to the identification of new therapeutic targets for the 
endothelial dysfunction associated with cardiovascular diseases that can begin to develop 
well before adulthood.  
The specific aims of each study within this project are listed below. 
 
Study 1 
We undertook this study to more completely understand how growth affects 
endothelium-dependent control of skeletal muscle arterioles.  This was the first step 
toward a greater appreciation of how microvascular function is altered during postnatal 
development, and was the springboard for all subsequent studies. 
 
Study 2 
Because H2O2 can serve as an important endothelium-derived vasoactive factor in 
the cerebral microcirculation of newborn pigs, we undertook this study to determine if 
H2O2 also mediates endothelium-dependent dilation in skeletal muscle arterioles of young 
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 rats.  A second aim of this study was to determine if there are any age-related differences 
in the mechanism by which H2O2 can influence arteriolar smooth muscle tone.  
 
Study 3 
Because CO has been identified as an important vasoactive factor in the cerebral 
microcirculation of newborn pigs, we undertook this study to determine if CO could be 
playing a similar role in the endothelium-dependent dilation of skeletal muscle arterioles 
from young rats.  A second aim of this study was to determine if there the mechanism by 
which CO influences arteriolar tone undergoes a change during rapid juvenile growth. 
 
Study 4 
We previously found that gracilis muscle arterioles from weanling rats develop a 
significantly higher level of resting tone than arterioles from juvenile rats, suggesting that 
arteriolar smooth muscle responsiveness to myogenic stimuli may be greater in the 
younger rats.  We therefore undertook this study to more rigorously investigate potential 
alterations in myogenic activity that may occur during microvascular network maturation 
in skeletal muscle arterioles. 
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 II. STUDY 1: Growth-Dependent Changes in Endothelial 
Factors Regulating Arteriolar Tone 
 
Used with permission from The American Physiological Society 
(granted May 30, 2007) 
 
Abstract 
 
 Previous studies from this laboratory suggest that during maturation, rapid 
microvascular growth is accompanied by changes in the mechanisms responsible for 
regulation of tissue blood flow.  To further define these changes, we studied isolated 
gracilis muscle arterioles from weanling (~25 days) and juvenile (~44 days) Sprague- 
Dawley rats to test the hypothesis that endothelial mechanisms for the control of 
arteriolar tone are altered with growth.  Responses to the endothelium-dependent dilator 
acetylcholine (ACh) were greater in weanling arterioles (WA) than in juvenile arterioles 
(JA), whereas there were no consistent differences between age groups in arteriolar 
responses to other endothelium-dependent agonists (A23187, VEGF and simvastatin).  
Inhibition of nitric oxide synthase (NOS) with L-NAME attenuated ACh-induced dilation 
in JA, but not in WA.  In JA, combined inhibition of NOS and cyclooxygenase (with 
indomethacin) reduced the dilator responses to ACh and simvastatin by ~90% and ~70%, 
respectively, but had no effect in WA.  Cytochrome P450 epoxygenase inhibition (with 
PPOH) had no effect on responses to ACh or simvastatin in either age group.  Inhibition 
of Ca2+-activated or ATP-dependent potassium channels (with TEA or glibenclamide, 
respectively) reduced these arteriolar responses in JA but not WA.  These findings 
suggest that in fully grown microvascular networks, endothelium-dependent arteriolar 
dilation is mediated by the combined release of endothelial nitric oxide and vasodilator 
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 prostanoids, and in part through activation of KCa and KATP channels.  However, during 
earlier microvascular growth, this dilation is mediated by other factors yet to be 
identified.  This may have significant implications for the regulation of tissue perfusion 
during microvascular development. 
Introduction 
 
There is mounting evidence to suggest that postnatal growth of the 
microvasculature is accompanied by progressive changes in a number of factors that can 
influence arteriolar tone and blood flow (Zellers & Vanhoutte, 1991; Olesen et al., 1994; 
Linderman & Boegehold, 1996, 1999; Nurkiewicz & Boegehold, 2004).  During this 
rapid growth phase, the overall impact of any phenotypic changes in the endothelium or 
vascular smooth muscle could also be amplified or otherwise modulated by concomitant 
changes in arteriolar wall structure and/or local hemodynamic forces (Zweifach et al., 
1981; Wang & Prewitt, 1991; Linderman & Boegehold, 1999).  Profound growth-related 
changes also occur at the capillary level.  For example, in growing skeletal muscle, there 
is an increase in total tissue blood flow and in the absolute number of capillaries (Aquin 
et al., 1980; Wang & Prewitt, 1991), but a decrease in capillary density, capillary 
hematocrit, and individual capillary blood flow (Sarelius et al., 1981).  Some of these 
changes may be necessary for the microvasculature to continually adapt to the changing 
metabolic demands associated with rapid tissue growth (Berg & Sarelius, 1996). 
Growth-related changes in endothelial function were first documented in conduit 
arteries.  Koga and colleagues reported that in rat aorta, endothelial P2 purinergic 
receptors coupled to the L-arginine/nitric oxide (NO) pathway are nonfunctional at 4-6 
weeks of age, but become fully functional by 13 weeks (Koga et al., 1992). This same 
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 group also found that rat aorta undergoes a progressive decline in its overall 
responsiveness to acetylcholine (ACh) from approximately 4 weeks to 4 months of age 
(Koga et al., 1989).  Not surprisingly, such changes in responsiveness can begin soon 
after birth.  For example, the endothelium-dependent relaxation of small porcine 
pulmonary arteries to ACh and BK increases from 3 to 10 days of age (Zellers & 
Vanhoutte, 1991).  In some cases, these changes may also be biphasic; BK causes 
endothelium-dependent contraction of small rat mesenteric arteries until 4 weeks of age, 
but endothelium-dependent relaxation of these vessels in older animals (DeMey & Gray, 
1985).   
Less is known about growth-related changes in endothelial function at the 
microvascular level.  Willis and Leffler (2001) have reported that although pial arterioles 
in newborn and juvenile pigs show similar responsiveness to BK, the predominant 
mediators of this dilation are endothelium-derived prostanoids in newborns and 
endothelium-derived NO in juveniles.  Previous studies in our laboratory demonstrated 
that although arteriolar responsiveness to ACh in rat spinotrapezius muscle is similar at 4 
and 8 weeks of age, these responses are more sensitive to L-NMMA in the 4 week-old 
animals, suggesting a greater contribution of NO to the overall dilation (Linderman & 
Boegehold, 1999).  We have also reported that vascular endothelial growth factor 
(VEGF) and simvastatin elicit a dose-dependent dilation of these arterioles at 8 weeks of 
age, but not at 4 weeks of age (Nurkiewicz & Boegehold, 2004).  These two agonists 
stimulate endothelial NO release via activation of the phosphatidylinositol 3-kinase 
(PI3K)/Akt pathway, leading to direct phosphorylation and increased activity of eNOS at 
low cytoplasmic Ca2+ levels (Kureishi et al., 2000).  Therefore, Ca2+-independent 
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 signaling pathways for endothelial NO release may not yet be functional in arterioles of 
the younger animals.   
We undertook the current study to gain further insight into these growth-related 
changes in the endothelium-dependent control of skeletal muscle arterioles.  In this study, 
arterioles were isolated and studied in vitro to eliminate the possibility of any indirect and 
potentially complicating effects on arteriolar behavior due to circulating or tissue-derived 
factors.  A clearer understanding of how the endothelium translates biochemical signals 
into vascular responses during blood vessel growth may ultimately lead to the 
identification of new therapeutic targets for the endothelial dysfunction associated with 
cardiovascular diseases that can begin to develop well before adulthood.  
 
Materials and Methods 
 
Animals:  All surgical and experimental procedures were approved by the West 
Virginia University Animal Care and Use Committee.  Experiments were performed on 
isolated gracilis muscle arterioles from male Sprague-Dawley rats (Harlan Sprague 
Dawley, Indianapolis, IN) of two age groups: 3-4 weeks (“weanlings”) and 6-7 weeks 
(“juveniles”).   
Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 
mg/kg body weight), with supplemental anesthetic (10% of original dose) administered if 
needed.  The right carotid artery was cannulated with polyethylene tubing (PE-10 for 
weanlings, PE-50 for juveniles) for measurement of mean arterial pressure, which was 
assessed before removal of gracilis arteriole.  
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 Preparation of Isolated Vessels:  An arteriolar branch of the femoral artery 
supplying the gracilis muscle was removed, handling only the surrounding connective 
tissue to minimize vessel stretching or damage.  The rat was then sacrificed immediately 
following vessel removal by intracardiac injection of sodium pentobarbital.  The vessel 
was then placed in warmed physiological salt solution (PSS) equilibrated with 21% O2, 
5% CO2, and 74% N2 and having the following composition (mM): 119 NaCl, 4.7 KCl, 
1.17 MgSO4, 1.6 CaCl2, 1.18 NaH2PO4, 24 NaHCO3, 0.026 EDTA, and 5.5 glucose.  
After isolation, each vessel was prepared for in vitro video microscopy as previously 
described (Fredricks et al., 1994a).  Briefly, the vessel was mounted in a heated (37º C) 
chamber that allowed its lumen and exterior surface to be perfused and superfused, 
respectively, with PSS from separate reservoirs.  The vessel was cannulated at both ends 
with glass micropipettes (50- and 70-µm tip diameters for weanling and juvenile vessels, 
respectively) and secured to the inflow and outflow pipettes using 9-0 nylon suture.  Any 
side branches were ligated with a single strand teased from 6-0 silk suture.  The inflow 
pipette was connected to a reservoir perfusion system for control of intralumenal pressure 
and flow.  The vessel was then extended to its in situ length and equilibrated at 80% of 
the animal’s mean arterial pressure to approximate its in vivo perfusion pressure (DeLano 
et al., 1991). 
Vessel diameter was measured using an onscreen video micrometer.  Any vessel 
that did not demonstrate endothelial viability, as judged by responsiveness to 10-7 M 
ACh, was not used in the study.  Diameter measurements were made under static, zero-
flow conditions after a 30-minute equilibration period with continuous perfusion.  
Resting vascular tone was calculated as (∆D/Dmax)•100, where ∆D is the diameter 
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 increase from rest in response to Ca2+-free PSS (30-40 minute equilibration with Ca2+-
free bath solution and no lumenal flow), and Dmax is the maximum diameter measured 
under these conditions.   
Agonists:  All agonists were dissolved in PSS unless otherwise noted.  ACh 
(Sigma Chemical, St. Louis, MO), at bath concentrations of 10-5, 10-6, or 10-7 M, and the 
Ca2+-ionophore A23187 (Sigma) at a bath concentration of 10-9 M, were used to assess 
arteriolar capacity for Ca2+-dependent endothelial NO formation (Ungvari et al., 2001).  
To produce the desired concentration, 1 milligram A23187 was first dissolved in 50 µl of 
dimethylsulfoxide (DMSO) and then diluted with Dulbecco’s phosphate-buffered saline 
(PBS) before addition to the bath. 
VEGF (BD Biosciences, Lexington, KY) and simvastatin (Merck Research 
Laboratories, Rathway, NJ) were used to assess arteriolar capacity for Ca2+-independent 
endothelial NO formation (Nurkiewicz & Boegehold, 2004).  VEGF was dissolved in 
PBS at a concentration of 5 µg/ml and added directly to the bath.  Simvastatin was 
activated by alkaline lysis (5.25 ml of 0.1 N NaOH per 140 mg, dissolved in 3.5 ml of 
ETOH) at 50ºC for 2 h.  The resulting solution was then diluted to a volume of 35 ml 
with PBS, and neutralized to pH 7.4 with HCl.  One-ml aliquots of this solution were 
then serially diluted with PBS, producing a final bath concentration of 10-4, 10-5, 10-6, or 
10-7 M.   
To assess intrinsic vascular smooth muscle responsiveness to NO, the 
endothelium-independent vasodilator sodium nitroprusside (SNP, Sigma) was used at 
bath concentrations of 10-5 M and 10-7 M. 
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 Endothelial Denudation:  To determine the role of the endothelium in mediating 
arteriolar responses to ACh and simvastatin, the endothelium was removed by 
mechanical abrasion (Uluoglu & Zengil, 2003).  The pipette tips on both sides of the 
vessel were gently advanced through the vessel lumen at least three times to ensure 
elimination of the endothelium.  In order to ensure that the endothelial denudation did not 
adversely affect underlying arteriolar smooth muscle, vasoconstrictor responses to 10-5 M 
phenylephrine and vasodilator responses to 10-5 M SNP were assessed before and after 
the denudation procedure, and only those vessels with unchanged responses to both 
agonists were included in this study. 
Inhibition of NOS, Cyclooxygenase, and Cytochrome P450 Enzymes:  To 
determine the contribution of endothelial NO production to arteriolar dilation, the NOS 
inhibitor Nω-nitro-L-arginine methyl ester (L-NAME) was added to the bath at a 
concentration of 10-4 M (Frisbee et al., 2001).  To assess the contribution of vasodilator 
prostanoids, the cyclooxygenase inhibitor indomethacin was added to the bath at a 
concentration of 10-6 M (Fredricks et al., 1994a).  To assess the specific contribution of 
cytochrome P450 (CP450) epoxygenase-derived metabolites of arachidonic acid, the 
selective suicide substrate inhibitor 6-(2-propargyloxyphenyl) hexanoic acid (MS-PPOH) 
was added to the bath at a concentration of 10-5 M (Wang et al., 1998).  All inhibitors 
were purchased from Sigma. 
Inhibition of Potassium Channels:   Since endothelium-derived hyperpolarizing 
factors (EDHFs) modulate arteriolar tone through activation of potassium channels 
(Welsh & Segal, 2000; Coleman et al., 2001), the contribution of EDHFs to arteriolar 
dilation was assessed by using tetraethylammonium (TEA) (Fredricks et al., 1994b; 
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 Lombard et al., 1999; Fallet et al., 2001), or the antidiabetic sulphonylurea, 
glibenclamide (Lombard et al., 1999).  We used a 10-3 M bath concentration of TEA to 
selectively block Ca2+-activated K+ (KCa) channels (Nelson & Quayle, 1995), and 10-6 M 
glibenclamide to selectively block KATP channels (Standen et al., 1989). 
To independently assess the effectiveness of these inhibitors in blocking 
potassium channels, we used 1-(2’-hydroxy-5’-trifluoromethylphenyl)-5-trifluoromethyl-
2(3H)benzimidazolone (NS 1619), a synthetic BKCa channel opener, (Fallet et al., 2001) 
(Olesen et al., 1994), and pinacidil, a nonspecific KATP channel opener (24).  NS 1619 
was dissolved in ETOH to a produce a 69 mM stock solution, which was then diluted to a 
30 µM bath concentration with PSS (Olesen et al., 1994; Fallet et al., 2001).  A 10-2 M 
stock solution of pinacidil (in 100% DMSO) was diluted with PSS to produce a final bath 
concentration of 10-5 M (Mabanta et al., 2006).  At their final bath concentrations, neither 
the ETOH vehicle nor the DMSO vehicle had any effect on resting arteriolar diameters, 
indicating that they were not intrinsically vasoactive.  After the response to either 
potassium channel opener was assessed under control conditions, the response was re-
assessed after treatment of the vessel with TEA and glibenclamide separately and then in 
combination. 
Data and Statistical Analyses:  To account for age-related differences in resting 
and passive arteriolar diameters (see Table 1), dilator responses were expressed as 
percent of maximum dilation ([diameter change/(Dmax – control diameter)] x 100). 
 All data are presented as mean ± SE.  For all analyses, a probability value of p < 
0.05 was considered to be statistically significant.  Dilation in response to Ca2+-free PSS 
is expressed as percent increase from control diameter.  Differences between the means 
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 of individual experimental groups were determined by ANOVA/Newman-Keuls test, or 
by an unpaired Student’s t-test when two means were compared.   
 
Results 
 
General characteristics of all rats from which vessels were removed are reported 
in Table 1.  Age, body weight, and mean arterial pressure were significantly greater in 
juvenile rats than in weanling rats.  Table 1 also summarizes the general characteristics of 
all vessels studied.  Resting and passive diameters of arterioles from juvenile rats were 
significantly greater than those of arterioles from weanling rats, whereas the level of 
spontaneous tone that developed with vessel pressurization was significantly less in 
juvenile arterioles than in weanling arterioles. 
All agonists dilated both weanling and juvenile arterioles, with a slightly smaller 
dilation to ACh seen in juvenile arterioles (Figure 1).  However, there were no consistent 
differences between age groups in the magnitude of dilation to the other agonists, except 
for a moderately smaller response of juvenile arterioles to 10-7 M simvastatin (Figure 1).  
Neither L-NAME nor indomethacin treatment, alone or in combination, changed the 
resting diameters of either juvenile or weanling arterioles (data not shown).  For juvenile 
arterioles, the mean response to a concentration of each agonist that initially caused close 
to half-maximal dilation was reduced by 60-90% in the presence of L-NAME (Figure 2, 
top panel).  Indomethacin significantly reduced only those responses to A23187 and 
simvastatin (by 90% and 63%, respectively).  In contrast, the responses of weanling 
arterioles to each of these agonists were unaffected by L-NAME or indomethacin (bottom 
panel). 
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 The remainder of this study was focused exclusively on arteriolar responses to 
ACh and simvastatin.  As shown in Figure 3, removal of the endothelium completely 
abolishes the arteriolar dilation to each agonist in both age groups, verifying that these 
responses are endothelium-dependent.  Simultaneous exposure to L-NAME and 
indomethacin reduced the mean dilator responses of endothelium-intact juvenile 
arterioles to ACh and simvastatin by ~90% and ~70%, respectively (Figure 4, top panel), 
but had no effect on the responses of weanling arterioles to these agonists (bottom panel).  
In contrast, juvenile and weanling arterioles exhibited similar responses to two different 
concentrations of SNP (Figure 5). 
 PPOH had no effect on the resting diameters of either juvenile or weanling 
arterioles (data not shown), and PPOH by itself had no effect on the responses of juvenile 
or weanling arterioles to either ACh or simvastatin (Figure 6).  Furthermore, whereas 
juvenile arteriolar responses to ACh and simvastatin were greatly reduced by PPOH + L-
NAME + indomethacin, the magnitude of this effect was similar to that of L-NAME + 
indomethacin without PPOH (Figure 4, top panel).  The combination of PPOH, L-NAME 
and indomethacin had no effect on the responses of weanling arterioles to ACh or 
simvastatin (Figure 6, bottom panel). 
Glibenclamide had no effect on the resting diameters of either weanling or 
juvenile arterioles, whereas 1 mM TEA reduced the resting diameters of both juvenile 
and weanling arterioles by approximately the same amount (10-12%) (Table 2).  The 
combination of glibenclamide + TEA significantly reduced the resting diameters of both 
juvenile and weanling arterioles by approximately the same amount as TEA alone.  
Glibenclamide alone had no significant effect on the dilation of juvenile arterioles to 
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 ACh, but reduced the dilation of these vessels to simvastatin (Figure 7, left).  In contrast, 
TEA alone markedly reduced the responses of these vessels to both agonists (Figure 7, 
center).  Consistent with glibenclamide’s lack of effect on ACh responses, glibenclamide 
and TEA in combination reduced these responses by the same magnitude as TEA alone 
(Figure 7, right).  Glibenclamide + TEA also abolished juvenile arteriolar responses to 
simvastatin.  Neither glibenclamide nor TEA, alone or in combination, reduced the 
dilation of weanling arterioles to either agonist (Figure 7, bottom panels).  Responses of 
weanling arterioles to ACh also remained unchanged when bath TEA concentration was 
increased to 5 mM, although responses to 10-5 M simvastatin were reduced (by 44.5 ± 
0.4%) under these conditions (data not shown).   
Treatment with glibenclamide significantly attenuated responses to the KATP 
channel opener pinacidil in both weanling and juvenile arterioles (Table 3).  Although 
treatment with 1mM TEA also attenuated the pinacidil responses of weanling arterioles, 
it had no effect on these responses in juvenile arterioles.  Treatment with both 
glibenclamide and TEA attenuated pinacidil responses in both groups.  Treatment with 
glibenclamide had no effect on arteriolar responses to the BKCa channel opener NS 1619 
in either group, whereas TEA abolished these responses in both groups (Table 4).  As 
expected, the effect of glibenclamide + TEA on NS 1619-induced dilation (complete 
abolition) was the same as that of TEA alone in both groups.   
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 Table 1: General characteristics of all rats and vessels used in this study 
 
Animal Characteristics Weanlings Juveniles 
N 68 52 
   Age (days) 25.3 ± 0.3 42.0 ± 0.7 * 
   Body Weight (g) 63.1 ± 1.3 181.4 ± 2.9 * 
   MAP (mmHg) 82.3 ± 0.9 100.2 ± 1.4 * 
Vessel Characteristics Weanlings Juveniles 
n 68 52 
   Resting Diameter (µm) 44.1 ± 1.5 61.6 ± 2.1 * 
   Passive Diameter (µm) 67.8 ± 1.9 85.6 ± 2.2 * 
   Resting Vascular Tone (%) 34.5 ± 1.6 28.0 ± 1.5 * 
Values are given as means ± SE.  * P<0.05 vs. weanling group.  
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 Table 2: Summary of vessel diameters under control conditions and after treatment with 
glibenclamide and TEA separately and in combination 
  
Arteriolar Diameter (µm) 
 Control 
[n=8] 
Glib Control 
[n=5-6] 
TEA Control 
[n=8] 
Glib + TEA 
Weanlings 39.8±4.0 39.6±3.8 42.3±2.5 38.3±2.6* 39.8±4.0 34.2±3.6* 
Juveniles 55.3±3.7 55.2±3.9 56.7±3.7 49.8±4.5* 55.3±3.7 47.8±3.0* 
 
Values are given as means ± SE.  * P<0.05 vs. Control.
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 Table 3: Responses to the KATP channel opener pinacidil  
 
 Pinacidil 
 
[n=5-6] 
Pinacidil 
+ Glib 
Pinacidil 
 
[n=4] 
Pinacidil 
+ TEA 
Pinacidil 
 
[n=5-6] 
Pinacidil 
+ 
Glib/TEA 
Weanlings 56.7±9.3 9.4±3.0* 50.2±6.6 24.7±7.1* 56.7±9.3 13.0±5.0* 
Juveniles 56.7±5.4 14.7±4.5* 43.6±3.5 33.7±6.0 56.7±5.4 11.5±1.1* 
 
Responses of arterioles (in % maximum dilation) from weanling and juvenile rats to 
pinacidil (10-5 M) before and after inhibition of KATP channels with 10-6 M glibenclamide 
(Glib) or inhibition of KCa channels with 1 mM TEA, separately and in combination.  
Values are given as means ± SE.  * P<0.05 vs. preceding response to pinacidil. 
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 Table 4: Responses to the BKCa channel opener NS 1619  
 
 NS 1619 
 
[n=5] 
NS 1619 + 
Glib 
NS 1619 
 
[n=4] 
NS 1619 
+ TEA 
NS 1619 
 
[n=5] 
NS 1619 
+ 
Glib/TEA 
Weanlings 30.6±4.4 32.6±6.9 58.0±22.1 3.7±6.4* 30.6±4.4 -1.5±2.6* 
Juveniles 31.3±2.6 31.9±2.8 32.5±11.5 -15.0±4.7* 31.3±2.6 1.9±1.9* 
 
 
Responses of arterioles (in % maximum dilation) from weanling and juvenile rats to NS 
1619 (30 µM) before and after inhibition of KATP channels with 10-6 M glibenclamide 
(Glib) or inhibition of KCa channels with 1 mM TEA, separately and in combination.  
Values are given as means ± SE.  * P<0.05 vs. preceding response to NS 1619.  
 75
 Figure 1: Responses of isolated gracilis muscle arterioles from weanling and juvenile 
rats to ACh, simvastatin, A23187 and VEGF 
Weanlings 
(n=18) 
Juveniles 
(n=17) 
%
 M
ax
im
um
 D
ila
tio
n
0
10
20
30
40
50
60 A23187 (10-9 M) 
%
 M
ax
iu
m
um
 D
ila
tio
n
0
10
20
30
40
50
60 VEGF (5 µg/ml) 
Weanlings 
(n=18) 
Juveniles 
(n=14) 
%
 M
ax
im
um
 D
ila
tio
n
0
10
20
30
40
50
60
%
 M
ax
im
um
 D
ila
tio
n
0
10
20
30
40
50
60
70
ACh 
Simvastatin 
Weanlings 
Juveniles 
Weanlings 
Juveniles 
(n=31) 
(n=51) (n=39) 
(n=57) 
* 
10-7 M 10-5 M 
(n=52) 
(n=37) 
* 
* 
 
 
n = number of vessels.  Values are given as means ± SE.  *p<0.05 vs. Weanlings at same 
agonist concentration.  
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 Figure 2: Responses of arterioles from juvenile and weanling rats to ACh, simvastatin, 
A23187 and VEGF after either L-NAME or indomethacin treatment 
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Data are presented under control conditions and following inhibition of NOS with L-
NAME (10-4 M) and cyclooxygenase with indomethacin (10-6 M).  n = number of 
vessels.  Values are given as means ± SE.  * p<0.05 vs. Control.  
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 Figure 3: Effect of endothelial removal on responses of juvenile and weanling arterioles 
to ACh and simvastatin 
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n=number of vessels. Values are given as means ± SE.  * p<0.05 vs. vessel with intact 
endothelium. 
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 Figure 4: Effect of combined NOS and COX inhibition on responses of juvenile and 
weanling arterioles to ACh and simvastatin 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control.  
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 Figure 5: Responses of arterioles from weanling and juvenile rats to SNP 
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n = number of vessels.  Values are given as means ± SE. 
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 Figure 6: Responses of arterioles from juvenile and weanling rats to ACh and 
simvastatin before and after inhibition of cytochrome P-450 epoxygenases with PPOH, 
alone and in combination with NOS + COX inhibition. 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control.  
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 Figure 7: Responses of arterioles to ACh and simvastatin before and after KATP and KCa 
channel inhibition  
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Responses of arterioles from juvenile and weanling rats to ACh and simvastatin before 
and after inhibition of KATP channels with glibenclamide (left panels), inhibition of KCa 
channels with 1 mM TEA (center panels), and combined inhibition of KATP and KCa 
channels (right panels).  n = number of vessels.  Values are given as means ± SE. * 
p<0.05 vs. control.  
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 Discussion 
 
Growth-related changes in the responsiveness of conduit arteries to endothelium-
dependent agonists have been well documented (DeMey & Gray, 1985; Koga et al., 
1989; Zellers & Vanhoutte, 1991; Koga et al., 1992).  Some investigators have reported 
varying degrees of such changes in endothelial function in the microcirculation (Nelson 
& Quayle, 1995; Linderman & Boegehold, 1999; Willis & Leffler, 2001), and the present 
study was designed to obtain further information on the endothelial factors that could 
control arteriolar tone at two different stages of juvenile growth.  Our findings indicate 
that for juvenile arterioles, endothelium-dependent dilations to the agonists we used are 
mediated largely by NO, with vasodilator prostanoids also making an important 
contribution to these responses in some cases.  However, metabolites of CP450 
epoxygenase do not appear to contribute to any of the responses we investigated, 
although the clear role of potassium channels in these responses is consistent with the 
possibility that another type of EDHF is involved.  In contrast, the endothelium-
dependent dilation of weanling arterioles does not appear to rely on endothelial NO, 
prostanoids, CP450 epoxygenase products or any other EDHF. 
BK-induced dilation of newborn porcine pial arterioles relies on prostaglandins, 
but becomes more reliant on NO release during juvenile growth (Willis & Leffler, 2001).  
Consistent with these observations, cyclooxygenase expression and activity is similar in 
newborn and adult porcine cerebral microvessels, whereas the adult microvessels have 
significantly higher NOS expression and activity (Parfenova et al., 2000).  From our 
current observations, it appears that NO, and in some cases cyclooxygenase products, 
contributes to the endothelium-dependent dilation of gracilis muscle arterioles from 
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 juvenile, but not weanling rats (Figures 2 and 4).  The absence of a role for NO in the 
endothelium-dependent dilation of weanling arterioles could theoretically be due to a lack 
of NO production, an accelerated breakdown of NO, or a reduced responsiveness of 
vascular smooth muscle to NO.  The latter possibility appears unlikely, in light of the 
similar responsiveness to SNP in both age groups (Figure 5).  This has been a consistent 
finding in other studies as well (Koga et al., 1989; Zellers & Vanhoutte, 1991; Linderman 
& Boegehold, 1999; Nurkiewicz & Boegehold, 2004). 
In adult animals, there is convincing evidence that endothelium-derived 
hyperpolarizing factors (EDHF) can contribute to endothelium-dependent arteriolar 
dilation (Rubanyi, 1993; Mombouli et al., 1996; Shimokawa et al., 1996).  EDHF also 
appears to be an important mediator of vasodilation in the neonatal cerebral 
microcirculation (Lacza et al., 2002).  Although there is no single EDHF, metabolites of 
arachidonic acid by cytochrome P450 epoxygenase appear to play this role in rat 
cremaster muscle arterioles (McSherry et al., 2006).  To assess the potential role of 
CP450 4A-derived epoxyeicosatrienoic acids in the dilator responses we studied, the 
vessels were exposed to PPOH, a selective inhibitor of arachidonate epoxygenation 
reactions catalyzed by CP450 enzymes.  PPOH had no effect on responses to ACh or 
simvastatin in either juvenile or weanling arterioles (Figure 6).  In juvenile arterioles, the 
reduction of ACh- and simvastatin-induced dilation by L-NAME + indomethacin + 
PPOH was not different from that caused by L-NAME + indomethacin without PPOH 
(Figure 4).  In weanling arterioles, addition of PPOH + L-NAME + indomethacin did not 
reduce responses to either ACh or simvastatin. Collectively, these observations indicate 
that CP450 epoxygenase metabolites do not contribute to the endothelium-dependent 
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 dilation of gracilis muscle arterioles from juvenile or weanling rats, which is consistent 
with previous findings in gracilis muscle arterioles of older (12 week-old) rats (Ungvari 
& Koller, 2001). 
It is possible that an EDHF derived from some other enzymatic pathway could 
have contributed to endothelium-dependent dilation in either or both of the age groups we 
studied.  EDHFs generally exert their effects through activation of vascular smooth 
muscle K+ channels (Welsh & Segal, 2000; Coleman et al., 2001).  Although some 
studies indicate that EDHFs only activate KCa channels (Ungvari & Koller, 2001), others 
have documented that KATP channels can also be activated by EDHFs (Brayden, 1990; 
Feletou & Vanhoutte, 1996).  Therefore, we chose to target both of these channel types as 
potential mediators of dilation.  The KATP channel inhibitor glibenclamide completely 
abolished simvastatin responses in juvenile arterioles, but had no effect on these 
responses in weanling arterioles, and had no effect on ACh responses in either juvenile or 
weanling arterioles (Figure 7).  Although inhibition of KCa channels with 1mM TEA 
significantly reduced responses to both acetylcholine and simvastatin in juvenile 
arterioles (by 72-79%), it had no effect on these dilations in weanling arterioles.  
Inhibition of both KATP and KCa channels reduced responses to ACh by 60% - 70% and 
completely abolished responses to simvastatin in juvenile arterioles, but had no effect on 
the responses of weanling arterioles.  We also used a high dose of TEA (5 mM) to block 
all KCa channels as well as other potential potassium channels in the weanling arterioles 
(Korn & Trapani, 2005), but only achieved a slight attenuation of the response to 10-5 M 
simvastatin (data not shown).  Therefore, although juvenile arterioles apparently rely on 
 85
 an EDHF to mediate dilations, we were not able to detect a contribution of EDHF to 
weanling arteriole dilations from our use of these potassium channel antagonists. 
The KATP channel opener pinacidil dilated arterioles from rats of both age groups 
(Table 3), indicating the presence of recruitable KATP channels that are capable of 
modulating vascular smooth muscle tone.  However, glibenclamide, at a concentration 
that inhibits most of this KATP channel activity, has no effect on the resting tone of 
arterioles from either group (Table 2).  This suggests that if there is some level of KATP 
channel activity in these arterioles under our steady-state conditions, it is not sufficient to 
modulate smooth muscle contractile activity.  In contrast, TEA, at a concentration that 
blocks the effect of a BKCa channel opener on arteriolar tone (Table 4), reduces the 
resting diameter of arterioles from both age groups by approximately the same amount 
(Table 2).  This suggests that under resting conditions, there is ongoing arteriolar BKCa 
channel activity that is high enough to influence smooth muscle contractile activity, and 
that the magnitude of this effect does not appreciably change during rapid juvenile 
growth.  This apparent influence of BKCa channel activity on gracilis muscle arteriolar 
tone is consistent with previous findings for this vessel (Ungvari & Koller, 2001), but 
these observations do not extend to arterioles in all skeletal muscles.  Other investigators 
have found that smooth muscle KCa channel activity is “silent” in arterioles under resting 
conditions in both hamster and rat cremaster muscle (Jackson, 2005).  Our interpretations 
based on the effects of TEA should be made with some caution; although TEA at a 
concentration of 1 mM will preferentially block KCa channels, the relatively broad 
specificity of this compound allows it to antagonize other types of potassium channels 
under some conditions (Fatherazi & Cook, 1991).  This may have occurred to some 
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 extent in the current study, as evidenced from our finding that 1 mM TEA did have some 
effect on the response of weanling arterioles to the KATP channel opener pinacidil (Table 
3). 
Consistent with the apparently similar influence of BKCa channels on resting tone 
in both age groups, the selective BKCa channel opener NS 1619 was as effective in 
dilating weanling arterioles as in dilating juvenile arterioles, with these responses being 
completely abolished by 1mM TEA in both age groups (Table 4).  This is not consistent 
with previous reports that there are changes in KCa channel activity and density with 
maturation and growth.  Teng et al (Teng et al., 2002) found that stretch-induced 
activation of KCa channels exert a greater effect on resting vascular tone in cerebral 
arteries from adult sheep than in those from fetal sheep.  Other investigators, using 
whole-cell patch-clamp recordings, determined that carotid body KCa channel expression 
increases with postnatal age in the rat (Hatton et al., 1997).  It is not clear why these 
differences exist, but perhaps some of the discrepancy can be explained by the use of 
different preparations and vessel size. 
Direct microvascular pressure measurements indicate that in situ, lumenal 
pressure in the vessels we studied is equal to approximately 80% of mean arterial 
pressure (DeLano et al., 1991).  When equilibrated at this pressure in vitro, arterioles 
from weanling rats develop a significantly higher level of resting tone than arterioles 
from juvenile rats (Table 1), suggesting that arteriolar smooth muscle responsiveness to 
myogenic stimuli could be greater in the younger rats.  However, a rigorous assessment 
of this possibility, which would require a determination of the different levels of 
myogenic tone developed over a wide range of intravascular pressures in each age group, 
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 is beyond the scope of this study.  Nevertheless, it may be germane to point out that over 
a wide range of lumenal pressures, the spontaneous tone developed by isolated small 
cerebral arteries from newborn mice is far greater than that developed by the same 
arteries from 6-8 week-old mice (Geary et al., 2003).  However, this is apparently not due 
to a greater myogenic responsiveness of smooth muscle in the younger vessels, but rather 
to less moderation of this myogenic tone by endothelial factors in these vessels.  It is 
possible that such a differential effect of the endothelium could also account for the 
difference in tone between the two age groups studied here, but this seems unlikely 
because we found no evidence for any endothelial modulation of resting tone, even in 
mature vessels (i.e., no effect of L-NAME, indomethacin or PPOH on resting arteriolar 
diameters).   
Using an in vivo exteriorized spinotrapezius muscle preparation, our laboratory 
previously found that Ca2+-independent signaling pathways for endothelial NO release do 
not appear to be operational in arterioles of weanling rats (Nurkiewicz & Boegehold, 
2004).  However, in the current study on isolated gracilis muscle arterioles, we found no 
systemic age-related differences in responsiveness to agonists that promote either Ca2+-
dependent NO release (acetylcholine, A23187) or Ca2+-independent NO release 
(simvastatin, VEGF), with the exception of the slightly smaller dilation of juvenile 
arterioles to one concentration of acetylcholine (Figure 1).  This discrepancy may be due 
to the inherent heterogeneity between vascular beds.   
As can be seen from Table 1, the period from 25 to 42 days of age is one of rapid 
juvenile growth in the rat, characterized by almost a 3-fold increase in body mass.  The 
phases of human growth that correspond to these ages are somewhat imprecise because 
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 they depend to some extent on the variables that are being compared.  For example, if a 
comparison is made on the basis of projected weight gain, then our 25-day old and 42-
day old rats, with average weights that are respectively 11% and 33% of an expected 550 
g adult weight (from comparing Table 1 with Harlan Sprague Dawley growth tables), 
would roughly correspond to boys at the ages of 2 and 8 years (from CDC growth charts).  
However, if the comparison is made on the basis of current age relative to an average life 
expectancy of 728 days for the rat (Harlan Sprague Dawley) vs. 71.5 years for U.S. males 
(CDC), then these ages in the rat would roughly correspond to boys at 2 and 4 years of 
age.  Finally, if the comparison is made on the basis of current age in relation to mean age 
of sexual maturity (57 days for rats; 13 years for human males), these ages in the rat 
would roughly correspond to boys at 6 and 10 years of age. 
 In conclusion, at any given time, the tone of skeletal muscle arterioles does not 
reflect a single mechanism, but rather an integrated effect of multiple mechanisms that, to 
some extent, may compensate for one another should one pathway be abolished.  
Endothelium-dependent arteriolar dilation in juvenile rats appears to be mediated by the 
combined release of endothelial nitric oxide and vasodilator prostanoids, with a non-
CP450-derived hyperpolarizing factor possibly also contributing to the dilation.  
However, during earlier microvascular growth, this dilation is mediated by other factors 
yet to be identified. 
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 III. STUDY 2: Hydrogen Peroxide Emerges as a Regulator of 
Arteriolar Tone in Skeletal Muscle during Juvenile Growth 
 
Used with permission from The Microcirculatory Society 
(granted June 12, 2007) 
 
Abstract 
 
 Endothelium-dependent dilation of skeletal muscle arterioles is mediated by 
factors that are yet to be identified in young rats, and partly mediated by at least one 
unidentified hyperpolarizing factor in older juvenile rats.  We assessed the possible 
contribution of hydrogen peroxide (H2O2) to this arteriolar dilation at both of these 
growth stages.  Gracilis muscle arterioles were isolated from rats at ages 24-26 days 
(weanlings) and 46-48 days (juveniles).  Simvastatin and ACh induced endothelium-
dependent dilations that were attenuated by catalase in juvenile, but not weanling, 
arterioles.  Juvenile, but not weanling, arterioles also displayed catalase-sensitive 2′,7′ 
dichlorofluorescein fluorescence that was increased by ACh.  In juvenile arterioles, 
exogenous H2O2 induced constriction at low concentrations and dilation at higher 
concentrations.  In weanling arterioles, H2O2 induced only constriction or had no effect.  
Responses to low and high concentrations of H2O2 were attenuated by NOS inhibition in 
juvenile, but not weanling, arterioles, but equally attenuated by endothelial removal in both 
groups.  In intact weanling and juvenile arterioles, the K+ channel inhibitors TEA and 
glibenclamide abolished constrictions to lower levels of H2O2, and unmasked constrictor 
responses to higher levels of H2O2.  These findings suggest that endogenous H2O2 
contributes to endothelium-dependent arteriolar dilation in juvenile rats but not in 
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 younger rats, and that this H2O2 acts in juvenile rats partly by stimulating endothelial NO 
release and activating K+ channels. 
 
Introduction 
 
Although increased levels of hydrogen peroxide (H2O2) are sometimes 
responsible for the vascular dysfunction associated with certain disease states (Lum & 
Roebuck, 2001; Cai, 2005), H2O2 at lower concentrations has also been recognized as an 
important signaling molecule that can mediate normal vascular function (Kunsch & 
Medford, 1999; Chen et al., 2003).  For example, endothelium-derived H2O2 has been 
identified as one of the factors that mediate arteriolar dilation to some agonists in the 
cerebral (Sobey et al., 1997), mesenteric (Matoba et al., 2000) and coronary (Matoba et 
al., 2003, Oltman et al.,, 2003) vascular beds, and there is mounting evidence for a true 
physiological role of arteriolar H2O2 in local coronary blood flow regulation (Miura et 
al., 2003; Yada et al., 2003; Koller & Bagi, 2004).  Our laboratory has recently reported 
that endogenous H2O2 can also contribute to the arteriolar dilation and hyperemia that 
accompanies skeletal muscle contraction (Marvar & Boegehold, 2006).  However, in that 
study we were not able to determine the extent to which this H2O2 originates from the 
arteriolar wall versus the surrounding muscle fibers.  In fact, there is little information on 
whether arterioles in skeletal muscle are intrinsically capable of releasing vasoactive 
amounts of H2O2 in response to any stimulus.   
Other studies from our laboratory have documented that postnatal growth of the 
microvasculature in skeletal muscle is accompanied by progressive changes in a number 
of factors that can influence arteriolar tone and blood flow (Linderman & Boegehold, 
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 1996; Linderman & Boegehold, 1999; Lum & Roebuck, 2001; Balch Samora et al., 
2007).  For example, skeletal muscle arterioles from young rats exhibit endothelium-
dependent dilation, but these responses are not mediated by either nitric oxide (NO) or 
cyclooxygenase metabolites, as they are in arterioles from mature rats (Balch Samora et 
al., 2007).  The endothelial factors that mediate this dilation in young arterioles have not 
been identified, but because H2O2 can serve as an important endothelium-derived 
vasoactive factor in the cerebral microcirculation of newborn pigs (Lacza et al., 2002), 
we undertook the current study to determine if H2O2 also mediates endothelium-
dependent dilation in skeletal muscle arterioles of young rats.  Arterioles from the gracilis 
muscle of rapidly-growing rats at two different ages were isolated and studied in vitro.  A 
second aim of this study was to determine if there are any age-related differences in the 
mechanism by which H2O2 can influence arteriolar smooth muscle tone.  
 
Materials and Methods 
 
Animals:  All surgical and experimental procedures were approved by the West 
Virginia University Animal Care and Use Committee.  Experiments were performed on 
gracilis muscle arterioles isolated from male Sprague-Dawley rats (Harlan Sprague 
Dawley, Indianapolis, IN) at 3-4 weeks of age (“weanlings”) or 6-7 weeks of age 
(“juveniles”).   
Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 
mg/kg body weight), with supplemental anesthetic (10% of original dose) administered if 
needed.  The right carotid artery was cannulated with polyethylene tubing (PE-10 for 
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 weanlings, PE-50 for juveniles) to measure mean arterial pressure before removal of the 
gracilis arteriole.  
Preparation of Isolated Vessels:  An arteriolar branch of the femoral artery 
supplying the gracilis muscle was removed, handling only the surrounding connective 
tissue to minimize vessel stretching or damage.  The rat was sacrificed by intracardiac 
injection of sodium pentobarbital immediately after vessel removal.  The vessel was 
placed in warmed physiological salt solution (PSS) equilibrated with 21% O2, 5% CO2, 
and 74% N2, and having the following composition (mM): 119 NaCl, 4.7 KCl, 1.17 
MgSO4, 1.6 CaCl2, 1.18 NaH2PO4, 24 NaHCO3, 0.026 EDTA, and 5.5 glucose.  After 
isolation, each vessel was prepared for in vitro video microscopy as previously described 
(Fredricks, Liu & Lombard, 1994).  Briefly, the vessel was mounted in a heated (37º C) 
chamber that allowed for its lumen and exterior surface to be perfused and superfused, 
respectively, with PSS from separate reservoirs.  The vessel was cannulated at both ends 
with glass micropipettes (50- and 70-µm tip diameters for weanling and juvenile vessels, 
respectively) and secured to the inflow and outflow pipettes using 9-0 nylon suture.  Any 
side branches were ligated with a single strand teased from 6-0 silk suture.  The inflow 
pipette was connected to a reservoir perfusion system for control of intralumenal pressure 
and flow.  The vessel was then extended to its in situ length and equilibrated at 80% of 
the animal’s mean arterial pressure to approximate its normal in vivo perfusion pressure 
(DeLano et al., 1991). 
Vessel diameter was measured using an onscreen video micrometer.  Any vessel 
that did not demonstrate endothelial viability, as judged by at least a 10% dilation in 
response to 10-7 M acetylcholine (ACh, Sigma Chemical, St. Louis, MO), was not used 
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 in the study.  Using this criterion, approximately 1 in 10 vessels from each age group 
were discarded.  In such cases, we then isolated and studied the identical arteriole from 
the animal’s contralateral gracilis muscle.  As a result, we were able to obtain a viable 
arteriole from each animal.  Diameter measurements were made under static, zero-flow 
conditions after a 30-minute equilibration period with continuous perfusion.  Resting 
vascular tone was calculated as (∆D/Dmax) x 100, where ∆D is the diameter increase from 
rest in response to Ca2+-free PSS (30-40 minute equilibration with Ca2+-free bath solution 
and no lumenal flow), and Dmax is the maximum diameter measured under these 
conditions.   
Agonists:  ACh, at bath concentrations of 10-5 or 10-7 M, was used to assess 
arteriolar capacity for Ca2+-dependent endothelial NO formation (Ungvari et al., 2001).  
Simvastatin (Merck Research Laboratories, Rathway, NJ) was used to assess arteriolar 
capacity for Ca2+-independent endothelial NO formation (Nurkiewicz & Boegehold, 
2004).  Simvastatin was activated by alkaline lysis (5.25 ml of 0.1 N NaOH per 140 mg, 
dissolved in 3.5 ml of ETOH) at 50ºC for 2 h.  The resulting solution was then diluted to 
a volume of 35 ml with PBS, and neutralized to pH 7.4 with HCl.  One-ml aliquots of this 
solution were then serially diluted with PBS, producing a final bath concentration of 10-5 
or 10-7 M.  The two concentrations of each agonist were applied in random order, 
separated by a washout period to allow the vessel to regain resting tone. 
For exogenous H2O2 application, a 3% H2O2 aqueous solution was diluted with 
PSS to concentrations of 1x10-6, 5x10-6, 1x10-5, 5x10-5, and 1x10-4 M, and these 
increasing concentrations were sequentially added to the bath.  After each application, the 
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 H2O2 was washed out of the chamber with PSS, and the vessel was allowed to return to 
its control diameter before the next H2O2 application. 
Assessment of Arteriolar H2O2 Production:  2′,7′ dichlorodihydrofluorescein 
diacetate (DCFH-DA) was used to detect intracellular H2O2 production (Miura et al., 
2003; Silveira et al., 2003) in arterioles at rest or during exposure to 10-5 M ACh, either 
with or without catalase (Sigma, 80 U/ml, from bovine liver) present in the bath.  To 
ensure maximal scavenging of H2O2, this concentration of catalase was higher than the 
concentration we have previously found to scavenge all H2O2 formed during arteriolar 
superoxide (O2-) generation in vivo (Lenda et al., 2000).   
Non-fluorescent DCFH-DA freely enters the cell, where it is de-acetated to DCFH 
and then oxidized by H2O2 to form fluorescent 2′,7′ dichlorofluorescein (DCF) (Tarpey & 
Fridovich, 2001).  Under some conditions, DCFH can also be oxidized in vivo by cellular 
peroxidases, peroxynitrite, or even hypochlorous acid (Tarpey & Fridovich, 2001; Silveira 
et al., 2003).  Therefore, we considered only the portion of DCF fluorescence that could be 
reduced by catalase as an indicator of H2O2 activity.   
 After the arteriole was isolated, cannulated and allowed to develop spontaneous 
tone at 80% of mean arterial pressure, 5x10-5 M DCFH-DA was added to the vessel bath 
under one of the conditions described above.  After 20 minutes of exposure to DCFH-
DA, the arteriole was quickly removed from the glass micropipettes and transferred to the 
stage of a fluorescence microscope coupled to a high-sensitivity black and white CCD 
video camera (Dage-MTI, Michigan City, IN), and then epi-illuminated for 1 second 
using a mercury lamp and the appropriate excitation and emission filters for detection of 
DCF fluorescence (460-490 nm excitation, 515-550 nm barrier).  In all cases, an 
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 instantaneous image of the vessel was obtained immediately upon opening of the 
illumination diaphragm, with identical illumination settings and optical parameters used 
for each vessel.  Metamorph software (v. 6.01, Universal Imaging, Downingtown PA) 
was used to acquire, digitize and store images for subsequent analysis (Zhu et al., 2004).  
Average fluorescence intensity was determined for the entire vessel wall (V) as well as 
for the background (B) of each vessel.  Fluorescence intensity, based on the standard 0-
255 gray scale (Klabunde & Anderson, 2002), was quantified using the following 
equation: 
B
BVI MAX −−= 255%  
where %IMAX  is percent of maximum fluorescence intensity, V is the intensity of the 
vessel wall, and B is the background. 
Scavengers and Inhibitors: To assess the role of reactive oxygen species in 
vessel responses, vessels were pretreated with catalase (see above) or the membrane-
permeable superoxide dismutase (SOD) mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine 
1-oxyl (tempol) (Thiemermann, 2003) (Sigma, 10-4 M), alone or in combination.  These 
agents were added to the bath for 30 minutes before vessels were challenged with 
agonists.  As a control for active catalase, the effects of denatured catalase on arteriolar 
responses to ACh and H2O2 were also assessed.  For denaturization, catalase was boiled 
for 10 minutes.  To determine the contribution of endothelial NO production to vessel 
responses, the NOS inhibitor Nω-nitro-L-arginine methyl ester (L-NAME) was added to 
the bath at a concentration of 10-4 M for 20 minutes before agonist challenge (Frisbee et 
al., 2001). 
 100
  Since many endothelium-derived relaxing factors reduce arteriolar tone at least in 
part through activation of smooth muscle potassium (K+)  channels (Welsh & Segal, 
2000; Coleman et al., 2001; Ungvari et al., 2002), the contribution of these channels to 
arteriolar dilation was assessed by using tetraethylammonium (TEA, Sigma) (Fredricks et 
al., 1994; Lombard et al., 1999; Fallet et al., 2001), and the antidiabetic sulphonylurea, 
glibenclamide (Sigma) (Lombard et al., 1999), in both intact and endothelium-denuded 
vessels (see below).  We used a 10-3 M bath concentration of TEA to selectively block 
Ca2+-activated K+ (KCa) channels (Nelson & Quayle, 1995), and 10-6 M glibenclamide to 
selectively block KATP channels (Standen et al., 1989).   
Endothelial Denudation:  To determine the role of the endothelium in mediating 
arteriolar responses to exogenous H2O2, the endothelium was removed in some 
experiments by mechanical abrasion (Uluoglu & Zengil, 2003).  The pipette tip at each 
end of the vessel was gently advanced through the vessel lumen at least three times to 
ensure elimination of the endothelium.  We have previously verified that this method 
successfully denudes the endothelium of gracilis muscle arterioles without affecting the 
underlying smooth muscle (Balch Samora, 2007). 
 All data are presented as mean ± SE.  For all analyses, a probability value of p < 
0.05 was considered to be statistically significant.  Dilation in response to Ca2+-free PSS 
is expressed as percent increase from control diameter.  Differences between the means 
of individual experimental groups were determined by ANOVA/Newman-Keuls test, or 
by an unpaired Student’s t-test when two independent means were compared.   
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 Results 
 
General characteristics of all rats from which vessels were removed for functional 
studies are reported in Table 1.  Age, body weight, and mean arterial pressure were 
significantly greater in juvenile rats than in weanling rats.  Table 1 also summarizes the 
general characteristics of all arterioles utilized for functional studies.  Resting and passive 
diameters of the arterioles from juvenile rats were significantly greater than those of the 
arterioles from weanling rats, whereas there was no difference between groups in the level 
of spontaneous tone (resting vascular tone) that developed with vessel pressurization. 
There were no differences between age groups in overall arteriolar responsiveness to 
ACh or simvastatin (Figure 1).  Treatment with catalase, tempol, or catalase + tempol had 
no effect on the resting diameter of either weanling or juvenile arterioles (Table 2).  
However, catalase dramatically reduced responses to ACh and simvastatin in juvenile 
arterioles, but not in weanling arterioles (Figure 2, left panels).  Denatured catalase had no 
effect on responses to ACh in either group (Table 3), verifying that the effects of catalase 
on juvenile arterioles were specifically due to the enzymatic activity of the molecule.  
Tempol by itself was without effect on responses to ACh or simvastatin in either group.  In 
the juvenile arterioles, combined treatment with both catalase and tempol reduced ACh and 
simvastatin responses to levels that were not different from those with catalase treatment 
alone (top right panel).  In weanling arterioles, catalase + tempol had no effect on responses 
to either agonist (bottom right panel).    
A total of 26 juvenile arterioles and 22 weanling arterioles were examined after 
DCFH-DA exposure for determination of relative H2O2 levels.  Compared to their 
respective control levels, 10-5 M ACh significantly increased DCF fluorescence in juvenile 
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 arterioles (from 29 ± 4 to 44 ± 4% of maximum intensity), but not in weanling arterioles 
(Figure 3).  Catalase reduced DCF fluorescence under control conditions as well as during 
ACh exposure in juvenile arterioles, but had no significant effect in weanling arterioles.    
Application of exogenous H2O2 at concentrations ranging between 1x10-6 and 1x10-4 
M elicited concentration-dependent responses from juvenile arterioles, with the lower 
concentrations causing constriction and the higher concentrations causing dilation (Figure 
4).  In 44% of these vessels, the dilation to higher concentrations of H2O2 was preceded 
by a transient constriction.  Weanling arterioles also constricted in response to H2O2 at the 
lower concentrations, and these constrictions were significantly greater than those of the 
juvenile arterioles.  However, whereas juvenile arterioles clearly dilated in response to 
higher concentrations of H2O2, weanling vessels did not. 
Treatment with L-NAME had no significant effect on the resting diameters of either 
juvenile arterioles (51.3 ± 4.4 μm before vs. 48.1 ± 5.7 μm after L-NAME) or weanling 
arterioles (41.8 ± 3.4 μm vs. 39.3 ± 2.8 μm).  However, L-NAME significantly attenuated 
the constriction of juvenile arterioles to H2O2 at the lowest concentration (10-6 M), and 
reduced the dilations of these vessels in response to higher concentrations of H2O2 (Figure 5, 
top panel).  In contrast, L-NAME had no significant effect on weanling arteriolar responses 
to H2O2 at any concentration (bottom panel).  Subsequent addition of catalase to the bath 
completely abolished the residual L-NAME-insensitive dilation of juvenile arterioles (top 
panel), and abolished the constriction to 1x10-6 M and 5x10-6 M H2O2 in weanling arterioles 
(bottom panel).   
  Treatment with TEA + glibenclamide significantly reduced the resting diameters 
of juvenile arterioles (50.9 ± 4.7 μm before vs. 35.9 ± 3.3 μm after treatment) and weanling 
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 arterioles (35.9 ± 3.3 μm vs. 29.7 ± 1.5 μm).  When expressed as percent reduction from 
control diameter, the magnitude of this effect was similar in the two groups (25-29%).  
For juvenile arterioles, TEA + glibenclamide abolished constrictor responses to 1x10-6 
and 5x10-6 M H2O2, and converted the dilator responses to higher concentrations of H2O2 
into constrictor responses (Figure 6, top panel).  For weanling arterioles, TEA + 
glibenclamide converted the constrictor responses to lower concentrations of H2O2 into 
dilator responses but led to constrictor responses to H2O2 at higher concentrations (Figure 
6, bottom panel).  Both weanling and juvenile arterioles constricted to the two higher 
doses of H2O2 when pretreated with TEA + glibenclamide, with the constriction of 
weanling arterioles being significantly greater than that of juvenile arterioles. 
Endothelial removal tended to reduce the resting diameters of juvenile arterioles 
(53.7 ± 2.3 μm before vs. 47.3 ± 4.2 μm after de-endothelialization) and weanling arterioles 
(35.9 ± 2.7 μm vs. 29.1 ± 1.8 μm), but these reductions did not reach statistical 
significance.  However, removal of the endothelium significantly reduced the constrictor 
responses to 1x10-6 M and 5x10-6 M H2O2 in both juvenile and weanling arterioles, as 
well as constrictor responses to 1x10-5 M H2O2 in weanling arterioles (Figure 7).  The 
dilation of juvenile arterioles to the higher concentrations of H2O2 (5x10-5, 1x10-4 M) was 
also significantly attenuated by endothelial removal.  Treatment of the de-endothelialized 
vessels with TEA + glibenclamide further reduced the dilator responses to H2O2 in 
juvenile arterioles, but had no further effect on the constrictor responses in either group. 
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   Table 1: General characteristics of all rats and vessels used for functional studies 
 
Animal Characteristics Weanlings Juveniles 
N 42 39 
   Age (days) 25.2 ± 0.3 46.3 ± 0.8 * 
   Body Weight (g) 57.6 ± 1.2 170.4 ± 3.3 * 
   MAP (mmHg) 79.5 ± 1.9 96.4 ± 2.1 * 
Vessel Characteristics Weanlings Juveniles 
n 42 39 
   Resting Diameter (µm) 39.1 ± 1.4 55.9 ± 2.0 * 
   Passive Diameter (µm) 58.2 ± 1.8 82.6 ± 1.7 * 
   Resting Vascular Tone (%) 32.2 ± 2.0 32.3 ± 1.9  
 
MAP = mean arterial pressure. Values are given as means ± SE.  * P<0.05 vs. weanling 
group.  
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Table 2: Summary of resting vessel diameters under control conditions and after 
treatment with catalase and tempol, separately and in combination 
 
Arteriolar Diameter (µm) 
 Control 
 
Catalase 
(80 U/ml) 
Control 
 
Tempol 
(10-4 M) 
Control 
 
Catalase + 
Tempol 
Weanlings 45.4 ± 3.9 42.7 ± 4.5 45.4 ± 3.9 42.9 ±4.6 43.2 ± 2.6 43.4 ± 4.2 
Juveniles 64.0 ± 4.0 62.4 ± 4.8 64.0 ± 4.0 58.2 ± 4.5 63.8 ± 3.8 59.9 ± 6.1 
 
Values are given as means ± SE.  
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 Table 3: Magnitude of arteriolar diameter changes in response to ACh and H2O2 before 
and after treatment with denatured catalase 
 
 Weanlings (n=3) Juveniles (n=3) 
 Control Inactivated 
catalase 
Control Inactivated 
catalase 
10-5 M ACh 32.3 ± 3.6 41.2 ± 7.9 32.8 ± 2.8 39.7 ± 7.6 
10-6 M H2O2 -22.5 ± 10.4 -22.4 ± 9.4 -13.4 ± 2.7 -11.7 ± 5.0 
10-5 M H2O2 -22.4 ± 9.4 -26.6 ± 11.1 -0.69 ± 4.1 -2.3 ± 1.1 
10-4 M H2O2 -7.2 ± 3.9 -3.0 ± 3.0 16.8 ± 3.8 18.5 ± 8.0 
 
Values are given as means (% maximum dilation) ± SE.  n = number of vessels. 
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 Figure 1: Responses of gracilis muscle arterioles from juvenile and weanling rats to ACh 
and simvastatin 
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n = number of vessels.  Values are given as means ± SE.   
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 Figure 2: Effect of catalase and tempol, alone and in combination, on responses of 
juvenile and weanling arterioles to ACh and simvastatin  
10-7 M 
Acetylcholine Simvastatin 
10-5 M 10-5 M 10-7 M 
%
 M
ax
im
um
 D
ila
tio
n
0
20
40
60
80
100
Control
Catalase
Tempol
%
 M
ax
im
um
 D
ila
tio
n
0
20
40
60
80
100
Juvenile Rats (n=11)
Weanling Rats (n=6)
%
 M
ax
im
um
 D
ila
tio
n
0
20
40
60
80
100
Control
Catalase+Tempol
%
 M
ax
im
um
 D
ila
tio
n
0
20
40
60
80
100
Juvenile Rats (n=10)
Weanling Rats (n=12)
10-7 M 
Acetylcholine Simvastatin 
10-5 M 10-5 M10-7 M 
10-7 M 10-5 M 10-7 M 
Acetylcholine Simvastatin 
10-5 M 
10-7 M 10-5 M 10-7 M 
Acetylcholine Simvastatin 
10-5 M 
* 
* 
* 
* 
* 
* 
* 
* 
  
 
n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control.  
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 Figure 3: Effect of ACh, alone or with catalase, on DCF fluorescence intensity  
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Representative microscopic images showing DCF fluorescence in arterioles exposed to 
DCFH-DA.  Left: juvenile vessels.  Right: weanling vessels.  Bottom panel: Effect of 10-5 
M ACh, alone or with catalase, on mean DCF fluorescence intensity in weanling and 
juvenile arterioles.  * p<0.05 vs. Control in same age group.  † p<0.05 vs. ACh in same 
age group.   ‡p<0.05 vs. Control in juvenile arterioles. 
 110
 Figure 4: Responses of juvenile and weanling arterioles to exogenous H2O2 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. juvenile arterioles. 
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 Figure 5: Responses of juvenile and weanling arterioles to exogenous H2O2, before and 
after L-NAME treatment, alone and in combination with catalase 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control. 
 112
 Figure 6: Responses of juvenile and weanling arterioles to exogenous H2O2 before and 
after inhibition of KCa channels and KATP channels 
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n = number of vessels.  Values are given as means ± SE. * p<0.05 vs. Control. 
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 Figure 7: Effect of endothelial removal on responses of juvenile and weanling arterioles 
to exogenous H2O2 before and after combined treatment with TEA and glibenclamide 
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n=number of vessels. Values are given as means ± SE.  * p<0.05 vs. Control. 
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 Figure 8: Schematic diagram illustrating possible elements of the signaling pathways 
through which H2O2 may elicit either arteriolar constriction or arteriolar dilation  
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 Discussion 
 
Growth-related changes in microvascular endothelial function have been reported 
by our laboratory and others (Linderman & Boegehold, 1999; Willis & Leffler, 2001; 
Nurkiewicz & Boegehold, 2004; Balch Samora, 2007).  In a recent study (Balch Samora, 
2007), we found that skeletal muscle arterioles from mature rats exhibit endothelium-
dependent dilations to ACh  and simvastatin that are due in part to endothelial NO 
release, with vasodilator prostanoids and at least one unidentified endothelium-derived 
hyperpolarizing factor (EDHF) also contributing to these responses in some cases.  
However, in that study, we also found that the endothelium-dependent dilation of 
arterioles from younger (weanling) rats is not mediated by any of these factors.  Since 
H2O2 can mediate endothelium-dependent dilation in the cerebral circulation of newborn 
pigs (Lacza et al., 2002), we undertook the current study in part to determine if H2O2 
could be playing an analogous role in the skeletal muscle circulation of weanling rats.   
 
Contribution of H2O2 to endothelium-dependent responses of juvenile arterioles 
Exogenous catalase greatly reduced the dilation of juvenile arterioles to both ACh 
and simvastatin (Figure 2).  Furthermore, we found a large, catalase-sensitive component 
of DCF fluorescence in these vessels at rest (approximately 50% of total fluorescence) 
that was further increased (to approximately 63% of total fluorescence) when the vessels 
were challenged with ACh (Figure 3, bottom panel).  These findings indicate that 
endogenous H2O2 contributes to, rather than opposes, the dilation of these vessels to ACh 
and simvastatin, and suggests that these agonists stimulate a relatively large increase in 
H2O2 within the arteriolar wall.  Furthermore, our recent finding that endothelial removal 
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 completely abolishes both ACh- and simvastatin-induced dilation of these arterioles 
(Balch Samora, 2007) indicates that this H2O2 is endothelial in origin. 
The O2- from which this H2O2 is formed could be generated during electron 
transport within the mitochondria, or from the intracellular activity of various enzymes, 
including membrane-bound NADPH oxidase, xanthine oxidase, cyclooxygenase, 
cytochrome P450 monooxygenase or nitric oxide synthase (Cai & Harrison, 2000).  
Mitochondrial and cytosolic SODs would quickly convert this O2- to H2O2, which can 
diffuse across the plasma membrane and into the extracellular space (Cai & Harrison, 
2000; Abid et al., 2001).  It is also possible that some H2O2 may be generated 
extracellularly from O2- formed by xanthine oxidase (Li et al., 2001;Seshiah et al., 2002; 
Coyle et al., 2006).  Because it is uncharged, relatively stable and freely diffusible, 
extracellular H2O2 could diffuse to nearby cells and exert its effect (Griendling & 
Harrison, 1999; Chen et al., 2003). 
Because any agonist-induced increase in H2O2 production must first involve 
increased O2- formation, we initially expected that in the presence of the SOD mimetic 
tempol, ACh or simvastatin application would trigger a greater amount of H2O2 
production and therefore a larger dilation.  However, we did not find this to be the case 
(Figure 2, top panel), which suggests that the intrinsic SOD capacity of these vessels may 
be high enough to dismutate all of the additional O2- that is formed in response to these 
agonists, such that treatment with tempol would have no additional effect.  
The responses of juvenile arterioles to exogenously applied H2O2 were complex, 
with lower concentrations of H2O2 eliciting constriction and higher concentrations of 
H2O2 eliciting dilation (Figure 4).  The constrictor responses were reduced by both NOS 
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 inhibition (Figure 5, top panel) and endothelial removal (Figure 7, top panel), and 
completely abolished by inhibition of K+ channels (Figure 6, top panel).  H2O2 can 
stimulate O2- formation in ECs (Coyle et al., 2006), and O2- readily interacts with 
endothelial NO to produce peroxynitrite (ONOO-), which increases the tone of gracilis 
muscle arterioles by inhibition of KCa channel activity (Frisbee et al., 2002).  Our 
findings are therefore consistent with a role for ONOO- as a mediator of these 
constrictions.  However, such a mechanism would be difficult to reconcile with our 
speculation that SOD activity is normally high in these vessels.  Although high SOD 
activity could explain why tempol does not increase arteriolar responses to ACh or 
simvastatin, it would reduce the likelihood of there being excess O2- available to interact 
with NO during exposure to H2O2 at low concentrations.  It is possible that the amount of 
O2- generated during H2O2 application is greater than that generated during ACh or 
simvastatin application, since H2O2 can activate NAD(P)H oxidase in both endothelium 
and vascular smooth muscle to produce O2- in a feed-forward mechanism (Li et al., 2001; 
Seshiah et al., 2002; Coyle et al., 2006).  In our juvenile arterioles, 10-6 M H2O2 may 
therefore increase O2- production to the point that it supersedes the system’s capacity for 
dismutation of this O2-.  With the resulting accumulation of O2-, there could be significant 
ONOO- formation if local NO levels are sufficiently high.  In contrast, neither ACh nor 
simvastatin, at the concentrations we used, may have triggered a large enough increase in 
H2O2 to stimulate this accelerated O2- production.   
Cseko et al (2004) found that although H2O2-induced constriction of gracilis 
muscle arterioles could be completely abolished by the prostaglandin H2 /thromboxane 
A2 (PGH2/TxA2) receptor antagonist SQ-29548, this H2O2-induced constriction was only 
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 reduced (not abolished) by endothelial removal.  This suggests that H2O2 increases 
arteriolar tone via the release of constrictor prostanoids from both the endothelium and 
vascular smooth muscle.  The possibility that ONOO- may mediate juvenile arteriolar 
constriction to 10-6 M H2O2 in our current study does not necessarily conflict with these 
earlier findings.  Cseko and colleagues did not study the effect of SQ-29548 on responses 
to H2O2 at concentrations less than 3 x 10-5 M, which is 300 times the concentration at 
which we suggest that H2O2 may lead to ONOO- formation.  At 5x10-6 M H2O2, which is 
closer to the minimum concentration used by Cseko et al., and at still higher 
concentrations that actually overlap those used by Cseko et al., we found no evidence that 
would suggest a role for ONOO- in the constriction, raising the possibility that 
PGH2/TxA2 could be mediating the constriction at these concentrations of H2O2 in our 
study as well.   
The dilation of juvenile arterioles to higher concentrations of H2O2 was also 
reduced following endothelial removal (Figure 7), implying an important role for 
endothelium-derived mediators in these responses as well.  Endothelial removal has also 
been shown to reduce H2O2-induced dilation in mouse coronary arterioles (Thengchaisri 
& Kuo, 2003).  However, these findings contrast with a report by Miura et al. that 
endothelial denudation does not affect H2O2-induced dilation of human coronary 
arterioles (Miura et al., 2003).  Although this may reflect species-specific differences, it 
could also be due to different study conditions.  The coronary arterioles studied by Miura 
et al. were obtained from patients with various diseases (e.g., coronary artery disease, 
diabetes mellitus, hypertension), and therefore could have displayed some degree of EC 
dysfunction, including impairment of NO bioavailability, oxidative stress, and even EC 
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 injury and apoptosis (Simionescu, 2007).  It is possible that the mechanism by which 
H2O2 influences vascular tone may be altered under pathologic conditions.  
As shown in the top panel of Figure 5, inhibition of NOS in intact juvenile 
arterioles reduced the magnitude of H2O2-induced dilation to a level similar to that 
achieved by de-endothelialization, which implicates endothelium-derived NO as a major 
contributor to this response.  We also found that blockade of KCa and KATP channels 
completely abolished the residual endothelium-independent portion of this dilation 
(Figure 7, top panel), suggesting that there is also a direct relaxing effect of H2O2 on 
vascular smooth muscle in these vessels due to K+ channel activation.  This is consistent 
with previous studies demonstrating that H2O2 can induce smooth muscle 
hyperpolarization and vasodilation by opening K+ channels, although the main 
contributing channel type (i.e., KCa vs. KATP channels) can vary with the species or 
vascular bed studied (Campbell et al., 1996; Filipovic & Reeves, 1997; Miura et al., 
1999; Iida& Katusic, 2000; Matoba et al., 2000). 
Figure 8 summarizes the signaling events that our current findings suggest could 
be involved in the H2O2-induced constriction or dilation of rat gracilis muscle arterioles.  
Further studies will be necessary to critically test each of these hypothesized pathways, 
and to identify other cellular and biochemical events that contribute to these responses.         
 
Absence of H2O2 in weanling arterioles  
 
In contrast to our findings in juvenile arterioles, catalase had no effect on the 
responses of weanling arterioles to ACh or simvastatin (Figure 2, bottom panel), or on 
DCF fluorescence in these vessels either at rest or during ACh exposure (Figure 3, 
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 bottom panel).  Therefore, H2O2 apparently does not contribute to the endothelium-
dependent dilation of weanling arterioles to these agonists.  In further support of this 
conclusion, exogenous H2O2 did not induce dilation of weanling arterioles, even at 
concentrations that are clearly above maximum endogenous H2O2 levels (Figure 4) 
(Cosentino et al., 1998).  
L-NAME had no effect on H2O2-induced constriction of weanling arterioles 
(Figure 5, bottom panel), which is not surprising in light of earlier findings that these 
vessels may produce little or no NO (2).  Therefore, the mechanism underlying this 
constriction must be different from that in juvenile arterioles (see above).  In the presence 
of K+ channel inhibitors, weanling arterioles became responsive to higher concentrations 
of H2O2, showing pronounced constriction (Figure 6, bottom panel).  This suggests that a 
constrictor mechanism not involving K+ channel inhibition is usually masked by an 
offsetting K+ channel-dependent hyperpolarization of vascular smooth muscle.  
Curiously, blocking the two main types of K+ channels in the weanling arterioles 
converted the constrictions to lower concentrations of H2O2 into dilations.  The 
mechanism of this effect is not clear and will require further study.    
Overall, our findings suggest that an intact endothelium is required for the full 
expression of both constrictor and dilator responses to H2O2 in vessels from both age 
groups.  In contrast to our findings in intact weanling arterioles, application of K+ channel 
blockers to endothelium-denuded weanling arterioles caused no further reduction in 
responses to H2O2 (Figure 7), implying that endothelium-derived K+ channels are 
predominantly involved in mediating H2O2  responses in the younger animals. 
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 In conclusion, H2O2 apparently contributes to the endothelium-dependent dilation 
of skeletal muscle arterioles from juvenile rats, but not those from weanling rats.  A 
sizable fraction of the response to H2O2 appears to be endothelium-dependent in both 
weanling and juvenile arterioles, but smooth-muscle derived K+ channels also contribute 
to this response in juvenile vessels.  Whereas NO plays an important role in contributing 
to the juvenile arteriolar response to H2O2, it is not involved in weanling arteriolar 
response to H2O2. 
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 IV. STUDY 3: Growth-Dependent Changes in the 
Contribution of Carbon Monoxide to Arteriolar Function 
 
Abstract 
 
Endothelium-dependent dilation of skeletal muscle arterioles is mediated by 
factors that are yet to be identified in very young rats.  We assessed the possible 
contribution of carbon monoxide (CO) to arteriolar dilation at two growth stages.  
Gracilis muscle arterioles were isolated from rats at ages 24-26 days (weanlings) and 46-
48 days (juveniles).  Exogenously applied CO (10-6 – 10-4 M) in the presence or absence 
of chromium mesoporphyrin (CrMP) constricted arterioles from both groups.  Inhibition 
of nitric oxide synthase (NOS) with L-NAME or endothelial removal attenuated CO-
induced constriction of juvenile arterioles, but these treatments had no effect on the 
weanling arterioles.  Inhibition of K+ channels with iberiotoxin + glibenclamide abolished 
the constriction of weanling arterioles, but had no effect on juvenile arterioles.  CrMP had 
no effect on resting tone in either group, whereas the heme precursor δ-aminolevulinic 
acid (δ-ALA) constricted juvenile arterioles but had no effect on weanling arterioles.  
CrMP abolished endothelium-dependent dilations of juvenile arterioles to simvastatin and 
significantly reduced ACh- and simvastatin- induced dilations of weanling arterioles.  
The expression of heme oxygenase isoforms HO-1 and HO-2 was similar in weanling 
and juvenile arterioles.  These findings suggest that relatively high concentrations of CO 
can constrict arterioles in both groups, with the primary mechanism being inhibition of 
endothelium-derived NO in juvenile arterioles but inhibition of K+ channels in weanling 
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 arterioles.  Endogenous CO produced at lower concentrations may mediate endothelium-
dependent dilation in both age groups.   
 
Introduction 
 
Studies from our laboratory have documented that postnatal growth of the 
microvasculature is accompanied by progressive changes in a number of factors that can 
influence arteriolar tone and blood flow (Linderman & Boegehold, 1996, 1999; Balch 
Samora et al., 2007a; Balch Samora et al., 2007b).  For example, skeletal muscle 
arterioles from young rats exhibit fully-developed endothelium-dependent dilation, but 
these responses are not mediated by nitric oxide (NO), cyclooxygenase metabolites, or 
hydrogen peroxide (H2O2), as they are in arterioles from more mature rats (Balch Samora 
et al., 2007a; Balch Samora et al., 2007b).  The chemical mediator(s) of arteriolar 
endothelium-dependent dilation in these younger animals have not yet been identified. 
Carbon monoxide (CO), a signaling molecule that can be important for the 
regulation of vascular tone and blood flow under some conditions (Gonzales & Walker, 
2002; Fiumana et al., 2003; Kanu et al., 2006), is produced via metabolism of heme by 
heme oxygenase (HO), with biliverdin and free iron also being generated in the process 
(Maines, 1997).  Two of this enzyme’s three known isoforms, HO-1 and HO-2, have 
been found in endothelial (Marks et al., 1997; Parfenova et al., 2001) and vascular 
smooth muscle (Christodoulides et al., 1995; Yet et al., 1997) cells.  HO-1 is an inducible 
isoform; its expression can be dramatically increased by numerous stimuli including 
hypoxia, hypertension, endotoxic shock, and shear stress (Ewing et al., 1994; Yet et al., 
1997).  In contrast, HO-2 is constitutively expressed and therefore presumably 
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 responsible for moment-to-moment changes in vascular CO production (Ding et al., 
1999). 
Carbon monoxide is generally considered to be a vasodilator molecule (Johnson 
et al., 1999); among other vessel types, CO has been found to relax rabbit and rat aorta 
(Lin & McGrath, 1988; Furchgott & Jothianandan, 1991), dog coronary arteries 
(Furchgott & Jothianandan, 1991), rabbit pulmonary arteries (Steinhorn et al., 1994), rat 
afferent arterioles (Thorup et al., 1999) and pial arterioles in newborn pigs (Leffler et al., 
1999).  However, CO can also reduce NO synthesis by inhibiting NOS (White & 
Marletta, 1992; Pufahl & Marletta, 1993; Matsuoka et al., 1994), and at least one study 
has demonstrated a constrictor role for CO in vivo (Marks et al., 2003).  The effect of CO 
on arteriolar tone in skeletal muscle is variable.  Some investigators have found CO-
dependent dilation of gracilis muscle arterioles (Kozma et al., 1997), whereas others have 
found that both exogenously applied and endogenously formed CO elicits a constriction 
of these arterioles after pretreatment with phenylephrine (Johnson & Johnson, 2003).  
Such discrepancies may be due in part to differences in the concentration of CO reached 
at or within the vessel wall.  For example, at high CO levels, NO release from rat afferent 
arterioles is suppressed, whereas at low CO levels, NO release from these vessels is 
maximal (Thorup et al., 1999).   
Because CO has been identified as an important vasoactive factor in the cerebral 
microcirculation of newborn pigs (Leffler et al., 1999), we undertook the current study to 
determine if CO could be playing a similar role as a mediator of endothelium-dependent 
dilation in skeletal muscle arterioles of young rats.  A second aim of this study was to 
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 determine if there is a change in the mechanism(s) by which CO influences arteriolar tone 
during rapid juvenile growth. 
 
Materials and Methods 
 
Animals:  All surgical and experimental procedures were approved by the West 
Virginia University Animal Care and Use Committee.  Experiments were performed on 
isolated gracilis muscle arterioles from male Sprague-Dawley rats (Harlan Sprague 
Dawley, Indianapolis, IN) of two age groups: 3-4 weeks (“weanlings”) and 6-7 weeks 
(“juveniles”).   
Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 
mg/kg body weight), with supplemental anesthetic (10% of original dose) administered if 
needed.  The right carotid artery was cannulated with polyethylene tubing for 
measurement of mean arterial pressure, which was assessed immediately before removal 
of the gracilis arteriole.  
Preparation of Isolated Vessels:  An arteriolar branch of the femoral artery 
supplying the gracilis muscle was removed, handling only the surrounding connective 
tissue to minimize vessel stretching or damage.  The rat was sacrificed immediately after 
vessel removal by intracardiac injection of sodium pentobarbital.  The excised vessel was 
placed in warmed physiological salt solution (PSS) equilibrated with 21% O2, 5% CO2, 
and 74% N2, and having the following composition (mM): 119 NaCl, 4.7 KCl, 1.17 
MgSO4, 1.6 CaCl2, 1.18 NaH2PO4, 24 NaHCO3, 0.026 EDTA, and 5.5 glucose.  After 
isolation, each vessel was prepared for in vitro video microscopy as previously described 
(Fredricks et al., 1994).  Briefly, the vessel was mounted in a heated (37º C) chamber that 
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 allowed for its lumen and exterior surface to be perfused and superfused, respectively, 
with PSS from separate reservoirs.  The vessel was cannulated at both ends with glass 
micropipettes (50- and 70-µm tip diameters for weanling and juvenile vessels, 
respectively) and secured to the inflow and outflow pipettes using 9-0 nylon suture.  Any 
side branches were ligated with a single strand teased from 6-0 silk suture.  The inflow 
pipette was connected to a reservoir perfusion system for control of intralumenal pressure 
and flow.  The vessel was then extended to its in situ length and equilibrated at 80% of 
the animal’s mean arterial pressure to approximate its normal in vivo perfusion pressure 
(DeLano et al., 1991). 
Vessel diameter was measured using an onscreen video micrometer.  Any vessel 
that did not demonstrate endothelial viability, as judged by pronounced dilation to 10-7 M 
acetylcholine (ACh, Sigma Chemical, St. Louis, MO), was not used in this study.  
Changes in vessel diameter to all agonists and inhibitors (see below) were made under 
static, zero-flow conditions after a 30-minute equilibration period with continuous 
perfusion.  Resting vascular tone under zero-flow conditions was calculated as (∆D/Dmax) 
x 100, where ∆D is the diameter increase from rest in response to Ca2+-free PSS (30-40 
minute equilibration with Ca2+-free bath solution), and Dmax is the maximum diameter 
measured under these conditions.   
Agonists:  Endothelium-dependent dilation was elicited by application of ACh or 
simvastatin (Merck Research Laboratories, Rathway, NJ) at bath concentrations of 10-5 or 
10-7 M (Balch Samora et al., 2007a; Balch Samora et al., 2007b).  Simvastatin was first 
activated by alkaline lysis (5.25 ml of 0.1 N NaOH per 140 mg, dissolved in 3.5 ml of 
ETOH) at 50ºC for 2 h.  The resulting solution was then diluted to a volume of 35 ml 
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 with PBS, and neutralized to pH 7.4 with HCl.  One-ml aliquots of this solution were 
then serially diluted with PBS for addition to the vessel bath. 
Carbon monoxide-saturated solution (C.P. Grade 99.5%, Airgas Mid America) 
was prepared as described by Johnson and Johnson (2003).  Briefly, ice-cold distilled 
H2O was vigorously bubbled with CO through a glass gas diffuser for 30 minutes to 
prepare a 10-2 M solution.  Increasing volumes of this solution were incrementally added 
to the vessel bath to produce final CO concentrations of 10-6, 10-5, or 10-4 M.  After each 
application, the vessel was allowed to return to its control diameter before the next CO 
application.  Control experiments were performed using ice cold H2O bubbled with N2 
(Airgas Mid America).  To stimulate endogenous CO production through HO activity, the 
heme precursor δ-aminolevulinic acid (δ-ALA, Frontier Scientific, Logan, UT) was 
added to the bath at a concentration of 10-6 M (Andresen et al., 2006).   
Inhibitors: Some vessels were pretreated with chromium (III) mesoporphyrin IX 
chloride (CrMP, Frontier Scientific), a photostable competitive inhibitor of HO (Vreman 
et al., 1993).  Although there are many commercially-made metalloporphyrins that inhibit 
HO, CrMP was chosen because it is the most selective inhibitor of HO activity (Appleton 
et al., 1999).  A 10-2 M stock solution of CrMP in 0.1 N NaOH was diluted in the bath to 
produce a final concentration of 10-5 M (Andresen et al., 2006).  During exogenous CO 
application, endogenous CO production was also inhibited with CrMP to more directly 
assess intrinsic vascular responsiveness to CO.   
To evaluate possible interactions of exogenous or endogenous CO with the NO 
system, the NOS inhibitor Nω-nitro-L-arginine methyl ester (L-NAME, Sigma) was 
added to the bath at a concentration of 10-4 M (Frisbee et al., 2001), alone or in the 
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 presence of CrMP.  Both CrMP and L-NAME were administered for 20 minutes before 
vessels were challenged with agonists. 
 The contribution of potassium (K+) channels to arteriolar responses was assessed 
by using iberiotoxin (Ibtx, Sigma) (Nelson & Quayle, 1995), and the antidiabetic 
sulphonylurea, glibenclamide (Glib, Sigma) (Lombard et al., 1999).  We used a 10-7 M 
bath concentration of Ibtx to selectively block Ca2+-activated K+ (KCa) channels (Nelson 
& Quayle, 1995; Frisbee et al., 2001), and 10-6 M glibenclamide to selectively block 
ATP-sensitive K+ (KATP) channels (Standen et al., 1989).   
Endothelial Denudation:  To determine the role of the endothelium in mediating 
arteriolar responses to exogenous CO, the endothelium was removed in some 
experiments by mechanical abrasion (Uluoglu & Zengil, 2003).  The pipette tip at each 
end of the vessel was gently advanced and then retracted through the vessel lumen three 
times to ensure elimination of the endothelium.  We have previously verified that this 
method successfully denudes the endothelium of gracilis muscle arterioles without 
affecting the underlying smooth muscle (Balch Samora et al., 2007a).  To verify that 
smooth muscle function was intact following denudation in the current experiments, 
vasoconstrictor responses to 10-5 M phenylephrine (Sigma) and vasodilator responses to 
10-5 M sodium nitroprusside (SNP, Sigma) were assessed before and after the denudation 
procedure.  Only those vessels with unchanged responses to both agonists were included 
in the final data set. 
HO-1 and HO-2 protein measurements:  Femoral and gracilis artery/arteriole 
segments were harvested from weanling and juvenile rats, snap frozen in liquid N2, and 
stored at -80ºC until analysis.  Protein expression was determined by Western blotting, as 
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 described by Liu et al (Liu et al., 2002).  Briefly, tissue samples were thawed at room 
temperature and lysed in Price Laemmli buffer (Laemmli, 1970), boiled and then 
sonicated.  Twenty µg of the extracted protein was separated by SDS-PAGE and 
electrophoretically transferred to nitrocellulose membranes.  The membranes were 
incubated for 1 h in PBS containing Tween 20 (0.05%) and nonfat milk (5%).  Blots were 
incubated with either rabbit anti-HO-1 or anti-HO-2 polyclonal antibody (1:5000 
dilution) for 1 h.  Membranes were then incubated for 1h with horseradish peroxidase-
conjugated goat anti-rabbit antibody (1:5,000 dilution).  Blots were developed by ECL 
and relative protein levels were quantified by scanning densitometry.  β-actin levels were 
also assessed to verify equal protein loading among lanes. 
Statistics:  All data are presented as mean ± SE.  For all analyses, a probability 
value of p < 0.05 was considered to be statistically significant.  Dilation in response to 
Ca2+-free PSS is expressed as percent increase from control diameter.  Differences among 
the means of individual experimental groups were determined by ANOVA/Newman-
Keuls test, or by an unpaired Student’s t-test when two independent means were 
compared.   
 
Results 
 
General characteristics of all rats from which vessels were removed for functional 
studies are reported in Table 1.  Age, body weight, and mean arterial pressure were 
significantly greater in juvenile rats than in weanling rats.  Table 1 also summarizes the 
general characteristics of all arterioles utilized for functional studies.  Resting and passive 
diameters of arterioles from juvenile rats were significantly greater than those of 
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 arterioles from weanling rats.  However, the level of spontaneous tone that developed 
with vessel pressurization was modestly but significantly greater in the weanling 
arterioles. 
CrMP had no effect on resting arteriolar diameters for either age group (Table 2).  
δ-ALA significantly reduced the resting diameter of juvenile arterioles (by 25 ± 1%), but 
not weanling arterioles.  Exogenous CO caused significant arteriolar constriction in both 
groups, with weanling arterioles constricting significantly more than juvenile arterioles in 
response to 10-6 M and 10-5 M CO (Figure 1).  The vehicle alone (equilibrated with N2) had 
no effect in either group (data not presented).  CrMP was without effect on these responses 
to exogenous CO in either group, indicating that alterations in endogenous CO production 
were not influencing arteriolar behavior under these conditions (data not shown).   
L-NAME treatment reduced the resting diameter of both juvenile arterioles (from 55 
± 5 to 40 ± 5 μm, a 27% average diameter reduction) and weanling arterioles (from 35 ± 4 
to 25 ± 3 μm, a 29% average diameter reduction).  In contrast, L-NAME had no effect on 
resting diameters in either group if CrMP was present (44 ± 6 μm before vs. 44 ± 4 μm 
after L-NAME in juveniles and 30 ± 3 μm before vs. 37 ± 4 μm after L-NAME in 
weanlings).  However, L-NAME abolished the constrictor responses of juvenile arterioles to 
exogenous CO whether or not CrMP was present (Figure 2, top panels).  L-NAME had no 
effect on weanling arteriole responses to CO at any concentration (Figure 3, top left panel), 
although it tended to reduce these responses to CO in the presence of CrMP (significantly at 
10-6 M CO) (Figure 3, top right panel).    
  Treatment with Ibtx + Glib reduced the resting diameters of both juvenile 
arterioles (from 51 ± 6 to 35 ± 4 μm, a 31% average diameter reduction) and weanling 
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 arterioles (from 43 ± 2 to 29 ± 3 μm, a 33% average diameter reduction).  CrMP did not 
modify the effect of Ibtx + Glib on the tone of juvenile arterioles, but completely 
abolished this effect on the tone of weanling arterioles (data not shown).  For juvenile 
arterioles, Ibtx + Glib had no effect on CO-induced constriction, whether or not CrMP 
was present (Figure 2, bottom panels).  However, for weanling arterioles, Ibtx + Glib 
abolished the constrictor responses to exogenous CO at all concentrations, whether or not 
CrMP was present (Figure 3, bottom panels).   
 Endothelial removal tended to reduce the resting diameters of both juvenile 
arterioles (55 ± 2 μm before vs. 49 ± 2 μm after de-endothelialization) and weanling 
arterioles (26 ± 3 μm vs. 20 ± 2 μm), but these reductions did not reach statistical 
significance.  Endothelial removal had no effect on CO-induced constriction of weanling 
arterioles, but significantly reduced these responses in juvenile arterioles (Figure 4). 
Although treatment with CrMP did not affect the dilation of juvenile arterioles to 
ACh, it abolished the dilation of these vessels to simvastatin (Figure 5, top panel).  
However, CrMP treatment reduced the dilation of weanling arterioles to both ACh and 
simvastatin (bottom panel).  Addition of L-NAME after CrMP treatment abolished 
dilation to ACh and had no further effect on simvastatin responses in juvenile arterioles 
(Figure 6, top panel), and had no further effect on weanling arteriolar responses to ACh 
or simvastatin (bottom panel).  In juvenile arterioles, treatment with Ibtx + Glib following 
CrMP abolished responses to ACh and had no further effect on responses to simvastatin 
(Figure 7, top panel).  In weanling arterioles, treatment with Ibtx + Glib following CrMP 
had no effect on ACh responses, but reduced the dilation to 10-5 M simvastatin (bottom 
panel). 
 137
 Western blot analysis of femoral artery/ gracilis arteriole homogenates revealed 
no difference in either HO-1 or HO-2 protein expression between weanling and juvenile 
rats (Figure 8). 
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 Table 1: General characteristics of all rats and vessels used for functional studies  
 
 
Animal Characteristics Weanlings Juveniles 
N 47 52 
   Age (days) 25.3 ± 0.3 43.8 ± 0.5 * 
   Body Weight (g) 62 ± 1 168 ± 2 * 
   MAP (mmHg) 76 ± 1 97 ± 2 * 
Vessel Characteristics Weanlings Juveniles 
n 47 52 
   Resting Diameter (µm) 34 ± 1 51 ± 2 * 
   Passive Diameter (µm) 57 ± 1 79 ± 2 * 
   Resting Vascular Tone (%) 41 ± 2 35 ± 2 * 
 
MAP = mean arterial pressure. Values are given as means ± SE.  * P<0.05 vs. weanling 
group. 
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 Table 2: Summary of resting arteriolar diameters under control conditions and after 
treatment with CrMP or δ-ALA 
 
 n Control CrMP (10-5 M) n Control δ-ALA (10-6 M) 
Juveniles 16 47 ± 3 47 ± 3 10 52 ± 3 39 ± 6 * 
Weanlings 17 32 ± 2 37 ± 3 7 35 ± 3 38 ± 4 
 
Values are given as means ± SE.  * P<0.05 vs. Control. 
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 Figure 1: Responses of gracilis muscle arterioles from juvenile and weanling rats to 
increasing concentrations of exogenous CO 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Juvenile response. 
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 Figure 2: Responses of arterioles from juvenile rats to exogenous CO alone or in the 
presence of CrMP, L-NAME, Ibtx/Glib or combined treatments  
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Responses of arterioles from juvenile rats to exogenous carbon monoxide before and after 
NOS inhibition with Nω-nitro-L-arginine methyl ester (L-NAME) alone (top left panel) 
or in the presence of CrMP (top right panel), and before and after inhibition of KCa and 
KATP channels with iberiotoxin (Ibtx) + glibenclamide (Glib) alone (bottom left panel) or 
in the presence of CrMP (bottom right panel).  n = number of vessels.  Values are given 
as means ± SE.  * p<0.05 vs. Control. 
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 Figure 3: Responses of arterioles from weanling rats to exogenous CO alone or in the 
presence of CrMP, L-NAME, Ibtx/Glib or combined treatments 
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Responses of arterioles from weanling rats to exogenous carbon monoxide before 
and after NOS inhibition with Nω-nitro-L-arginine methyl ester (L-NAME) alone 
(top left panel) or in the presence of CrMP (top right panel), and before and after 
inhibition of KCa and KATP channels with iberiotoxin (Ibtx) + glibenclamide (Glib) 
alone (bottom left panel) or in the presence of CrMP (bottom right panel).  n = 
number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control. 
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 Figure 4: Effect of endothelial removal on responses of juvenile and weanling arterioles 
to exogenous CO 
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n=number of vessels. Values are given as means ± SE.  * p<0.05 vs. Control. 
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 Figure 5: Effect of CrMP on responses of juvenile and weanling arterioles to ACh and 
simvastatin 
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n = number of vessels.  Values are given as means ± SE.  * p<0.05 vs. Control.  
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 Figure 6: Responses of arterioles from juvenile and weanling rats to ACh and 
simvastatin before and after treatment with CrMP and L-NAME 
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n = number of vessels.  Values are given as means ± SE. * p<0.05 vs. Control.   
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 Figure 7: Responses of arterioles from juvenile and weanling rats to ACh and 
simvastatin before and after treatment with CrMP and Ibtx-Glib 
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n = number of vessels.  Values are given as means ± SE. * p<0.05 vs. Control.   
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 Figure 8: Assessment of heme oxygenase (HO)-1 and -2 protein expression by Western 
blot in weanling and juvenile femoral artery/ gracilis arteriole segments 
Weanlings Weanlings Juveniles Juveniles
HO-1 32kDa HO-2 36kDa
WeanlingsWeanlings
 
 
N
or
m
al
iz
ed
 O
pt
ic
al
 D
en
si
ty
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35 Juveniles
N
or
m
al
iz
ed
 O
pt
ic
al
 D
en
si
ty
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4n = 3 experiments n = 3 experiments Juveniles
 148
 Discussion 
 
Growth-related changes in microvascular endothelial function have been reported 
by our laboratory and others (Nelson & Quayle, 1995; Linderman & Boegehold, 1999; 
Willis & Leffler, 2001; Balch Samora et al., 2007a).  In our recent investigations on 
gracilis muscle arterioles (Balch Samora et al., 2007a, 2007b), we ruled out NO, 
prostanoids, cytochrome P-450 metabolites and H2O2 as possible mediators of 
endothelium-dependent dilation in weanling rats.  Since CO has been found to mediate 
endothelium-dependent dilation of cerebral arterioles in newborn pigs (Leffler et al., 
1999), we undertook the current study in part to determine if CO could be playing an 
analogous role in the skeletal muscle circulation of weanling rats.   
 
 
Juvenile Response 
The HO inhibitor CrMP had no effect on the resting diameters of juvenile 
arterioles (Table 2), suggesting that under the conditions of our study, basal CO release in 
these vessels is insufficient to influence resting smooth muscle tone.  This is similar to 
previous findings in rat tail artery (Wang et al., 1997), aorta (Kozma et al., 1999) and 
femoral artery (Kozma et al., 1999), whereas treatment with CrMP has been found to 
dilate newborn pig pial arterioles (Leffler et al., 1999).  Still others have demonstrated 
that CrMP promotes constriction of gracilis muscle arterioles in the presence of L-NAME 
(Kozma et al., 1997; Kozma et al., 1999).  These variable effects may reflect differences 
among vascular beds or species, but may also be related to some nonspecific effects of 
metalloporphyrin HO inhibitors, such as NOS inhibition or activation (Luo & Vincent, 
1994; Chakder et al., 1996; Grundemar & Ny, 1997; Appleton et al., 1999). 
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 Treatment with L-NAME reduced the diameter of juvenile arterioles under 
normal resting conditions, but not after CrMP treatment.  This suggests that some level of 
HO activity must be present for there to be an influence of basally-released NO on resting 
tone.  This confirms findings in other vessel types (Foresti et al., 2002), but the exact 
mechanism of this synergistic effect is not known.  CO is not a required cofactor or co-
substrate for NOS, but the smooth muscle signaling pathways through which CO and NO 
act appear to share many common elements, including cGMP activation (Foresti et al., 
2002).  It is possible that basally-released CO, even at concentrations too low to exert a 
direct effect on resting vascular tone (see above), could act to “prime” the NO signaling 
pathway in vascular smooth muscle, thereby increasing smooth muscle sensitivity to 
basally-released NO.  Further studies are required to critically test this hypothesis. 
The heme precursor δ-ALA increases arteriolar CO production in a dose-
dependent manner (Leffler et al., 2003) and our finding that 1μM δ-ALA reduces 
juvenile arteriole diameters by ~25% (Table 2) demonstrates that this increase in 
endogenous CO production triggers an increase in vascular tone.  δ-ALA-induced 
constriction was previously reported in a study on much larger arterioles from rat gracilis 
muscle (Johnson & Johnson, 2003), although that effect was more modest (a constriction 
of ~7% in response to 80μM δ-ALA).  The difference in responsiveness to δ-ALA 
between the two studies may reflect a difference in HO activity or substrate availability 
between different branch orders within the arteriolar network.  In the current study, 
exogenous CO at concentrations from 10-6 to 10-4 M also caused arteriolar constriction 
(Figure 1), which is consistent with the earlier study on larger gracilis muscle arterioles 
(Johnson & Johnson, 2003).   
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We observed constriction of gracilis muscle arterioles taken from juvenile rats in 
response to exogenous CO, ranging from 10-6 - 10-4 M (Figure 1).  In phenylephrine- 
pretreated rat gracilis arterioles, exogenous CO in the range of 10-6 - 10-3 M also produces 
vasoconstriction (Johnson & Johnson, 2003), but in an initial rapid communication, 
Kozma et al (1997) reported that exogenous CO elicits the dilation of gracilis muscle 
arterioles pretreated with L-NAME in the presence and absence of CrMP.  Two years 
later, this same group reported that exogenous CO (10-4 M) does not produce dilation of 
L-NAME pretreated arterioles not previously exposed to CrMP (Kozma et al., 1999).  
The reasons for these conflicting findings are not readily apparent.  In our juvenile 
arterioles, exogenous CO promotes vasoconstriction that is sensitive to L-NAME at the 
highest CO concentration (Figure 2), which agrees with findings by Johnson and Johnson 
(2003).  There is mounting evidence that relatively high concentrations of CO induce 
constriction by inhibiting NO release (White & Marletta, 1992; Puhfal & Marletta, 1993; 
Thorup et al., 1999; Foresti et al., 2002; Johnson & Johnson, 200).  Our finding that CO-
induced constriction in juvenile arterioles is abolished by L-NAME (Figure 2, top panels) 
and dramatically reduced after our endothelial denudation procedure (Figure 4, top panel) 
is consistent with this mechanism.  A comparison of the two data sets reveals that 
endothelial denudation was actually less effective than L-NAME in reducing arteriolar 
responses to 10-5 M and 10-4 M CO.  This unexpected finding may indicate that some of 
the NO inhibited by CO is of smooth muscle origin, or it may simply be due to 
incomplete removal of the endothelium.  However, the latter possibility appears less 
 151
 likely given that this denudation procedure completely abolished responses to ACh in 
these vessels. 
Simultaneous blockade of KCa and KATP channels had no effect on CO-induced 
constriction of juvenile arterioles (Figure 2, bottom panels), indicating that a change in 
K+ channel activity normally does not mediate or attenuate CO-induced constriction in 
juvenile arterioles. 
Whereas CrMP had no effect on the ACh-induced dilation of these vessels, it 
completely abolished dilator responses to simvastatin (Figure 5, top panel).  This result is 
somewhat intriguing as it suggests that endogenous CO may be involved in this 
endothelium-dependent dilation, whereas, as described above, increasing HO substrate 
availability (with δ-ALA) or exogenously applying CO produced arteriolar constriction.  
Such divergent results may be due to differences in the actual periarteriolar CO achieved 
by these experimental procedures.  In isolated rat renal afferent arterioles, CO at lower 
concentrations (0.01-0.1 μM) triggers maximal NO release, whereas CO at higher 
concentrations suppresses NO release (Thorup et al., 1999).  In the rat gracilis muscle 
arterioles studied here, perhaps simvastatin induces significantly less CO production than 
δ-ALA treatment, and leads to arteriolar wall CO levels that are less than that achieved 
with exogenous CO in the range of 10-6 - 10-4 M.  If this is correct, than the constriction 
of these vessels to exogenous CO in the range of 10-6 - 10-4 M (Figure 1) may reflect a 
relatively large increase in arteriolar wall CO levels, similar to or greater than that 
triggered by δ-ALA.  Furthermore, because CrMP completely abolishes the dilation to 
simvastatin (Figure 5, top), CrMP may have had some non-specific effects in this study, 
as we previously demonstrated that part of the simvastatin response in these vessels is 
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 due to endothelial NO release (Balch Samora et al., 2007a).  In fact, some of the 
demonstrated effects of metalloporphyrin HO inhibitors include either NOS inhibition 
(Luo & Vincent, 1994) or activation (Chakder et al., 1996), or inhibition of sGC 
(Grundemar & Ny, 1997). 
Combined treatment with CrMP + L-NAME abolished the dilation of juvenile 
arterioles to ACh as well as simvastatin (Figure 6, top panel).  We previously 
demonstrated that these responses are entirely endothelium-dependent, and that L-NAME 
treatment alone reduces juvenile arteriole responses to ACh and simvastatin by ~90% and 
~60%, respectively (Balch Samora et al., 2007a).  Our current findings, taken in context 
of these previous findings, suggest that although simvastatin releases endothelium-
derived CO in addition to NO, ACh does not.   
Combined K+ channel inhibition abolished ACh-induced dilations in the presence 
of CrMP (Figure 7, top panel).  Because CrMP alone abolished simvastatin dilations 
(Figure 5), combined K+ inhibition after CrMP treatment had no further effect.  We 
previously demonstrated that inhibition of both KATP and KCa channels significantly 
reduced responses to ACh (by 60% - 70%) and completely abolished responses to 
simvastatin in juvenile arterioles (Balch Samora et al., 2007a).  Combined treatment with 
CrMP abolished the residual dilation to ACh, which is surprising since CrMP treatment 
alone had no effect on ACh-induced dilation.  This finding may be attributable to some 
nonspecific effect of CrMP in these experiments. 
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 Weanling Response 
As with juvenile arterioles, CrMP treatment had no effect on the resting tone of 
weanling arterioles (Table 2), suggesting that CO does not influence basal tone in the 
arterioles from younger rats.  However, unlike juvenile arterioles, the tone of weanling 
arterioles was unaffected by δ-ALA.  This suggests that even under conditions that lead 
to increased substrate for or activation of HO, CO is not produced in a sufficient amount 
to alter the basal tone of arterioles at this earlier stage of growth. 
Leffler and colleagues (1999) have reported that exogenous CO dilates cerebral 
arterioles of newborn pigs in vivo.  In contrast, we found that exogenous CO constricts 
the weanling arterioles studied here (Figure 1).  Although this could reflect normal 
differences between species or vascular beds, it is also possible that, as discussed above, 
differences in CO concentration reached within the arteriolar wall could explain these 
divergent observations.  Whereas the CO-induced dilations in newborn pigs occurred at 
superfusate concentrations ranging from 10-11 to 10-7 M, with maximal dilation at 10-9 M 
(Leffler et al., 1999), we observed constrictions to CO at bath concentrations between  
10-6 and 10-4 M.  Although there is limited information regarding CO levels in vivo, 
tissue contents of CO are reported to be 1-50 pmol/mg fresh weight (Vreman et al., 
2000), which others have calculated to be approximately 1 x 10-6 – 5x10-5 M (Johnson & 
Johnson, 2003).  As discussed above, CO can either dilate or constrict arterioles, 
depending on its effective concentration (Thorup et al., 1999).   
Although weanling arterioles did not dilate in response to exogenous CO, we 
found a reduced dilator response to ACh and simvastatin in the presence of CrMP (Figure 
5, bottom panel), suggesting that a portion of this endothelium-dependent dilation is due 
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 to endogenous CO release.  In these experiments, endogenously produced CO within the 
arteriolar wall may have been within the range of concentrations reached by Leffler et al., 
which could produce dilation, rather than the higher concentrations we applied 
exogenously (10-6 to 10-4 M), which resulted in constriction. 
In contrast to juvenile arterioles, L-NAME did not affect CO-induced constriction 
of weanling arterioles (Figure 3, top panels), suggesting that a decrease in NO production 
does not mediate these responses.  Although L-NAME did reduce the resting diameter of 
the weanling arterioles, this did not happen after CrMP treatment, which was similar to 
our findings in juvenile arterioles and suggests that some level of HO activity is also 
required for basal NO to modulate resting arteriolar tone at this earlier stage of growth.   
In contrast to our findings in the juvenile arterioles, combined inhibition of K+ 
channels with iberiotoxin and glibenclamide abolished CO-induced constriction of 
weanling arterioles, both alone and in the presence of CrMP (Figure 3, bottom panels).  
This suggests that CO constricts weanling arterioles through K+ channel inhibition and 
depolarization of the vascular smooth muscle (VSM).  Endothelial denudation did not 
affect CO-induced constriction of these vessels (Figure 4, bottom panel), which is also 
consistent with inhibition of smooth muscle K+ channel activity being the predominant 
mechanism of CO-induced arteriolar constriction at this age.  
HO-1 and HO-2 have previously been identified in both the vascular smooth 
muscle and endothelium of gracilis muscle arterioles (Johnson et al., 2002).  However, 
we found no differences between weanling and juvenile rats in femoral artery/gracilis 
arteriole HO-1 or HO-2 protein levels (Figure 8).  This suggests that changes in the 
regulation of HO activity, rather than its expression, underlie the differences we found 
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between weanling and juvenile arterioles.  Leffler’s group found that regulation of CO 
production in the pig cerebral circulation can involve changes in both heme availability 
and HO-2 catalytic activity (Leffler et al., 2003).   
 
Conclusion 
In summary, the role of CO in regulating arteriolar tone appears to change during 
postnatal growth.  Exogenously applied CO in a range of 10-6 – 10-4 M results in 
arteriolar constriction mediated by K+ channel inhibition and vascular smooth muscle 
depolarization in weanling vessels, but by NO inhibition in juvenile vessels.  
Endogenously produced CO mediates the endothelium-dependent dilation of arterioles 
from both age groups, but this role for CO may be more widespread in weanling 
arterioles.  Such differences underscore the importance of further studies to define the 
effect of maturation on microvascular function to more fully understand how tissue 
demands can be met throughout postnatal growth. 
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V. STUDY 4: Increased Myogenic Responsiveness of Skeletal 
Muscle Arterioles with Juvenile Growth 
 
Abstract 
 
Previous studies from this laboratory suggest that during maturation, rapid 
microvascular growth is accompanied by changes in some of the mechanisms responsible 
for regulation of tissue blood flow.  To further define these changes, we studied isolated 
gracilis muscle arterioles from Sprague Dawley rats at approximately 27 days of age 
(“weanlings”) and approximately 42 days of age (“juveniles”) to test the hypothesis that 
myogenic mechanisms for the control of arteriolar tone are altered with growth.  When 
studied at their respective in vivo pressures, the myogenic index (instantaneous slope of 
the active pressure-diameter curve) for juvenile arterioles was greater than that for 
weanling arterioles.  Endothelial denudation, or PGH2/TXA2 receptor antagonism (SQ-
29548) without denudation, significantly reduced the myogenic responsiveness of 
juvenile arterioles over a wide range of pressures, but had no consistent effects on the 
myogenic responsiveness of weanling arterioles.  Inhibition of heme oxygenase with 
chromium (III) mesoporphyrin IX chloride had no effect on the myogenic activity of 
arterioles from either group.  These findings suggest that arteriolar growth during 
juvenile maturation is accompanied by an increase in myogenic responsiveness, possibly 
because endothelium-derived PGH2 or TXA2 assumes a role in reinforcing myogenic 
activity over this period.  The results of this study further support the idea that alterations 
in the mechanisms of vascular tone regulation occur with growth and maturation, and that 
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these changes may have significant implications for the regulation of tissue perfusion 
during microvascular development. 
 
Introduction 
 
Postnatal growth of the microvasculature in skeletal muscle is accompanied by 
progressive changes in vessel structure, in lumenal pressure, flow and shear stress, and in 
other factors that can influence either resting arteriolar tone or the capacity for acute 
adjustments in this tone (Aquin et al., 1980; Sarelius et al., 1981; Zweifach et al., 1981; 
Wang & Prewitt, 1991; Linderman & Boegehold, 1996, 1998, 1999).  This is not 
surprising, since tissue growth during this period is associated with changing metabolic 
demands that should require corresponding changes in the gain of local blood flow 
control mechanisms (Hudlicka, 1985; Kelly et al., 1991; Krijgsveld et al., 2001).   
The myogenic behavior of resistance vessels contributes importantly to local 
blood flow regulation (Davis, 1993; Davis & Hill, 1999).  In most vascular beds, this 
myogenic activity is the direct result of stretch-dependent changes in smooth muscle 
contractility, although endothelium-derived factors can modulate the magnitude of this 
activity (Harder, 1987; Katusic et al., 1987; Rubanyi, 1988; Kuo et al., 1991).  We have 
consistently found that the specific factors that mediate endothelium-dependent control of 
arteriolar tone can change during juvenile growth (Linderman & Boegehold, 1998, 1999; 
Nurkiewicz & Boegehold, 2004; Balch Samora et al., 2007a; Balch Samora et al., 
2007b), but the impact of such changes on arteriolar myogenic behavior has not been 
investigated.  In addition, there may be changes in the intrinsic responsiveness of 
vascular smooth muscle to stretch during rapid network growth.  In a previous study, we 
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found that when pressurized to their respective in vivo pressures, isolated gracilis muscle 
arterioles from weanling rats develop a significantly higher level of spontaneous tone 
than arterioles from juvenile rats (Balch Samora et al., 2007a), suggesting that arteriolar 
smooth muscle responsiveness to myogenic stimuli could be greater in the younger rats.  
We undertook the current study to more directly investigate the possibility that alterations 
in myogenic responsiveness, or in the ability to modulate this responsiveness, may occur 
during microvascular network growth in skeletal muscle arterioles. 
 
Materials and Methods 
 
Animals:  All surgical and experimental procedures were approved by the West 
Virginia University Animal Care and Use Committee.  Experiments were performed on 
isolated gracilis muscle arterioles from male Sprague-Dawley rats (Harlan Sprague 
Dawley, Indianapolis, IN) of two age groups: 3-4 weeks (“weanlings”) and 6-7 weeks 
(“juveniles”).   
Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 
mg/kg body weight), with supplemental anesthetic (10% of original dose) administered if 
needed.  The right carotid artery was cannulated with polyethylene tubing for 
measurement of mean arterial pressure, which was assessed immediately before removal 
of the gracilis supply arteriole.  
Preparation of Isolated Vessels:  An arteriolar branch of the femoral artery 
supplying the gracilis muscle was removed, handling only the surrounding connective 
tissue to minimize vessel stretching or damage.  The rat was then sacrificed by 
intracardiac injection of sodium pentobarbital.  The vessel was placed in warmed 
physiological salt solution (PSS) equilibrated with 21% O2, 5% CO2, and 74% N2 and 
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having the following composition (mM): 119 NaCl, 4.7 KCl, 1.17 MgSO4, 1.6 CaCl2, 
1.18 NaH2PO4, 24 NaHCO3, 0.026 EDTA, and 5.5 glucose.  After isolation, each vessel 
was prepared for in vitro video microscopy as previously described (Fredricks et al., 
1994).  Briefly, the vessel was mounted in a heated (37º C) chamber that allowed its 
lumen and exterior surface to be perfused and superfused, respectively, with PSS from 
separate reservoirs.  The vessel was cannulated at both ends with glass micropipettes (50- 
and 70-µm tip diameters for weanling and juvenile vessels, respectively) and secured to 
the inflow and outflow pipettes using 9-0 nylon suture.  Any side branches were ligated 
with a single strand teased from 6-0 silk suture.  The inflow pipette was connected to a 
reservoir perfusion system for control of intralumenal pressure and flow.  The vessel was 
then extended to its in situ length and equilibrated at 80% of the animal’s mean arterial 
pressure to approximate its in vivo perfusion pressure (DeLano et al., 1991).   
Experimental Protocols: Vessel diameter was measured using an onscreen video 
micrometer.  During equilibration, all vessels developed spontaneous tone.  Any vessel 
that did not demonstrate endothelial viability, as judged by pronounced dilation to 10-7 M 
acetylcholine (ACh, Sigma Chemical, St. Louis, MO), was not used in the study.  
Changes in vessel diameter to all agonists and inhibitors were made under static, zero-
flow conditions after a 30-minute equilibration period with continuous perfusion.   
To evaluate the myogenic responsiveness of each arteriole, the perfusate outflow 
line from the vessel was clamped and the height of perfusion reservoir was increased or 
decreased to vary intralumenal pressure, in 20-mmHg steps, between 40 and 140 mmHg.  
Steady-state vessel diameter was measured before and then 3-5 minutes after each 
pressure change.  The order in which the different pressure steps were applied was as 
follows: 80→100→120→140→60→40 mmHg.  After the active arteriolar diameter 
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responses to each pressure change were measured, the superfusate was replaced with 
Ca2+-free PSS, and, after full vessel relaxation, passive diameter was determined at each 
of the pressure steps previously used. 
Endothelial Denudation:  To determine the role of the vascular endothelium in 
modulating myogenic activity, the endothelium was removed in some experiments by 
mechanical abrasion (Uluoglu & Zengil, 2003).  To accomplish this, the pipette tip at 
each end of the vessel was gently advanced and then withdrawn through the vessel lumen 
at least three times to ensure elimination of the endothelium.  After vessel responses to 
each step change in intralumenal pressure were determined under control conditions, the 
endothelium was removed and responses to each pressure step were re-evaluated.  We 
have previously verified that this method successfully denudes the endothelium of 
gracilis muscle arterioles without affecting the underlying smooth muscle (Balch Samora 
et al., 2007a).  To verify that smooth muscle function was intact following denudation in 
the current experiments, vasoconstrictor responses to 10-5 M phenylephrine (Sigma) and 
vasodilator responses to 10-5 M sodium nitroprusside (SNP, Sigma) were assessed before 
and after the denudation procedure.  Only those vessels with unchanged responses to both 
agonists were included in the final data set. 
Inhibitors and Agonists:  All chemicals were purchased from Sigma unless 
otherwise specified.  Because previous investigations have documented a role for 
constrictor prostanoids in modulating the myogenic activity of skeletal muscle arterioles 
(Hill et al., 1990; Huang et al., 1993; Huang & Koller, 1997; Ungvari & Koller, 2000), 
pressure-diameter relationships in some vessels were investigated under control 
conditions and then in the presence of the prostaglandin H2/thromboxane A2 
(PGH2/TxA2) receptor antagonist SQ-29548 (10-6 M) (Cseko et al., 2004).  Since 
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endogenously produced carbon monoxide (CO)  can also modulate the myogenic activity in 
isolated gracilis arterioles (Zhang et al., 2001), pressure-diameter relationships in other 
vessels were assessed before and after exposure to the selective heme oxygenase (HO) 
inhibitor chromium (III) mesoporphyrin IX chloride (CrMP, Frontier Scientific).  For 
these experiments, a 10-2 M stock solution of CrMP in 0.1 N NaOH was diluted in the 
bath to produce a final concentration of 10-5 M (Andresen et al., 2006).  Vessels were 
incubated with either SQ-29548 or CrMP for 20 minutes before reassessing pressure-
diameter curves.   
Data and Statistical Analysis:  The myogenic index (MI), which is an indicator of 
the relative slope of the active pressure-diameter relationship for an arteriole at a given 
pressure, was determined using the following equation:  MI = 100•[(rf- ri)/ri]/(Pf-Pi), 
where rf is the final radius, ri is the initial radius, Pf is the final intralumenal pressure and 
Pi is initial intralumenal pressure.  The more powerful the myogenic responsiveness, the 
more negative the MI. 
All data are presented as mean ± SE.  For all analyses, a probability value of p < 
0.05 was considered to be statistically significant.  Dilation in response to Ca2+-free PSS 
is expressed as percent increase from control diameter.  Differences between the means 
of individual experimental groups were determined by ANOVA/Newman-Keuls test, or 
by an unpaired Student’s t-test when two means were compared. 
 
Results 
 
General characteristics of all rats from which vessels were removed and studied 
are reported in Table 1.  Age, body weight, and mean arterial pressure were significantly 
greater in juvenile rats than in weanling rats.  Table 1 also summarizes the general 
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characteristics of all vessels studied, measured at equilibration pressures of 61 ± 1 mmHg 
for weanling arterioles and 77 ± 2 mmHg for juvenile arterioles (80% of mean arterial 
pressure, which approximates steady-state in vivo pressures for these vessels).  Resting 
and passive diameters of arterioles from juvenile rats were significantly greater than those 
of arterioles from weanling rats, but at these “in vivo” equilibration pressures, resting 
vascular tone was significantly less in the juvenile arterioles than weanling arterioles. 
 Arterioles from both age groups exhibited clear myogenic activity, as judged by a 
constriction to increases in intralumenal pressure above 80 mmHg in juvenile arterioles 
and maintenance of a constant diameter at intralumenal pressures above 80 mmHg in 
weanling arterioles (Figure 1).  Calculated myogenic indices were similar for weanling 
and juvenile arterioles at pressures between 40 and 80 mmHg, but significantly more 
negative for juvenile arterioles at pressures of 100 and 120 mmHg, indicating a greater 
myogenic responsiveness (Figure 2, top panel).  When intralumenal pressures were 
normalized to each age group’s estimated in vivo arteriolar pressure, the difference in 
myogenic responsiveness between weanling and juvenile arterioles was even more 
profound, especially at pressures closest to their respective in vivo values (Figure 2, 
bottom panel).      
As shown in Figure 3 (left panels), endothelial denudation significantly reduced 
the steady-state diameter of juvenile arterioles at pressures of 60 and 80 mmHg, whereas 
denudation shifted the myogenic indices of these vessels to less negative values 
(indicating reduced myogenic responsiveness) between 80 and 120 mmHg.  In contrast, 
endothelial denudation only had a significant effect on the steady-state diameter of 
weanling arterioles at 140 mmHg (a slight increase), and had no consistent effect on the 
myogenic index of these vessels (Figure 3, right panels). 
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Whereas the PGH2/TXA2 receptor antagonist SQ-29548 did not change the 
steady-state diameter of juvenile arterioles at any pressure, it had an effect on the 
myogenic index of these vessels that was similar to that of endothelial removal: a shift to 
less negative values at pressures between 80 and 120 mmHg (Figure 4, left panels).  In 
contrast, SQ-29548 tended to increase the steady state diameter of weanling arterioles (a 
significant effect at 40, 60 and 140 mmHg), but had no significant effect on the myogenic 
index for these vessels at any pressure (Figure 4, right panels).     
The HO inhibitor CrMP had no effect on steady state diameters or the myogenic 
indices for either juvenile or weanling arterioles (Figure 5). 
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Table 1: General characteristics of all rats and vessels used in this study  
 
 
Animal Characteristics Weanlings Juveniles 
N 39 29 
   Age (days) 26.6 ± 0.3 42.4 ± 0.4 * 
   Body Weight (g) 62 ± 1 173 ± 3 * 
   MAP (mmHg) 77 ± 2 96 ± 2 * 
   Vessel Characteristics (at lumenal pressure = 0.8 x MAP) 
n 39 29 
   Resting Diameter (µm) 34 ± 1 60 ± 3 * 
   Passive Diameter (µm) 56 ± 2 88 ± 2 * 
   Resting Vascular Tone (%) 38 ± 2 31 ± 3 *  
 
MAP = mean arterial pressure. Values are given as means ± SE.  * p<0.05 vs. Weanling 
group. 
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Figure 1: Active and passive diameters as a function of intralumenal pressure in juvenile 
and weanling gracilis muscle arterioles 
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Figure 2: Calculated myogenic indices of juvenile and weanling arterioles as a function 
of absolute intralumenal pressure and as a function of intralumenal pressure normalized 
to the estimated in vivo arteriolar pressure for that age group.  
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Figure 3: Effect of endothelial removal on steady-state diameters and myogenic indices 
over entire pressure range for juvenile and weanling arterioles 
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Figure 4: Effect of SQ 29548 treatment on steady-state diameter and myogenic indices 
over entire pressure range for juvenile and weanling arterioles 
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Figure 5: Steady-state diameters and myogenic indices over entire pressure range before 
and after treatment with the heme oxygenase inhibitor chromium (III) mesoporphyrin IX 
chloride (CrMP) for juvenile and weanling arterioles.  
 
Juvenile Arterioles (n=8) Weanling Arterioles (n=8)
Intralumenal Pressure (mmHg)
20 40 60 80 100 120 140 160
Ve
ss
el
 D
ia
m
et
er
 ( μ
m
)
20
25
30
35
40
45
50
55 Control
CrMP
Intralumenal Pressure (mmHg)
20 40 60 80 100 120 140 160
Ve
ss
el
 D
ia
m
et
er
 ( μ
m
)
20
25
30
35
40
45
50
55 Control
CrMP
Intralumenal Pressure (mmHg)
20 40 60 80 100 120 140 160
M
yo
ge
ni
c 
In
de
x
-1.0
-0.5
0.0
0.5
1.0
Intralumenal Pressure (mmHg)
20 40 60 80 100 120 140 160
M
yo
ge
ni
c 
In
de
x
-1.0
-0.5
0.0
0.5
1.0
In-vivo
pressure
In-vivo
pressure
 
 
n = number of vessels.
  176
Discussion 
 
The myogenic mechanism assists in the establishment of basal vascular tone, as 
well as in the autoregulation of blood flow and capillary hydrostatic pressure (Davis & 
Hill, 1999).  During rapid postnatal growth, autoregulatory mechanisms may play a 
crucial role in maintaining sufficient blood flow to growing tissues.  Investigators have 
found that myogenic responses of mesenteric arteries from 1-day old piglets are 
significantly greater than those from 10-day old piglets (Su et al., 2003).  Furthermore, 
the spontaneous tone developed by pressurized cerebral arteries from newborn mice is 
greater than that developed by those from 6-8 week-old mice over a range of 
intravascular pressures (Geary et al., 2003).  Consistent with these findings, we recently 
found that gracilis muscle arterioles isolated from weanling rats develop a significantly 
higher level of resting tone than those isolated from juvenile rats when equilibrated at 
their respective in vivo pressures (Balch Samora et al., 2007a).  Therefore, we undertook 
the current study to more vigorously test the hypothesis that arteriolar smooth muscle 
responsiveness to myogenic stimuli is greater in the younger rats.  As in our earlier study, 
we found a higher level of spontaneous tone in weanling arterioles than in juvenile 
arterioles (Table 1).  However, our calculations of myogenic index suggest that if 
anything, weanling arterioles have a smaller myogenic gain than juvenile arterioles when 
studied at their respective in vivo pressures, and also at pressures of 120 and 140 mmHg 
(Figure 2).  
 Because growth-related changes in arteriolar endothelial function have been 
reported by our laboratory and others (Linderman & Boegehold, 1999; Willis & Leffler, 
1999; Nurkiewicz & Boegehold, 2004; Balch Samora et al., 2007a), and because factors 
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released from the vascular endothelium can modulate smooth muscle myogenic tone (Hill 
et al., 1990; Kuo et al., 1991; Ekelund et al., 1992; Sun et al., 1995; de Wit et al., 1998; 
Geary et al., 2003), we examined the effects of endothelial denudation on the relationship 
between pressure and arteriolar diameter in both age groups.  In juvenile arterioles, 
removal of the endothelium reduced steady-state diameters at pressures of 60 and 80 
mmHg (Figure 3, top left panel), but this enhanced basal tone is apparently not myogenic 
in origin.  This conclusion is based on our finding that after endothelial removal, the 
myogenic gain of these vessels is significantly reduced (i.e., a less negative myogenic 
index) at pressures from 80-120 mmHg (Figure 3, bottom left panel).  This is not 
consistent with a previous report that endothelial removal has no effect on the myogenic 
index of gracilis muscle arterioles isolated from Wistar rats of the same age as our current 
juvenile group (Sun et al., 1994).  This may reflect differences in the strain of animal, 
such that even the same vessel under study may respond differently to changes in 
pressure.  Supporting this theory is the finding of a consistent myogenic index from 60-
120 mmHg in endothelial-intact 1st order arterioles in Sun’s study, such that there is no 
change in slope, whereas in our study, from 40-100 mmHg, the myogenic index becomes 
progressively more negative, with a steep negative slope.  However, it is also possible 
that the endothelium in the Wistar arterioles may contribute to myogenic activity, such 
that endothelium-derived vasoactive factors are released upon changes in pressure.  
However, when the vessels are denuded, all endothelium-derived substances (both 
constrictor and dilator factors) are removed, resulting in an overall consistent myogenic 
response that reflects only the smooth muscle contribution.  This possibility was not 
tested in that study.  Finally, this discrepancy may also be explained by differences in 
method of endothelial denudation, as Sun’s group injected air into the lumen, whereas we 
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mechanically abraded the internal lumen.  However, this explanation is less likely given 
the abolished response to ACh after denudation in the Wistar vessels.  The reduction in 
the myogenic gain that we found after endothelial removal suggests that in the juvenile 
arterioles we studied, an endothelium-derived constrictor factor normally augments 
myogenic activity over a wide range of pressures.  Application of SQ-29548 altered the 
myogenic index of juvenile arterioles in a manner similar to that seen with endothelial 
removal, i.e., a less negative index at pressures from 80-120 mmHg (Figure 4, bottom left 
panel).  This finding is consistent with the possibility that PGH2 or TXA2 is the 
endothelial factor responsible for reinforcing the myogenic activity of these vessels.  
Other investigators have found a similar role for endothelium-derived constrictor 
prostanoids, but more typically in hypertensive rats (Huang & Koller, 1997; Ungvari & 
Koller, 2000).  Ungvari and Koller (2000) determined that endothelium-derived 
endothelin and PGH2/TxA2 enhance arteriolar myogenic reactivity in hypertensive 
animals by increasing Ca2+ sensitivity of the vascular smooth muscle. 
In contrast to our finding in juvenile arterioles, endothelial removal had no 
significant effect on the steady-state diameter of weanling arterioles, except for a modest 
dilation at 140 mmHg (Figure 3, top right panel), which is clearly above the physiological 
pressure range for these animals.  Endothelial removal also had no consistent effect on 
the myogenic index of these vessels (Figure 3, bottom right panel).  These observations 
suggest that an endothelial influence on the tone of weanling arterioles (myogenic or 
otherwise) arises in skeletal muscle sometime between 4 and 6 weeks of age.  However, 
it is important to keep in mind that the arterioles in the present study were not being 
perfused, and therefore were not exposed to endothelial shear stress.  In vivo, the release 
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(and therefore the influence) of endothelial dilator or constrictor factors at either age may 
be different than in the current situation. 
TXA2, a metabolite of PGH2, is one of the most potent smooth muscle-contracting 
substances (Hamberg et al., 1975).  PGH2/TXA2 receptor antagonism tended to increase 
the steady-state diameter of weanling arterioles (Figure 4, top right panel), suggesting 
that basally-released PGH2 or TXA2 contributes to the tone of these vessels.  However, 
this is apparently not through an effect on myogenic activity, since the myogenic index is 
unaltered by SQ-29548 (Figure 4, bottom right panel).  In light of our finding that 
endothelial removal had no effect on the steady-state diameter of weanling arterioles, any 
PGH2 or TXA2 that influences the tone of these vessels must be of smooth muscle origin 
(Peredo & Enero, 1993; Cseko et al., 2004). 
Because we recently found a role for endogenous CO in mediating endothelium-
dependent dilations in weanling and juvenile gracilis muscle arterioles, with exogenous CO 
at higher concentrations causing endothelium-independent constriction (unpublished 
observations), we reasoned that CO may also be playing a role in modulating  myogenic 
reactivity.  Based on their use of CrMP, Zhang et al (Zhang et al., 2001) concluded that 
isolated gracilis muscle arterioles are capable of generating CO, and that this CO modulates 
myogenic vasoconstriction.  However, in the present study, treatment with CrMP had no 
significant effect on myogenic responses in either group (Figure 5).  Because the rats used in 
Zhang’s study weighed 250-300 g, whereas our weanlings and juveniles weighed 
approximately 60 g and 170 g, respectively, a modulating role for CO in these responses 
may not arise until after adolescence. 
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Conclusion 
These findings suggest that arteriolar growth during juvenile maturation is 
accompanied by an increase in myogenic responsiveness, possibly because endothelium-
derived PGH2 or TXA2 assumes a role in reinforcing myogenic activity over this period.  
The results of this study further support the idea that alterations in the mechanisms of 
vascular tone regulation occur with growth and maturation, and that these evolving 
patterns may have significant implications for the regulation of tissue perfusion during 
microvascular development. 
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 VI.  GENERAL DISCUSSION 
 
 
The primary objective of this dissertation project was to determine how 
microvascular function (specifically, the regulation of arteriolar tone) changes with 
postnatal growth and development.  We found that endothelium-dependent arteriolar 
dilation in juvenile rats appears to be mediated by the combined release of endothelial 
NO, vasodilator prostanoids, H2O2, and CO.  CO was the only observed mediator of 
endothelium-dependent dilation in vessels from weanling rats, although there must be 
other unidentified mediators, as HO inhibition only blunted endothelium-dependent 
responses.  We also found that vessel growth is accompanied by an increase in overall 
arteriolar myogenic responsiveness, most likely due to increase in the contribution of 
PGH2/TXA2 to arteriolar myogenic behavior. 
There are some practical implications of our studies.  We were able to more 
thoroughly determine some of the changing mechanisms of vascular function during 
postnatal growth and maturation.  A thorough understanding of the normal changes in 
endothelial/ smooth muscle signaling pathways and vascular mechanics during postnatal 
growth may lead to a better understanding of the pathophysiological changes that can 
also occur over this time in some disease states.    
The public health implications of these studies are important given rapidly 
increasing rates of hypertension, diabetes, and dyslipidemia among children and 
adolescents in the United States (Wyatt et al., 2006).  The vascular dysfunction 
associated with some cardiovascular diseases has been found to develop well before 
adulthood (Bohlen & Lobach, 1978; Zweifach et al., 1981; Prewitt et al., 1982; Bohlen, 
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 1987; Kunert et al., 2001), so that changes linked to the pathological process become 
superimposed on the changes in vascular function that normally occur with juvenile 
growth.  Increased rates of cardiovascular disease result in bleak medical, social, and 
economic consequences and can even shorten the longevity of Americans (Wyatt et al., 
2006).  Therefore, to more clearly elucidate the mechanisms of progressive vascular 
dysfunction under such circumstances, it is necessary to gain a deeper understanding of 
those changes in vascular function that accompany normal growth, which we have begun 
to achieve with these studies.  A clearer understanding of how the endothelium and 
smooth muscle work together to translate biochemical signals into vascular responses 
during blood vessel growth may ultimately lead to the identification of new therapeutic 
targets for the endothelial dysfunction associated with cardiovascular diseases that can 
begin to develop well before adulthood.  
There are several limitations of our studies.  First and foremost, we were unable to 
uncover the reasons for these mechanistic changes during postnatal growth.  There are 
multiple changes which occur during development which may contribute to such vascular 
modifications.  The mechanisms responsible for controlling arteriolar resistance and 
blood flow are not fixed at birth, but instead undergo marked changes during 
microvascular growth.  Although there is a progressive increase in microvascular 
pressure and volume flow during arteriolar network growth in skeletal muscle (Zweifach 
et al., 1981; Wang & Prewitt, 1991; Linderman & Boegehold, 1998, 1999), flow-related 
shear stress actually decreases due to a proportionately greater increase in arteriolar 
diameters than in blood flow velocity (Linderman & Boegehold, 1998, 1999).   
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 Not only are arteriolar, capillary and venular networks rapidly growing (Sarelius 
et al., 1981; Unthank & Bohlen, 1988; Wang & Prewitt, 1991; Linderman & Boegehold, 
1996), and microvascular wall mass increasing during this time (Bohlen & Lobach, 1978; 
Wang & Prewitt, 1991), but anatomical modifications such as increases in fiber cross-
sectional area of muscles (Enesco & Puddy, 1964; Sillau & Banchero, 1977; Ripoll et al., 
1979; Aquin et al., 1980), and increases in length, diameter and wall mass of arterioles 
(Wang & Prewitt, 1991) are also taking place.  Other changes include a decline in 
capillary density (Sillau & Banchero, 1977; Ripoll et al., 1979; Sarelius et al., 1981), and 
modifications in local endothelial cell environment and function over time (Risau, 1995; 
Garlanda & Dejana, 1997). 
Another limitation is that the majority of our studies were conducted on vessels 
isolated from Sprague Dawley rats.  Although in vitro studies allow investigators to 
control multiple varibles and explore potential physiological pathways and mechanisms 
of action, they are generally oversimplifications of the in vivo environment.  All 
parenchymal and neural influences as well as humoral and endocrine effects are 
eliminated, which does not accurately reflect the in vivo milieu; these changes essentially 
remove the manifold subtle interactions that occur within the live animal. 
 
Potential Role of Androgens 
 
There are several reports in the literature suggesting that androgens can affect 
vascular reactivity, although there are not consistent findings (Barrett-Connor, 1995; 
Alexandersen et al., 1996; Plut et al., 2002).  Whereas observational studies have 
demonstrated an inverse relationship between endogenous testosterone levels and adverse 
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 cardiovascular events (Barrett-Connor, 1995; Alexandersen et al., 1996), androgen 
deficiency is associated with increased flow-mediated dilation of the brachial artery when 
compared with age-matched controls (Zitzmann et al., 2002).  In fact, vascular reactivity 
in the brachial artery is improved when older men with advanced prostate cancer are 
castrated when compared with age-matched and cancer controls (Herman et al., 1997).   
In one set of experiments, we explored the possibility that some of the observed 
mechanistic changes during arteriolar growth might have been initiated by alterations in 
androgen concentration.  Sprague-Dawley rats undergo puberty around postnatal day 50 
(Baker et al., 1979; Sharp & La Regina, 1998; Krinke, 2000), and reach sexual maturity 
at ~90 days (Ariyaratne & Chamindrani Mendis-Handagama, 2000).  The number of 
androgen receptors in rat Sertoli cells markedly increases from postnatal days 10-20 to 
35-60, and descent of the testes occurs around days 30-60 (Krinke, 2000).  At ages 28 
days and beyond, hypertrophy and hyperplasia of adult Leydig cells occurs, resulting in 
increases in testosterone production per testis in vitro (Ariyaratne & Chamindrani 
Mendis-Handagama, 2000).  Actually, adult Leydig cells begin to secrete significant 
amounts of testosterone only after Day 35.  Serum FSH levels, measured by 
radioimmunoassays in male Sprague-Dawley rats, peak between days 30 and 45.  A rise 
in LH as well as testosterone occurs from days 30 to sexual maturity (Lee et al., 1975).   
Given these extensive hormonal changes that are transpiring from the weanling 
(~22 days of age) to juvenile (~46 days) animal, it was imperative to test the hypothesis 
that androgens may be responsible for bringing about the vascular modifications.  This 
was accomplished by castrating one group of rats at age 22 days.  Briefly, aseptic 
technique, involving sterile instruments and gloves, and a surgeon's gown and mask, was 
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 used to perform either orchidectomy or sham surgeries on weanling rats.  Rats were given 
carprofen SQ immediately after anesthesia induction with isoflurane gas.  At 46 days, the 
juvenile animals were sacrificed after removal of gracilis muscle arterioles for in vitro 
measurements.  Arterioles from both groups were challenged with ACh and simvastatin 
alone, followed by treatment with either L-NAME, to inhibit NOS, indomethacin, to 
inhibit cyclooxygenase, or combined NOS/COX inhibition.   
Much to our surprise, we found no difference in vascular reactivity between the 
sham and castrated animals, suggesting that the striking hormonal changes that occur 
during this time frame are not responsible for the age-linked changes in vascular 
responses, at least with respect to the contribution of NO and prostanoids to endothelium-
dependent dilation. 
 
Timeframe of Mechanistic Changes 
 
 Throughout all of our studies, we have observed that these functional 
transformations in endothelium-dependent dilation occur within a window of 
approximately 3 weeks, between ~22 days of age (weanling animals) and ~46 days 
(juvenile animals).  In order to more closely pinpoint the period of change, we performed 
experiments on arterioles from ~35 day old animals.  Briefly, challenge with ACh and 
simvastatin in the presence of L-NAME, indomethacin, or the combined treatment of L-
NAME + indomethacin elicited the same response in vessels from the 35 day old animals 
as those from 46 day old animals, suggesting that the period of mechanistic change in the 
contribution of NO and dilator prostanoids to endothelium-dependent dilation may be as 
narrow as 13 days. 
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In Vivo Studies 
 
Because vascular tone, blood flow, endothelial function, and tissue metabolism 
are all interrelated, it is essential to investigate changes during postnatal growth with an 
in vivo approach to better understand the functional consequences of these changes.  
Using isolated vessels, we previously found age-related differences in myogenic 
responses and in the endothelial influence on arteriolar tone.  In addition to metabolic 
stimuli, changes in the release of endothelium-derived factors and myogenic tone are 
thought to contribute to reactive hyperemia (Wolin et al., 1990; O’Leary et al., 1994; 
Gryglewski et al., 1995; Meredith et al., 1996; Koller & Bagi, 2002; Koller & Bagi, 
2004; Toth et al., 2007).  Reactive or postischemic hyperemia, also referred to as flow- or 
shear-induced dilation, is defined as the transient increase in organ blood flow that 
follows a brief period of occlusion and represents an integrated and multifactorial 
perfusion response.  Because the ability to match blood flow to metabolic demand is 
essential during growth, it is important to assess differences in flow-mediated responses 
as animals mature.  
To measure vascular responses after brief (30 s) and longer (3 minute) occlusions 
in weanling and juvenile rats, we isolated and cleaned the left external iliac artery 
immediately proximal to the origin of the femoral artery.  A loose suture was placed 
around the proximal end of the iliac artery, and a microcirculation blood flow probe (0.7 
PSB, Transonic, Ithaca, NY) was placed around the artery distal to the suture to monitor 
hindlimb perfusion during the experimental procedures.  Vascular occlusion was 
accomplished by elevating the suture until blood flow was eliminated, as observed by the 
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 flow probe reading.  Lowering the suture restored perfusion through the artery.  The 
subsequent hyperemic response was monitored, with time-to-peak recorded for each 
group, and blood flow normalized to hind limb weight for each animal. 
Resting blood flow, normalized to tissue mass, in juvenile rats was less than in 
weanling rats (see Figure 1 below).  This agrees with findings in male hamster cremaster 
muscle, where significant decreases in resting erythrocyte velocity and estimated blood 
flow were observed to occur with postnatal growth (Sarelius, et al., 1981; Berg & 
Sarelius, 1996).  Similarly, in rat spinotrapezius muscle, there is a 25% volume flow 
increase from weanling to juvenile rats, but a decrease in blood flow per gram of tissue 
(Linderman & Boegehold, 1999).  This finding suggests that tissue metabolic demand or 
skeletal muscle oxidative metabolism may decrease during growth.  In fact, a decrease in 
oxidative capacity has been shown to occur during development in chickens (Hudlicka et 
al., 1973; Hudlicka, 1985), rabbits and kittens (Cotter, 1975), and mice (De Luise & 
Harker, 1989). 
Normalized peak flow after release of the 30 s occlusion was greater in juvenile 
rats than weanling rats with these values representing a 404 ± 10% increase above control 
flow in juvenile rats vs. a 164 ± 12% increase above control flow in weanling rats.  In 
contrast, peak flows recorded after 3 m occlusions were not different between age groups 
(Figure 1).  The amplitude and duration of reactive hyperemia in skeletal muscle are 
determined in part by the length of the ischemic period (Gentry & Johnson, 1972; 
Messina et al., 1977; Bjornberg et al., 1990; Koller & Kaley, 1990b; Toth et al., 2007).  
The dilation that occurs post-occlusion has traditionally been considered to occur either 
by myogenic or metabolic mechanisms, or by a combination of the two in a synergistic 
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 fashion (Shepherd, 1964).  It has been suggested that myogenic regulatory mechanisms 
dominate during brief occlusions (up to 30 seconds), but metabolic influences mediate 
hyperemic responses after longer occlusions (Johnson et al., 1976; Bjornberg et al., 1990; 
Koller & Kaley, 1990b; Toth et al., 2007).  If shorter occlusions do trigger myogenic 
mechanisms rather than metabolic influences, the finding of a greater than two-fold 
increase over basal flow in the juvenile vessels compared with the weanling vessels after 
a 30 s occlusion suggests that as animals mature, myogenic responses are enhanced.  
However, in Study 4, we found that calculated myogenic indices were similar for 
weanling and juvenile arterioles at pressures between 40 and 80 mmHg.  Nonetheless, we 
also determined that the myogenic indices were significantly more negative for juvenile 
arterioles at pressures of 100 and 120 mmHg, indicating a greater myogenic 
responsiveness at these higher pressures.  While the myogenic relaxation is induced by 
decreased stretch, there are various metabolic mechanisms, such as decreases in O2, or an 
accumulation of CO2, H+ ion, and other metabolites that may mediate postischemic 
hyperemia (Shepherd, 1964; Johnson et al., 1976; Lombard & Duling, 1981; Sherwood, 
2007; Toth et al., 2007).  Therefore, even though the response was similar in both groups 
after a 3 m occlusion, we cannot assert the presence of analogous metabolic influences 
throughout postnatal growth.   
There are few investigations which have focused on the possible modulation of 
hyperemic responses with growth and development.  Our findings differ from those 
observed in guinea pig coronary circulation, where postnatal growth is accompanied by a 
decrease in the peak hyperemic response following a 45-second occlusion (Toma et al., 
1985).  Measurements of cutaneous blood flow in premature newborn infants (postnatal 
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 age ranges from 0.3 to 72 days) after a one min occlusion indicate no influence of 
postconceptional age, postnatal age, weight, or transcutaneous O2 tension on reactive 
hyperemic responses (Beaufort-Krol et al., 1989).  These discrepancies may be due to 
vascular bed or interspecies variability, or to differences in duration of occlusion, which 
affect amplitude (Gentry & Johnson, 1972; Messina et al., 1977; Bjornberg et al., 1990; 
Koller & Kaley, 1990b).   
As also shown in Figure 1, the average time to reach the peak flow response also 
differed between groups, with weanling rats exhibiting a significantly slower response 
(an average time-to-peak that was more than twice that in the juvenile rats).  This is 
somewhat surprising, since it has been argued that younger animals may have a superior 
capability for regulation of skeletal muscle blood flow (Proctor et al., 1981).  There could 
be many reasons for this finding, all of which are speculative.  Because changes in tissue 
O2 affect reactive hyperemic responses (Lombard & Duling, 1981), it is important to 
have an idea of what, if any, the differences in O2 tension between groups might be.  The 
increase in tissue blood flow after occlusion is essentially a “repayment” of “flow-debt” 
(Zatta & Headrick, 2005).  Without having measured tissue O2 concentrations, it is 
difficult to determine how much metabolic “debt” each animal sustained.  Therefore, 
weanlings may not have needed as much functional recovery to return to metabolic 
balance.  In an earlier study, whereas resting tissue PO2 over a range of superfusate PO2 
values was found to be similar in 32, 60, and 80 day hamster cremaster muscle, in adult 
animals the tissue PO2 decreased significantly during muscle stimulation, but was 
relatively unchanged in the younger animals (Proctor et al., 1981).  These studies by 
Proctor and colleagues suggest that there may, in fact, be maturational changes in O2 
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 utilization and response, such that an age-associated decrease in tissue O2 consumption 
occurs. 
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 Figure 1: Hindlimb blood flow in juvenile and weanling rats 
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Top panel: Hindlimb blood flow in juvenile and weanling rats under resting conditions, 
and peak values reached after relase of 30 second and 3 minute occlusions of the left 
external iliac artery.  Middle panel: Time to peak flow value after occlusion release in 
both age groups.  Bottom panel: % change in flow/time.  n = number of animals.  Values 
are given as means ± SE.  * p<0.05 vs. Control.  † p<0.05 vs. corresponding juvenile 
value. 
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 VII. CONCLUSION    
 
Because there are few studies that have investigated how postnatal growth affects 
microvascular function, we undertook these experiments, in part, to help fill a critical gap 
in the literature.  Specifically, we wanted to gain further insight into growth-related 
changes in the control of skeletal muscle arterioles.   
We found that at any given time, the tone of skeletal muscle arterioles does not 
reflect a single mechanism, but rather an integrated effect of multiple mechanisms that, to 
some extent, may compensate for one another should one pathway become compromised.  
During early microvascular growth, endothelium-dependent dilation appears to rely on 
CO, but not prostanoids, NO, H2O2, cytochrome P-450 metabolites, or any other EDHF.  
As animals mature, more vascular reliance on NO, dilator prostanoids, H2O2 and K+ 
channels occurs.  Arteriolar growth during juvenile maturation is also accompanied by an 
increase in myogenic responsiveness, possibly because endothelium-derived PGH2 or 
TXA2 assumes a role in reinforcing myogenic activity over this period.  In vivo 
experiments demonstrated that although significant decreases in resting blood flow occur 
with growth, peak flow after release of short occlusions is significantly enhanced with 
growth and development.   
Further investigation is needed in order to determine the extent to which changes 
in the control of skeletal muscle arterioles occurs with growth and maturation.  A clearer 
understanding of how the endothelium and smooth muscle work together to translate 
biochemical signals into vascular responses during blood vessel growth may ultimately 
 196
 lead to the identification of new therapeutic targets for the endothelial dysfunction 
associated with cardiovascular diseases that can begin to develop well before adulthood.   
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 IX. Techniques/programs/software training during PhD 
experience 
 
AcqKnowledge Software 
DataTrax 
EndNote X 
Kodak 1D 3.6 
Metamorph 6.01  
Microsoft Office Suite 
Optimus 6.2 
Sigma Stat 3.0 
Sigma Plot 9.0 
Catheterization of the carotid artery and jugular vein 
Isolated Vessel System 
Cell Culture (human alveolar cell line A549; rat alveolar macrophages) 
Olympus IX70 inverted microscope (with Dage CCD-72S monochrome camera) to  
determine % cellular confluence  
Pressure-flow BET instrument to determine surface area of particles 
JEOL 6400 Scanning Electron Microscope to determine particulate diameter  
Intratracheal instillation  
Bronchoalveolar lavage (BAL) 
Spinotrapezius preparation (for in vivo microscopy) 
Iontophoresis 
Intraluminal Injection 
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 Myobath vessel system 
Western Blot 
Skin-fold test 
Catheterization of the femoral artery and vein 
Hind limb preparation (isolation of soleus, gastrocnemius, and plantaris) for force  
transduction analysis after electrical stimulation and vascular flow and resistance 
measurements (femoral artery)  
Recovery surgery (sterile technique) 
Orchidectomy 
Venous and Arterial anastomosis 
End-to-end and end-to-side technique 
Right-side-up technique 
Vein grafting 
Renal transplants 
Proficiency obtained with fine forceps, needle holders, vannas, vascular clamps, clamp 
applicators, and vessel dilators 
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1996  National Society of Collegiate Scholars, recipient of Merit Award 
1996-1997 Lambda Sigma Honor Society 
1995-1996 Horizons and Emerging Leaders programs at Carnegie Mellon 
1995-1999 Dean’s List eight consecutive semesters 
1995-1999 Carnegie Mellon Music Scholarship 
1995-1999 Andrew Carnegie Scholarship 
 
Work Experience: 
 
2005  Public Administration Internship at Morgantown Pulmonary Associates, a  
physician- owned and operated private corporation that focuses on 
respiratory illnesses.  Posted insurance payments, completed and mailed 
insurance forms, aided with billing and collections, attempted to resolve 
outstanding insurance claims, helped with coding of procedures and 
diagnoses, contacted insurance companies regarding patient accounts, re-
filed charts, copied medical records, served as interim medical 
transcriptionist, completed black lung and Department of Labor reports, 
typed staff meeting notes, generated Explanation of Benefits (EOBs) for 
secondary and tertiary claim submissions. 
2000-2001 Visiting Artist Program, Pomperaug High School; Southbury, CT 
1999-2000 Music Instructor, United Cerebral Palsy Association of Southern  
Connecticut; Waterford, CT 
1999-2000       Waitress, Chart House; New Haven, CT 
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1996-1997 Student Assistant, Graduate School of Industrial Administration, Carnegie  
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Mellon University 
 
Conferences: 
 
2007  AMA National Advocacy Conference (NAC); Washington, D.C.  Skills  
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 learned include networking, creative problem solving, leadership, 
effective delivery and communication 
 
2007  Federation of American Societies for Experimental Biology (FASEB);  
Washington, D.C. (abstract submission and poster presentation) 
 
2007  American Educational Research Association (AERA) Annual Meeting;  
Chicago, IL (paper presentation) 
 
2006  Paul Ambrose Political Leadership Institute, through the American  
Medical Student Association (AMSA); Washington, D.C.  Skills 
learned include political strategizing, researching, public speaking, 
media relations and lobbying 
 
2006  Southern Medical Association (SMA)- Southern Group on Educational  
Affairs (SGEA) Third Annual Conference on Graduate Medical 
Education; Galveston, TX (oral presentation with Dr. Scott 
Cottrell) 
 
2006  Creating a Network of West Virginia Women in Science and Healthcare;  
Morgantown, WV (panelist) 
 
2006  Federation of American Societies for Experimental Biology (FASEB); San  
Francisco, CA (abstract submission and poster presentation) 
 
2006  Women’s Health Policy Conference; Charleston, WV  
 
2005  39th Annual Meeting of the West Virginia Political Science Association in  
conjunction with the American Society of Public Administration; 
Charleston, WV (panelist and moderator) 
 
2004  19th Annual National MD/PhD Student Conference; Keystone, Colorado  
(abstract submission and poster presentation) 
 
2004  Continuing Education Program on Quality and Accessibility of Health  
Care: Past, Present and Future.  Part of the “100 Years: Health 
Professsions Education” at West Virginia University School of 
Medicine (panelist) 
 
2004  38th Annual Meeting of the West Virginia Political Science Association in  
conjunction with the American Society of Public Administration, 
West Virginia Wesleyan College; Buckhannon, WV 
 
2004  Intercultural Cancer Council (ICC) 9th Biennial Symposium on  
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 Minorities, the Medically Underserved & Cancer; Washington, 
D.C. 
 
2004  National Leadership Conference for Students in Healthcare; Washington,  
D.C. 
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1. Balch Samora J, Frisbee JC, Boegehold, MA. Mechanisms of microvascular control 
during juvenile growth. 8th World Congress for Microcirculation, 2007, Milwaukee, WI. 
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C. Peer-Reviewed Manuscripts 
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Current Research Interests: 
 
Endothelium-dependent regulation of microvascular tone with growth and maturation. 
Vascular smooth muscle control of blood flow during growth and maturation. 
Antimicrobial resistance and health policy. 
Methods to detect and eliminate iatrogenic injury. 
Frequency and consequences of suicide misclassification. 
Frequency and consequences of health disparities and methods to eliminate them. 
Women’s Health Issues. 
 
Teaching: 
 
Undergraduate 
 
“Mechanisms of Body Function” Physiology 441, 300 undergraduate and graduate allied  
health students, Topics: Cardiac & Renal Physiology; West Virginia University 
School of Medicine, 2006. 
 
“Elementary School Health Program” CHPR 301, 20 undergraduate students, Topics:  
Aspects of Personal Health; West Virginia University School of Medicine, 2007. 
 
“Health of the Individual” CHPR 170, 40 undergraduate students, Topics: Mental Health,  
Reproductive Issues, DSM IV Paraphilias; WVU School of Medicine, 2007 and 2006. 
 
Adjunct Professor, “History of Jazz,” Class sizes roughly 20-30; Housatonic Community  
College; Bridgeport, CT, Fall 2000 & Spring 2001. 
 
Bassoon Instructor for undergraduate students; Yale University New Haven, CT, 2000- 
2001. 
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 Graduate/Medical 
 
“Medical Pharmacology” PCOL 761, Small group facilitator; West Virginia University  
School of Medicine, 2007 
 
“Issues in Men’s Health” PUBH 619, 20 graduate students, Topics: Cardiovascular  
Disease, Diseases specific to men; West Virginia University School of Medicine, 
2007. 
 
“Issues in Women’s Health” PUBH 621, 20 graduate students, Topics: Reproductive  
Issues; West Virginia University School of Medicine, 2007. 
 
“Occupational Toxicology” PCOL 562, 15 graduate students, Topic: Developmental and  
Reproductive Toxicology; West Virginia University School of Medicine, 2006 
and 2005. 
 
“Human Form and Function” CCMD 730: Small group facilitator, Topic: Physiology;  
  West Virginia University School of Medicine, 2005 and 2003. 
 
Teaching Assistant for four graduate level courses at Yale University: “Hearing &  
Theory,” “Music History Survey,” “American Music History,” “Modern Jazz:  
Bebop and Beyond” New Haven, CT, 2000-2001. 
 
Seminars 
 
Arteriolar function with growth and maturation: new insights. West Virginia University, 
Department of Physiology and Pharmacology, January, 2007. 
 
Growth dependent changes in the endothelial factors regulating arteriolar tone. West 
Virginia University, Department of Physiology and Pharmacology, December, 2005. 
 
High dietary salt and endothelial dysfunction: the role of tetrahydrobiopterin, eNOS, and 
superoxide. West Virginia University, Department of Physiology and Pharmacology, 
December, 2004. 
 
Other 
Music Affiliations: 
 
Summer, 2001  Schleswig-Holstein Musik Festival, Germany 
2000-2001  New World Symphony Orchestra, substitute; Miami, FL 
2000-2001  Performed with Orchestra New England, New Britain Symphony,  
Sienna Orchestra of Waterbury  
2001-2002  Invited as Principal Bassoon of the Daejeon Philharmonic  
    Orchestra in Korea (declined) 
1999-2000  Principal Bassoonist, Yale Philharmonic Orchestra 
1999-2000  Principal Bassoonist, Yale Opera Orchestra 
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 Summer, 2000  Music Academy of the West; Santa Barbara, CA 
2000 & 1999  Sarasota Music Festival; Sarasota, FL 
1996-2000  Jeunesses Musicales World Orchestra: Germany and Austria  
(Winter, 1999-2000);  Poland, Germany, Canada, Switzerland, and 
the U.S. (Summer, 1999); Germany (Winter, 1998-99); Taiwan, 
Japan, Korea, and the Philippines (Summer, 1998); Germany and 
Poland (Winter 1996-97); Switzerland and Holland (Summer, 
1996) 
1995-1999  Principal Bassoonist, Carnegie Mellon Philharmonic Orchestra 
1998 & 1996  Principal Bassoonist, Carnegie Mellon Opera Orchestra 
1995-1996  Principal Bassoonist, Pittsburgh Youth Symphony Orchestra 
1995   Principal Bassoonist, World Youth Symphony Orchestra;  
Interlochen, MI 
 
Travel: 
 
Fifty U.S. States, Argentina, Aruba, Australia, Austria, Bahamas, Barbados, Belgium, 
Belize, Brazil, Cambodia, Canada, China, Costa Rica, Curaçao, Czech Republic, 
Denmark, Dominican Republic, Egypt, England, Estonia, Finland, France, French 
Polynesia, Germany, Greece, Grenada, Holland, Honduras, Hong Kong, Indonesia, 
Ireland, Israel, Italy, Jamaica, Japan, Korea, Luxembourg, Macau, Malaysia, Martinique, 
Mexico, Norway, Panama, Paraguay, the Philippines, Poland, Puerto Rico, Russia, 
Scotland, Singapore, South Africa, Spain, St. Lucia, Sweden, Swaziland, Switzerland, 
Taiwan, Thailand, Turkey, Uruguay, Venezuela. 
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